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Preface 
Although defective heart valves are routinely replaced by either tissue or mechanical 
substitutes, neither alternative valve type is completely satisfactory. Tissue valves are 
subject to calcification and lipid deposition, while mechanical prostheses tend to cause 
thrombosis and hence require long-term anticoagulation therapy, which has undesirable 
side-effects. The thrombogenicity of mechanical heart valves, in particular, provided 
the motivation behind the work presented here. 
Thrombogenicity of prostheses is currently assessed by collation of experimental results 
from animal trials. This technique has several drawbacks, such as its great expense and 
the uncertainties due to species-related differences of blood. The use of blood in vitro, 
as an alternative way to assess thrombogenicity, is neither practical nor convenient; 
blood is valuable and relatively scarce, and it often behaves differently in vivo than 
in vitro. An alternative to blood for use in thrombogenicity trials in vitro is therefore 
desirable. Such a blood substitute could be used to investigate the influence of the flow 
characteristics of valves on their clotting propensities. The work reported here was 
accordingly intended to clarify the relationship between deposition tendency and flow 
conditions (as distinct from surface chemistry), by use of a blood analogue fluid. 
A milk preparation has been shown by several previous workers to have potential as 
a coagulable analogue fluid for the study of flow related thrombosis in vitro. Lewis 
found that a flowing milk mixture deposited clot in vitro in the neighbourhood of 
certain hydrodynamic disturbances particularly associated with thrombus formation in 
a similar flow of blood, and that the milk and blood deposits were similar in physical 
structure, both on a microscopic and gross scale. Christy used bodies of revolution 
in pulsed and steady milk mixture flows, in an attempt to identify the hydrodynamic 
causes of blood clotting in determinate and simple flow situations. The varying extent 
of deposition on the downstream-side of test-bodies of different shapes indicated stasis 
and some aspect of agitation in the vicinity of a surface as the concomitant conditions 
necessary for clot to occur on that surface. 
xvii 
The principal aim of the research reported here was to develop Christy's milk 
coagulation experiments further, by obtaining more information about deposit growth 
and hence to shed light, by inference, on mechanisms of flow-related thrombus 
formation. To this end, milk experiment reproducibility was improved, ways to 
eliminate bubble and wall clot formation were attempted, and the feasibility of 
ultrasonic imaging as a means for continuously measuring the thickness of deposited 
clot was assessed and subsequently employed. 
The use of real-time ultrasonic imaging enabled wall clot deposition, and its influence on 
milk experiments, to be continuously monitored macroscopically. It may also provide 
a way for assessing various methods aimed at preventing wall clot formation. The 
prospective advantages of ultrasonic imaging were not fully realized by the arrangement 
adopted in these preliminary experiments, but it now appears that ultrasonic imaging 
could be of use for studying curd deposition on test-objects, with certain recommended 
modifications to the current arrangement. 
Chapter 1 
Introduction 
1.1 The heart 
The heart comprises two synchronous pulsatile pumps working side by side (figure 
1.1); the right side pumps deoxygenated blood to the lungs while the left side pumps 
oxygenated blood to the body. There are four separate chambers, two receiving 
chambers, the atria, and two pumping chambers, the ventricles. Each receiving 
chamber is connected to a pumping chamber by a non-return valve, the right atrium 
and right ventricle by the tricuspid valve, the left atrium and left ventricle by the mitral 
valve. The two pumping chambers are connected to their respective arteries by one-way 
valves also; the right ventricle to the pulmonary artery by the pulmonary valve, the 
left ventricle to the aorta by the aortic valve']. 
The blood is progressively deoxygenated as it circulates round the body. It then collects 
in the great veins, flows into the right atrium and through the tricuspid valve into the 








Figure 1.1: Simple representation of the heart and l ungs [1 1131. 
blood being expelled through the pulmonary valve into the pulmonary artery. Carbon 
dioxide and oxygen are transferred from and to this blood, respectively, as it flows 
through the lungs. The reoxygenated blood then flows through four pulmonary veins 
into the left atrium. During diastole, the filling phase of the cardiac cycle, the blood 
flows through the left atrium and the mitral valve and into the left ventricle. The 
left atrium then contracts, near the end of this filling phase, to eject blood into the 
left ventricle. When the diastolic cycle is complete, ventricular systole occurs; the left 
ventricle abruptly contracts, the mitral valve closes and blood is ejected through the 
aortic valve, passing through the aorta and arterial tree[][]. 
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1.2 Heart valve defects 
A normal adult heart on average beats about 40 million times a year without failure. 
At rest, the heart beats at a rate of approximately 70 beats/mm, with a cardiac output 
close to 5 1/mm, while during rigorous exercise, a normal heart may deliver up to 35 
litres of blood in one minute at a heart rate of 180 b eat s /min [2]. Given the numerous 
demands on heart valves, both natural and artificial ones, it is not surprising that they 
may sometimes become defective. 
In many cases, abnormalities of the heart valves cause trivial effects on the function 
of the heart and, provided certain precautions are taken, will not interfere with the 
person's life. Occasionally, however, the effects may be more severe so that an undue 
strain is placed on the muscle of the heart. In such cases it may be necessary to operate 
on, or even replace, one or more valves. The replacement of diseased heart valves is 
not a rare operation; 51,000 artificial cardiac valves were implanted in patients in 1988 
in the United States alone. 
The two most common haemodynamic defects which natural heart valves can develop 
are called stenosis (narrowing of the valve orifice when open) and incompetence 
(failure of the valve to close completely on flow reversal allowing a regurgitant jet 
of blood to flow past the valve) [1][5][6].  These defects tend to affect mitral, aortic, 
tricuspid or pulmonary valves, in that order of incidence 151 . This order may be 
partially attributable to the larger systolic pressures experienced in the left ventricle. 
Obstruction of flow and inefficiency due to leakage result in increased strain and demand 
on the heart, causing the heart muscle to thicken. In time the supply of blood to this 
muscle will become insufficient to meet its increased demand. Angina, followed by 
death, awaits the sufferer unless treated. 
There are many occasions when valve replacement is necessary. When the aortic valve 
is diseased severely enough to need surgery it always has to be replaced[]; repair is 
never possible. However, repair of other damaged valves is sometimes appropriate, but 
conditions have to be absolutely right (i.e. the valve must not be too badly damaged 
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by disease) for a successful outcome. For this reason, if there is any doubt about the 
valve continuing to function properly in the long term, it will be replaced by a new 
one. It is then that the patient faces the risk of unappealing complications associated 
with current artificial heart valves. 
1.3 Artificial cardiac valve requirements 
The criteria for an ideal artificial heart valve are numerous. The substitute valve must 
not only fulfil the function of the natural valve but must also be compatible with both 
the blood and surrounding tissue. The main requirements of such a valve have been 
proposed [8-11];  the prosthesis must: 
conform to the heart structure, the volume swept out by the occluder lying within 
the limits of the dimensions of the heart 
offer minimum resistance to forward flow; have the maximum possible orifice size 
when the valve is open, to avoid the need for excessive pressure to maintain the cardiac 
output 
allow minimal reverse flow; at the onset of reverse flow, the valve must close quickly 
and completely to prevent regurgitation 
have low inertia, to minimize the work required of the weakened cardiac muscle in 
opening and closing the valve 
be surgically possible to insert; have ease of implantation and tolerance by 
surrounding tissues after healing 
be sterile 
cause no blood trauma; when open the valve must have a high flow rate with no 




cost as little as possible. 
There are two categories of valve that can be used to replace a diseased heart valve: 
mechanical (man-made, mechanical valves) and biological (valves made from human or 
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specially treated animal tissue). Tissue valves currently in use are mainly heterografts, 
usually of porcine or bovine tissue, and some homografts. They mimic the cusp 
structure of the natural valves, performing as central flow valves. Mechanical valves, 
such as poppet, tilting-disc, and hinged-disc valves, have either peripheral or semi-
central flow. Photographs of a few currently used heart valves of both categories are 
shown in figure 1.2. There are many unresolved problems associated in different degrees 
with both types of artificial valves, such as red cell destruction, thromboembolism, 
congestive heart failure, cardiomyopathy, infection, material fatigue, leakage and 
tearing of sewing suture. 
1.4 The shortcomings of prosthetic heart valves 
Since the 1960s, when replacement of diseased aortic and mitral valves with prosthetic 
devices began on a widespread basis, improved prosthesis design and increasing 
operative experience have reduced the morbidity and mortality associated with valve 
replacement. Valve replacement is, however, still palliative and not curative. A 
prosthetic valve has still to be designed which provides the ideal performance of the 
natural, healthy heart valve. Although many types of prosthetic valves are currently 
available, the complications and natural histories are similar for most of them. It is 
possible that every model of cardiac valve implant ever marketed has suffered some 
mechanical failures resulting from thrombosis, degradation, or structural fractures. 
Haemolysis and thrombosis are of concern with all systems designed to support or 
replace organs of the circulatory system, and are the two major postoperative problems 
of prosthetic valve implantation. The high shear stresses associated with regurgitation 
or back flow can cause haemolysis (the breakdown of red cells) which, in turn, can lead 
to the necessary replacement of erythrocytes putting a strain on the kidneys and bone 
marrow. Haemolysis can also induce the release of clotting factors that enhance cell-
wall adhesion[12],  promoting thrombus formation. Thrombus deposition on the foreign 
surface of a blood-handling device, potentially the more severe problem of the two, can 
impair the device's function and has the potential to generate emboli, which can be 
fatal. 
6 
(b) 	 •u11. 
(d) 
Figure 1.2: (a) and (b) are biological trileaflet valves; (c) and 
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To quantify statistically the predicament of the recipients of heart valve prostheses, 
curves of survival rates are normally constructed. Due to numerous variables' these 
plots can only be considered as approximate guides to expected prosthesis performance. 
Lytle et aL' 1 produced extensive long-term results that indicate the success rates 
one may expect. They considered primary aortic valve replacement only, employing 
either bioprostheses (tissue valves) or mechanical valves in a large group of patients 
(figure 1.3). As commonly found with increasing post-operative years, the number 
of surviving substitute valve recipients gradually decreases and of these survivors the 
number encountering no complications dwindles. 
48.1% 
22.1% 
YEARS 	 2 	 4 	 6 	 8 	 10 	 12 	 14 
NUMBER - 1216 	 1115 	 837 	 586 	 366 	 202 	 61 
AT RISK ---- 1095 966 678 447 248 121 38 
Figure 1.3: Late survival and event-free survival for 1317 in-hospital survivors of 
isolated aortic valve replacement from 1972 to 1983[ 14]. 
Lytle et •[4]  investigated the effects of a few variables on survival rate of prosthesis 
recipients. Figure 1.4 indicates that the age of the recipient is relevant to the post-
operative survival rate, the younger recipients apparently having better success, though 
the success of the implant is strongly dependent on other factors' also. Differences were 
Among the many variables, apart from age, associated with survival of prosthesis recipients are 
preoperative NYHA (New York Heart Association) function classification, symptoms and heart disease 












1 Introduction 	 8 
also found in the early and late survival of patients, when grouped into the categories 
of mechanical and bioprostheses, with and without anticoagulation therapy (warfarin) 
(figure 1.5). Shortcomings were demonstrated by both types of valve. 
It is far less common for recipients of tissue valves to need anti-coagulants than 
for mechanical valve recipients. Without anticoagulation therapy, the number of 
patients with tissue valves that had event-free survival was much greater than that 
for mechanical valve recipients, who were found to have more strokes, myocardial 
infarctions, bleeding complications, and thromboembolic events. Figure 1.5 clearly 
indicates that the quality of mechanical valve performance drastically decreases with 
time, when anticoagulation therapy is not employed. 
2 4 8 8 10 
NUMBER 	 142 134 190 78 51 
AT usx 198 190 153 121 70 
348 325 282 182 123 
388 354 245 169 101 
142 112 72 38 15 
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20 
YEARS 	 2 4 8 3 10 
NUMBER 	--- - - 502 467 285 156 56 
AT RISK 	.......... 51 4 477 411 326 
SI so 63 37 17 
31 76 66 54 
Figure 1.5: Survival according to valve-anticoagulation status 11 . 
Most surgeons believe that failure to anticoagulate exposes the mechanical heart valve 
recipient to an unreasonable risk of clotting complications, and accordingly provide 
the patient with long-term anticoagulation th erapy (15]. However, this treatment is not 
trouble-free. The dose of anticoagulant has to be precise; inadequate anticoagulation 
could be fatal, as could excessive anticoagulation which can cause haemorrhaging and 
puts a strain on the liver and kidneys 16 . Therefore, blood tests have to be made at 
regular intervals to ensure that the dosage is correct, and the patient must avoid, or 
at least be cautious when taking, drugs (such as aspirin, antibiotics, and alcohol) that 
can alter the effect of anticoagulants. 
Whilst bioprostheses are less thrombogenic than mechanical heart valves, they too 
have shortcomings, such as deterioration and stiffening of leaflets, and are prone to 
complications requiring reoperation, more so as the number of post-operative years 
increases (figure 1.6)[]. Hence, only a small number of tissue-valve recipients are 
I Introduction 	 10 
reported as long-term successes. It is the opinion of most surgeons worldwide that 
implanted tissue valves are less durable after ten years and should be reserved for 
very elderly patients and for those patients considered inappropriate for the long-term 
anticoagulation therapy necessary for all mechanical heart valves[hh]. 
HAZARD ESTIMATE 
0.9 
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Figure 1.6: Hazard function curves for the first occurrence of reoperation and 
endocarditis (i.e. inflammation of the endocardium) according to prosthesis t ype [14]. 
1.5 Evaluation of prosthetic valve thrombogenicity 
Thrombosis in flowing blood around mechanical prostheses can arise from both the 
materials of construction of the valve and the local haemodynamics('l. Artificial 
materials (e.g. pyrolytic and vitreous carbon) commonly used for mechanical valve 
construction are intrinsically less thrombogenic than the valves made from them, so the 
flow characteristics of these valves appear to be the aspect requiring more consideration. 
While research has revealed that the flow fields created by today's mechanical valves are 
considerably different from those of natural valves, involving areas of high fluid velocity 
associated with turbulence and high shear rates, slow-moving separated regions and 
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stagnation point flows, the fluid mechanical correlates of thrombus formation are as 
yet not understood or even fully identified. Clotting may occur in vivo in regions of the 
flow field that are not considerably disturbed by the presence of the prosthesis, even 
when the implant is constructed of inert and relatively athrombogenic materials; also, 
regions of large fluid mechanical disruption may show no link with thrombus formation. 
It appears that the next step forward to developing a mechanical valve which can be 
successfully employed without anticoagulant therapy is to find a way to identify aspects 
of the flow through present-day valves that lead to thrombus formation and then remove 
these flow characteristics or minimize their effects in new valve designs. 
The progress of designing devices more efficacious than current artificial heart valves has 
been hindered by the absence of a reliable non-clinical practical method for evaluating 
valve thrombogeni city. At present, the only avenue for evaluating mechanical valve 
designs with respect to their clotting propensity is by collation of experimental results 
from animal trials with different valves. Such methods are not only distasteful, costly 
and time-consuming, but are of questionable worth due to uncertain effects of species-
related differences between man and animals, with respect to blood characteristics and 
physiology [18]. 
If an in vitro method were devised for evaluating the influence of configurational changes 
on thrombogeni city, the use of blood would be neither practical nor convenient in such 
experiments. Blood is a valuable fluid which is difficult to work with, as it tends 
to clot indiscriminately on foreign surfaces, and in vivo it reacts differently to some 
substances than when in vitro[l6].  For example, it is not correct to assume that a 
substance which interferes with some aspect of the coagulation of shed blood will affect 
blood circulating in the mammal in the same way; the delicate protective balance 
of activating and inhibiting mechanisms which the intact mammal possesses is not 
present in shed blood. Considering blood transfusion as an illustration of this, it is 
found that the addition of calcium ions to the donor's (extracorporeal) blood, will clot 
it; however, the blood does not clot, once received, even though the recipient possesses 
more than enough calcium to clot the transfused blood. Laboratory tests involving 
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blood coagulation may not, therefore, give any indication of the situation in living 
vessels. An in vitro test may be best served by a blood analogue fluid. 
Work by Jolles [191 indicates milk is in many ways similar to blood in its coagulation 
behaviour, and other research by Lewis[ 20], Christy[21] and Macleod[22_24],  in this 
laboratory, has shown that a milk mixture, containing rennet and calcium chloride, 
is a promising coagulable blood analogue fluid. It has been attempted here to further 
this work with milk, with the ultimate goal of establishing a way to assess prosthetic 
heart valve thrombogenicity and to facilitate a systematic empirical approach to the 
design of valves which do not induce thrombosis. To this end the milk experiments 
conducted by Christy and Macleod have been repeated and attempts made to obtain 
more information about flow characteristics conducive to clotting. 
This thesis provides a review of the thrombosis mechanism and ways in which it can be 
initiated, of experimental findings and their limitations regarding blood clotting in vivo 
and in vitro, and of work conducted using milk as a coagulable blood analogue fluid. A 
method for observing milk clot deposition as it occurs is assessed, the recommissioning 
of Christy's and Macleod's experiment is described, and an investigation of the origin of 
experimental problems and the mechanism of clotting, achieved principally by means 
of the development and commissioning of an ultrasound visualization technique, is 
presented. 
Chapter 2 
Blood and its Coagulation 
There are two modes of blood coagulation: haemostasis, which occurs in stationary 
blood, and thrombosis, a distortion of the haemostatic process, involving the deposition 
of blood constituents from flowing blood. Haemostasis is the natural process of blood 
clotting by which the body inhibits bleeding from wounds, and can be regarded as 
the disturbance of the balance between two processes - coagulation and fib rinolys is[25]. 
Each of these reactions is strictly controlled by plasma protease inhibitors and in vivo 
clearance mechanisms. The major function of the blood coagulation system is the 
generation of insoluble fibrin at the site of injury or trauma in order to limit the 
amount of blood loss. When this aim has been achieved and tissue repair is under 
way, it is the function of the fibrinolytic pathway to remove deposits and restore the 
patency of the damaged blood vessel. General descriptions of blood, coagulation and 
fibrinolysis, and the factors affecting blood coagulation are provided in this chapter. 
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2.1 Blood and the coagulation cascade 
Blood is a viscous fluid suspension, consisting of deformable 'formed elements' 
suspended in a liquid medium called plasma. Red cells (erythrocytes), white cells 
(leukocytes) and platelets compose the formed elements and account for about 45% of 
blood's volume, while the remaining volume consists of plasma, an aqueous solution 
containing colloidal proteins and numerous low molecular weight organic and inorganic 
materials [26][27]. 
The proteins which participate in coagulation are termed factors and, for simplification, 
each has been assigned a Roman numeral [28].  Table 2.1 provides a list of these factors, 
along with their respective concentration in plasma. Plasma contains all but one of the 
coagulation factors, tissue factor (111)1,  and fibrinogen is the only coagulation protein 
of appreciable concentration in plasma. 
Blood coagulation entails a multistep cascade of activations of protein factors  that 
results in the polymerization of a polypeptide monomer (modified fibrinogen) into an 
insoluble gel called fibrin (figure 2.1). This complex series of enzymic reactions, in 
which a factor activated in one stage activates an inactive factor in the next stage, like 
• waterfall conversion, can be initiated either by the interaction of blood contacting with 
• foreign or non-endothelial surface (intrinsic pathway) or by damage to the vascular 
endothelium3 (extrinsic pathway). This leads to the production of thrombin, which 
catalyzes the conversion of fibrinogen to fibrin which then polymerizes into a mesh-like 
structure, in which blood platelets, erythrocytes and leukocytes are trapped[ 32]. 
In the intrinsic (contact activation) pathway, the plasma protein that is bound onto 
and activated by a foreign surface is called Hageman factor (factor XII). Activated 
factor XII in turn converts the zymogen factor XI to the enzyme XIa. The function 
'Tissue factor (III) is readily available for initiating coagulation if vascular injury occurs [291. 
2 Most of the factors exist as zymogens (factor precursors) and must be modified by hydrolytic 
cleavage to achieve full activity. 
3 The endothelium is a continuous, single-cell-thick lining of all surfaces of the circulatory system 
that would otherwise be in direct contact with bldt30111. 
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Factor number Common name Conc in imi plasma 
I fibrinogen —3mg 
II prothrombin s200ig 
III tissue factor 0 
IV calcium ions - 
V proaccelerin 
VI abandoned for Va - 
VII proconvertin 
VIII antihaemophilic factor 
IX Christmas factor 
X Stuart factor 
XI plasma thromboplastin antecedent 
XII Hageman factor 40pg 
XIII fibrin stabilizing factor - 
Table 2.1: Blood coagulation factors [25] 
of activated factor XII is enhanced by high molecular weight kininogen (HMWK), 
which is also a cofactor required for the activation of factor XII by ka11ikrein 1 . These 
contact-activated reactions are calcium independent, but some of the subsequent blood 
coagulation reactions (those inside the box of figure 2.1, and the activation of factor 
XIII [34] ), require phospholipids 351 and Ca' for rapid reaction rates 4 . It is likely 
that tissue factor provides the lipid for the extrinsic pathway, and platelets supply 
phospholipid for the intrinsic pathway(251137].  Factor XIa activates factor IX, and factor 
IXa catalyzes the conversion of factor X to Xa in the presence of activated factor VIII, 
calcium and negatively charged phospholipids. 
Factor X can also be activated by the extrinsic pathway, by exposing blood to tissue 
factor III, calcium and factor Vila. Factor VII does not express coagulant activity until 
bound to tissue factor (factor III), which is not normally present in the circulation and 
is released from the site of vascular injury, initiating the extrinsic system. The intrinsic 
and extrinsic pathways lead to a common pathway, where prothrombin is converted 
to thrombin, in the presence of factor Xa, calcium, phospholipid and factor Va. By a 
highly selective cleavage of two Arg-Gly peptide bonds from amongst 181 peptide bonds 
in human fibrinogen[ 8], thrombin converts soluble fibrinogen to fibrin, which initially 
'For example, the rate of conversion of prothrombin is five hundred times greater in the presence, 
as opposed to the absence, of phospholipidt361. 
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Intrinsic Pathway I 
Surface Contact 
& HMWK 
Prekallikrein 	> Kallikrein (+HMWK) 
xii 	
I Extrinsic 
. XIIa (+HNWK) 
-- Pathway 
XI 	.XIa 








XIII 	XIII a 
Fibrinogen > Fibrin_> Fibrin 
(soluble) (insoluble) 
Figure 2.1: Cascade mechanism of blood coagulation. There are a variety of 
postulated coagulation cascades [32][25][38].  The scheme above has a box enclosing 
reactions requiring phospholipid and Ca2+; broken lines representing positive and 
negative feedback loops; thick lines denoting the action of enzymes on their specific 
substrates; and solid lines indicating activation pathways. HMWK = high molecular 
weight kininogen, the subscript 'a' indicates an activated substance, and * denotes an 
enzymatic component which requires more than one factor in its activation. 
initially is relatively unstable and susceptible to proteolytic degradation'. Catalyzed by 
factor XIIIa, the fibrin monomers spontaneously polymerize into a crosslinked, insoluble 
fibrin network. 
'Thrombin not only proteolyzes fibrinogen, but plays other important roles in coagulation, including 
activating factor XIII (the fibrin-stabilizing factor), increasing the activity of factor V, and enhancing 
[ 25] . the aggregation of platelets and triggering theft release reaction 
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2.2 Platelets, haemolysis and thrombus growth 
The sequence of deposition of blood components on a foreign surface has been 
experimentally determined and a thrombus growth mechanism postulated [39][3h].  All 
nonphysiological surfaces brought into contact with blood rapidly acquire a thickening 
film of protein, followed by platelet adsorption and possibly platelet aggregation, 
depending on the conditions (figure 2.2). Blood platelets arrive continuously, but hardly 
any cell adhesion occurs until the "conditioning" film of protein achieves a critical but 
non-equilibrium state' 1 . It has been suggested[ °] that if the strength of the stimulus 
(i.e the concentration of activating species, which may be released through alteration 
or damage to platelets, red blood cells and/or connective tissue[411[26])  and the number 
of platelets carried to the surface are sufficient[42][43],  the coagulation process will be 
triggered, resulting in the formation of platelet aggregates, which are strengthened by 
a mesh of fibrin. If either of these conditions is not met then aggregate growth stops, as 
illustrated in figure 2.2. The thrombus growth mechanism is considered in more detail 
in section 3.3. 
ExposedSurface 
Protein Layer Adsorbed 
$ 
Formation of platelet monolayer - platelets 
adhere releasin activating agent 
New platelets stick, 	Is concentration of 
deform, aggregate activating species 	No .JArriving platelets 
and release more 	greater than 	 do not adhere 
activating species some critical value? 
t 	 Yes  
	
Yes Are there sufficient 	No Growth stops due 	I FUnstable cycle, I 	new platelets present to limit on arrival Growth continues to be activated? 	rate of new platelets I 
Figure 2.2: A postulated sequence of events leading to thrombus formation[ 39]. 
Platelets play a major role in the response of blood to the introduction of foreign 
materials, chemicals and infectious agents into the blood stream. In the normal 
circulation, the only structures which platelets normally encounter are red cells, white 
cells and the endothelial lining of blood vessel walls, so all other materials are foreign to 
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them. Human platelets have no tendency to adhere to blood vessel walls, to other blood 
cells or to each other, but have an ability to adhere to foreign surfaces, such as artificial 
heart valves and the subendothelium, and when exposed to a variety of chemical stimuli 
(including thrombin), will aggregate and release a number of substances which promote 
further platelet aggregation(][]. Platelets possess intracellular storage granules, 
which contain different materials, such as fibrinogen, adenosine diphosphate (AD?) 
and serotonin(46).  Secretion of these contents may accompany aggregation, which can 
promote additional platelets to aggregate and stimulate the coagulation process. 
Haemolysis (the disintegration of erythrocytes) can also promote thrombus growth, 
depending on the severity of the haemolytic process [ 4'1 and the concentration of the 
activating species released. If the components released from red blood cells, such as 
ADP, enter an area of stasis in the vicinity of a foreign surface, they may reach a 
concentration sufficient to result in platelet adhesion and activation of the coagulation 
process. 
2.3 Fibrinolysis 
Thrombogenesis is combatted or regulated by the endothelium, liver, inhibitors of 
activated coagulation factors and fibrinolysis 11 . The protective mechanism considered 
here is fibrinolysis. As healing and regeneration of the vessel wall occur, the fibrin 
clot becomes redundant and must be removed to restore full patency to the damaged 
vessel. Mammalian blood contains an enzymatic system capable of dissolving blood 
clots, called the fibrinolytic system [48]which is dependent on the presence in plasma 
of a number of activators and inhibitors (38] (49] (figure 2.3). The active enzyme involved 
in fibrin hydrolysis, plasmin, is normally absent from flowing blood, and blood 
plasminogen activator, responsible for generating plasmin from its inactive precursor, 
plasminogen, occurs in very small quantities. Plasminogen activation may occur via 
an intrinsic pathway, possibly mediated by the components of the contact activation 
process, or via an extrinsic mechanism, involving plasminogen activators derived from 
the vessel wall. The activity of the fibrinolytic system is modulated by inhibitors 
that serve to regulate both the activation of plasminogen and the proteolytic effect of 
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Figure 2.3: Basic representation of the interaction of the coagulation and fibrinolytic 
systems [25]. 
While deficient fibrinolysis may result in delayed clearance of fibrin and thus an 
increased susceptibility to thrombosis, excessive fibrinolysis can cause a thrombus to be 
dislodged, with the resultant thromboembolus capable of inducing a stroke by arresting 
the flow in one of the small cranial arteries. 
2.4 Factors affecting coagulation 
The initiation of the intrinsic system of coagulation occurs when blood contacts any 
one of the artificial surfaces that have been tested to date[50].  In the search for a way 
to avoid unwanted thrombus formation, scientists have concentrated on three distinct 
origins of coagulation activation in the vicinity of foreign surfaces, first proposed as 
determinants of clotting more than a century ago and known as Virchow's t riad[5 u1 : 
blood chemistry, the surface material and the flow dynamics (figure 2.4). The progress 
made regarding each of these factors is briefly discussed below. 
2.4.1 Biochemistry 
The inability of mechanical valve recipients to survive free of thrombus-related events 
has led to the need for long-term employment of anticoagulants, such as warfarin 
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Figure 2.4: Triad of sources of coagulation activation 
and heparin, which fail to offer completely satisfactory protection. Whilst heparin 
interferes with all stages of blood coagulation(161,  enhances fibrinolysis, and influences 
the aggregation of platelets and the release of chemicals from them, it also puts a 
strain on the kidneys and liver[ 1 , and if dosage is inaccurate, can itself be a cause of 
death 1121 . Accordingly, studies have been conducted to explore ways of replacing 
or improving the performance of anticoagulant drugs; for example, thrombolytic 
agents (e.g. streptokinase and urokinase), which supplement the role of therapeutic 
anticoagulants by enhancing fibrinolysis and thrombolysis[56],  and agents which prevent 
development of the initial platelet thrombus 1461 . 
2.4.2 Surface characteristics 
When choosing a nonphysiological material for blood contact applications, the texture, 
surface charge and surface chemistry of the substrate should be scrutinized. 
Since large pores may entrain cells and provide regions of stasis which can inhibit 
dilution of activating species, allowing reaction sequences to propagate, a surface that 
is smooth with respect to blood cells (i.e. having pores with diameter and depth of 
the order of lim or less) should be sought [311[,17.].  Since gas-liquid interfaces have been 
found to initiate aggregation and fragmentation of protein molecules[ 6], and bubbles 
can result in flow disturbances, all surface irregularities should be thoroughly prewetted 
or degassed before contact with protein-containing solutions[31].  Researchers] tend 
to prime their equipment with saline, in order to prevent the formation of an air-blood 
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interface and the trapping of air bubbles. Degassing has also been shown to reduce 
protein adsorption, when tiny air nuclei get trapped in the surface roughness [58]. 
The charge that a surface possesses appears to affect but not solely determine the 
thrombogenicity of that surface. Gott and his colleagues[591(601  have performed a large 
number of in vivo material biocompatibility tests in dogs, some of which included the 
use of vena caval rings constructed of charged materials[6h]  or materials with an induced 
charge(62]. They found that a methyl methacrylate ring dipped in graphite prior to 
testing was relatively free of clot after two hours in a canine vena cava, and this result 
was repeated when a small negative charge was applied to this ring; however, when 
this ring had an induced positive charge it completely thrombosed within one hour. 
Sawyer [63] has also found that positively charged surfaces are thrombogenic, and that 
materials which are homogeneously negative tend to be nonthrombogenic. Conversely, 
Gott et aI.(611  have found that both electronegative and electropositive materials provide 
significant thromboresistance. It has been said that while all blood proteins and cells are 
electrophoretically negative, they tend not to be repelled by negative surfaces, as their 
surfaces consist of both positive and negative groups["]. Perhaps the thrombogenicity 
of a surface is only partly dependent on its charge, and this lack of agreement of results 
is due to other differences in surface chemistry. 
The surface material reactivity determines to a large degree which blood components 
are adsorbed and how, and is thus relevant to th rombogenesis[64]. The sequence of 
events leading to thrombus deposition on a foreign surface (figure 2.2) begins with the 
adsorption of a protein layer[311[39],  which physically separates the foreign surface from 
blood flow. The nature of this layer determines, to some degree, whether or not the 
53 ensuing sequence of events lead to a thrombus 1 l. When a protein solution contacts 
a foreign surface, the quantity of protein adsorbed, the nature of the bond and the 
changes that take place in the configuration of the bound protein molecule depend 
primarily on the nature of the foreign surface and the structure and concentration of 
the proteins in solution ' 1 . Friedman et al.(65]  concluded that the platelet deposition 
rate is not a strong function of the type of surface, but the morphology, reactivity and 
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aggregation potential of the first adherent platelets, which may be why the deposition 
rate and final extent of thrombus have been found by others(3111661  to differ on different 
materials. The explanation for these findings might be that protein factors in blood 
may be activated, if they are adsorbed by a surface, in such a way that their native 
57 configuration is alteredE° 1 . Inert surfaces, such as certain types of carbon[671,  may 
adsorb proteins such that their structure is not distorted and/or a stable protein layer 
is achieved, resulting in the inhibition of platelet adhesion[681[53]. 
Generally, there are two ways to prepare materials with thromboresistant interfacial 
characteristics. The first is the biochemical approach where reagents, such as 
anticoagulants and platelet inhibitors, are immobilized on or slowly released from the 
surface of the material. The second method involves exploiting the physicochemical 
properties of micro domain- structured materials, such as block copolymers, to tailor 
protein adsorption patterns in a way that limits activation by alteration of adhering 
platelets [5 7a1[64][69_ 72]. 
The controlled release or immobilization of pharmaceuticals at the surface of short-
term implants has proved successful in preventing thrombogenesis[641[691  and provides 
a few advantages over conventional anticoagulant therapy, but has yet to be proven 
feasible for long-term implants in non-laminar blood flows. Immobilization of agents 
on polymer surfaces appears to be the more promising of the two biochemical 
approaches, as this method does not suffer drug depletion[69](73].  However, although 
some researchers ( 611  have found that coating artificial materials, with substances such as 
graphite- b enzalkonium- heparin (GBH), has enabled a number ofimplants in laminar 
blood flow to be thrombus-free after 2 years in dogs, such coating has not allowed 
implants to maintain a thrombus-free surface in non-laminar flow conditions similar to 
those near present-day prosthetic heart valves. The biochemical approaches mentioned 
above do, however, appear capable of preventing the global reduction of blood 
clottability and the embolic events which are observed with present-day anticoagulant 
therapy. 
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Microdomain-structured materials, such as Biomer (segmented polyether polyurethane-
urea)[], appear promising as athrombogenic materials. Kim and Okano[64]  have noted 
that the type and ratio of different proteins adsorbed on a surface are relevant to its 
thrombogenicity; polymers with a low ratio of adsorbed fibrinogen or -/-globulin to 
adsorbed albumin, tend to be blood tolerable. They also found that when contacting 
blood with a hydrophilic-hydrophobic microdomain surface, the adsorbed proteins form 
an organized structure corresponding to that of the surface microdomain; albumin 
adsorbs preferentially on the hydrophilic regions, while fibrinogen and 'y-globulin 
adsorb on the hydrophobic areas. Okano et constructed block copolymers which 
exhibited a hydrophilic-hydrophobic type of microdomain structure, and found that 
an arterio-venous shunt with a surface consisting of alternate lamellar microdomains 
experienced no thrombus formation for the 3 weeks it was in a rabbit. They attributed 
this result to suppression of platelet adhesion and minimal morphological changes 
of adhered platelets. Long-term results of devices composed of these substances are 
eagerly awaited. 
2.4.3 Haemodynamics 
The nature, extent and occurrence of thrombus deposition are influenced by the 
haemodynamic conditions present. It is made apparent that the composition and 
rheology of fibrin deposits are dependent on local flow conditions when comparing 
clots and thrombi, which form in stagnant and flowing blood, respectively. When 
stagnant blood contacts a foreign surface, it solidifies into a dark red, gelatinous clot of 
blood components evenly distributed in a fine web of fibrin. When flowing blood is in 
contact with a foreign surface, white, firm and friable deposits are observed, which have 
nonhomogeneous section, consisting largely of platelets, fibrin and white cells [16][75]. 
Kocha et al. [11b]  discovered that the kinetics of blood protein adsorption onto foreign 
surfaces was different in systems which were unstirred to ones that had controlled 
stirring, both in rate of uptake and composition of the steady-state adsorbed layer. 
Given this and the finding by Kim and Okano[64],  that the type and ratio of different 
proteins adsorbed by a surface influence that surface's thromb ogeni city, it would be 
expected that the haemodynamics will indeed play a role in determining the tendency 
of a surface to be thrombogenic. There are numerous examples where blood-material 
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interactions have been greatly influenced by haemodynamic conditions. For example, 
increasing the flow rate in a clotting chamber, which results in a smaller mean fluid 
residence time and elevated shear stresses, has been shown to reduce deposit extent, 
but can also cause lysis of cells, releasing species which can trigger the coagulation 
mechanism. Introduction of a separated flow region has been shown to transform a 
flow obstruction composed of an otherwise athrombogenic material into one which is 
prone to thrombus form ation [76]. 
The following chapter provides an overview of the fluid mechanics of blood and a review 
of some of the studies conducted by numerous investigators on the relation between 
thrombosis and flow conditions, outlining the results and limitations of this work. 
Chapter 3 
Thrombosis and Flow 
Conditions 
In the design and application of artificial implants, one of the most critical areas where 
fundamental knowledge is needed is the effect of fluid flow pattern on the incidence of 
thrombosis. Blood-material interactions are greatly influenced by the haemodynamic 
conditions. In particular, some of the causes of implant-induced thrombosis appear to 
be related to the nonphysiological flow characteristics of the implants themselves, as 
many artificial materials used for valve construction are essentially less thrombogenic 
than the valves made from them. Introduction of a valve occiuder into an aortic 
flow field generally produces regions of highly accelerated flow in the annular region 
between the occiuder and aortic walls, and these regions are associated with turbulence 
production and regions of stagnation and separated flows (figure 3.1). 
This chapter provides a survey of the search for a relationship between haemodynamic 
conditions and thrombus formation, preceded by a general look at the fluid mechanics 
of blood and cardiovascular modelling. 
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Figure 3.1: Instantaneous streamline flow patterns for three fully open prosthetic heart 
valves: the Starr-Edwards caged-ball (figure 1.2(c)), Bjork-Shiley tilting disc (figure 
1.2(d)) and the Kay-Shiley caged disc p rostheses [8hJ. 
3.1 Mechanical properties of blood 
Whole blood is a pseudoplastic, or shear-thinning, fluid with a density of about 1059 
kg/M3  I'll and a viscosity that is a function of shear stress, haematocrit (the percentage 
of the volume occupied by red cells relative to the total volume of blood), and plasma 
viscosity. Blood behaves in many circumstances as a fluid with shear-independent 
viscosity, but when the shear rate is reduced to less than 10 s_i it exhibits a non-
Newtonian behaviour largely due to red cell deformation and rotation and rouleaux 
(1 (long chain) formation. 
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Red blood cells are highly flexible, biconcave discoids which constitute 99% (vol.) of 
the cellular phase' in whole blood[ 80] and play a major role in the fluid mechanics of 
whole blood. Red cells have a tendency to aggregate side-by-side to form cylindrical 
stacks or arrays, termed vouleaux and illustrated in figure 3.2, and in a steady sheared 
flow the proportion of the cells aggregated into rouleaux at any instant diminishes 
with increasing shearrate[26].  Red cells are seen to deform and spin, with the rate at 
which they do so also being dependent on the shear-rate. The transformation from a 
suspension of rouleauc to a suspension of individual red cells occurs over a range of 
shear rates of 0.1 s to 10 s_i and results in a rapid variation of blood viscosity[I, as 
indicated in figure 3.3. At a shear rate of about 1 s_ i the cells bend as they spin, but as 
the shear-rate is increased they no longer spin and in pipe flow align themselves with the 
flow[26]. When the shear-rate rises above 100 s_i,  the apparent viscosity approaches an 
asymptotic value of about 0.0033 kg/ms[821  and blood displays Newtonian behaviour. 
Both the level of red cell aggregation and the plasma viscosity are increased by 
increasing plasma fibrinogen levels, with fibrinogen acting as a bridging macromolecule 
between red cells[83].  Recipients of substitute mechanical heart valves have been found 
to experience increases in plasma fibrinogen concentration [841  and are accordingly given 
thrombolytic therapy, which is said to 'thin' the blood as it lowers the fibrinogen 
concentration thus reducing plasma viscosity and red cell aggregation [85]. 
3.2 Modelling of the circulatory system 
Whilst only clinical application can offer proof of success of artificial heart valves, 
evaluation and comparison of new prosthetic valves prior to implantation in humans 
plays a vital role in their development and acceptance and can indicate the proper 
direction for improvement in the design of new valves. Ideally, such testing would be 
performed in an environment that accurately reproduces the clinical conditions that 
'The concentration, diameter and thickness of red cells in whole blood are about 5x106 /mm3 , 814m 
and 1-3 pm, respectively, and these cells comprise about 45% of the blood's volume. White cells 
are roughly spherical and have a respective concentration and diameter in whole blood of about 4-
11c103 /mm3 and 7-22 pm, constituting about 1% (by vol.) of blood. Platelets are rounded or oval, 
with a concentration, diameter and thickness of 250-500x103 /mm3 , 2-4 pm and 0.5 pm, respectively, 
comprising less than 1% of the volume of blood 1171  1261• 





Figure 3.2: Red cell rouleaux formation on a microscope slide [86]. 
rate of shear ( s - ') 
28 
Figure 3.3: Variation of apparent viscosity of human blood with rate of shear, assuming 
the viscosity of plasma is 1.2 x iO Ns/m2 [87]. 
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will be demanded of the implant, that permits controlled perturbation of each of the 
known variables, and that allows continuous analysis of the events associated with 
or caused by the prosthesis. Tests which do not mimic in vivo conditions accurately 
cannot provide definitive information. Some of the factors that determine an implant's 
thromboresistance are its configuration, the haematologic and haemodynamic variables 
and its exposure time to blood(88].  Tests that do not allow systematic control and 
alteration of each of these variables cannot be expected to produce precise information 
concerning the relative thromboresistance of an implant. At present, there is no testing 
technique that satisfies all the criteria of the ideal study method. 
However, flow models have been devised that allow some information to be gained 
regarding implant performance. Current cardiovascular models can generally be 
classified into three categories: mathematical and computer models 21 ; physical models; 
and animal models. Both physical and animal models are briefly examined here, with 
a discussion of the fundamental aspects that should be considered when attempting to 
mimic the human circulatory system and of some of the difficulties encountered when 
attempting such modelling. 
In order to determine the essential properties of a mock flow system, whether of in 
vivo or in vitro nature, it is necessary to consider the human circulatory system. 
The complexities of the cardiovascular system and blood make the construction 
of a model which mimics well the behaviour of the blood, the heart and its 
neighbouring passageways an ambitious goal. The characteristics of both blood 
and the cardiovascular system are quite different from those encountered in classical 
hydrodynamics; the unsteady flow of the non-homogeneous, complex fluid occurs in a 
system with distensible walls, frequent branchings, taper and curvature. The circulation 
of blood depends on the muscular and elastic powers of the heart and of the arteries. 
The overall elastic behaviour of a blood vessel is determined by its dimensions and the 
properties of its various constituent materials. About 70% of the walls of all blood 
vessels consist of water and the remainder of a composite of four different types of 
tissue: the smooth endothelial lining, which contacts blood; a smooth layer of elastic 
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fibres just behind the endothelial lining that provides elastic tension; collagen fibres, 
which produce a high resistance to distension when the vessel's size limit is approached; 
and smooth vascular muscles, which act to change the diameter of the vessel[21. 
The design of a flow experiment with the intention of mimicking another system 
necessitates careful attention to the requirements of dynamic similitude[891[901.  Dynamic 
similitude means that all fluid forces acting at any point in the original flow system 
are in the same ratio as those acting at the corresponding points in the model. The 
concept of corresponding points implies that the original and model systems must 
be geometrically similar; and as the ratios of forces acting at a given point are 
dimensionless, it is evident that a further condition for dynamical similarity is that the 
non-dimensional numbers representing all relevant force ratios should be the same for 
model and original. One must establish the kind and range of phenomena to be studied 
and thus the appropriate values for the relevant non-dimensional parameters. Then 
one must consider how these values can be achieved and, if some are not attainable, 
what departures are least unacceptable. For incompressible steady flows in rigid ducts 
and without any free fluid surface, the Reynolds number (Re) is the only parameter 
that must be maintained constant for a prototype and a geometrically similar model 
to be comparable[90a].  For steady-state oscillatory rigid pipe flows[ 2], the additional 
important parameter is the frequency parameter (a). Re (= ) represents the ratio 
of inertial force to viscous force (where i denotes the mean velocity of the blood flow 
in a vessel of diameter d, and u represents the kinematic viscosity of blood), and a (= 
is the ratio of the oscillatory inertial force to viscous force (where r is the vessel 
radius, w=27rf, and f is the pulsatile frequency). 
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3.2.1 Physical models 
Many researchers have devised physical models which consist of intricate mock 
circulation loops[90_931  or systems with simple flow patterns, and have used flow 
measurement apparatus 2 and blood analogue fluids, in order to determine the flow 
characteristics associated with prosthetic valves which are then used to predict valve 
performance in vivo. Generally, physical models may be classified into three categories: 
geometric models, which are scaled reproductions of the prototype; distorted models, 
where the model and the prototype may share only limited geometric resemblance; or 
dissimilar models that bear no geometric resemblance to the prototype. 
One of the most difficult aspects when designing a physical model, is the selection of the 
parameters that must be included in the model. It is customary to begin with a simple 
model, as total comprehension of the limitations and assumptions incorporated in the 
design of the model is essential for proper interpretation of all the results. Though 
simple physical models provide easy accessibility for carrying out measurements or 
observations, they have limited versatility, particularly in the number of parameters 
that may be controlled. In addition, when constructing a simple model, the omission 
of features that are judged to have only secondary importance, such as distensibility of 
the walls, or aortic sinuses[27),  may seriously distort the data. 
A well-designed flow model, with similar boundary motions and wall compliance and 
impedance to that in the cardiovascular system, is required to simulate the pulsatile 
flow and pressure waves found in the cardiovascular system. For an adult human at 
rest, about 5 l/min[] of blood flows through the arteries at a pulsatile rate of about 
70-80 beats/mm, with the typical period of systole being 0.3 s and that of diastole 0.5 
[27]• Using a positive-displacement pump in a mock flow loop, the operator can vary 
stroke volume, pulse rate and the length of the systolic and diastolic phases of the flow. 
However, even the use of moulded replicas of a human aorta and distensible tubing with 
directional reinforcements, in attempts to duplicate the shape, wall compliance and 
2 Many different flow visualization techniques have been used, including hot-wire, hot-film 91 and 
laser Doppler191 anemometry, and the use of dye injections [961. 
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anisotropy of the cardiovascular structure surrounding heart valves for in vitro testing, 
cannot at present provide the intricate and complex waveforms, haemodynamics and 
flexibility/rigidity variations occurring in the human heart. Such intricate models may 
provide a system bearing more resemblance to the physiological reality than a simple 
model, but how accurately these models duplicate the conditions in vivo, and thus how 
informative they can be, is questionable. 
The use of blood in vitro is impractical for a number of reasons. Blood clots 
indiscriminately on foreign surfaces, so in vitro systems require that the blood be 
anticoagulated; however, this limits the usefulness of using animal blood as an analogue 
to human blood since the response of different animal species to anticoagulants, such 
as heparin and citrate, varies widely[]. Even if this problem were avoided, by using 
human blood in an in vitro model, extrapolation from the behaviour of surfaces in 
vitro to their thrombogenic behaviour in vivo is not a reliable way for predicting blood 
compatibility [98]. The study of blood coagulation in vitro, in the absence of a vessel wall 
and of mechanisms that may operate at or through the vessel wall and in the presence of 
currently prescribed anticoagulant, all of which influence platelet behaviour 991 , can only 
provide approximations to coagulation in vivo. Many investigators use simple blood 
analogue fluids, as opposed to blood, for in vitro flow analysis tests of prosthetic heart 
valves. In many flow situations in vivo, such as in vessels of the size of the larger arteries 
and aorta, blood can be considered to be a homogeneous, Newtonian fluid 10091 with 
an absolute viscosity of about 0.003-0.004 kg/ms. Generally, researchers simulate the 
viscosity and density of blood by using a transparent glycerine-water solution, allowing 
valve motion and the associated flow field to be studied optically. 
Some investigators conduct steady, rather than pulsatile, flow experiments but the 
usefulness of these experiments is debatable. In their favour it has been pointed out 
that of the time for systole, the opening sequence of an aortic valve takes only 15 
percent followed by a quasi-steady phase, which approximates to steady flow[Sh],  for 55 
percent. If the region of interest lies in a vein, steady flow simulation may be acceptable 
since blood flow in veins has much less of a pulsatile nature than arterial flows. On 
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the other hand, while this suggests that steady flow experiments are useful, the fact 
that they can only provide incomplete information must be remembered; undesirable 
flow conditions arising due to pulsation will go undetected. For example, the question 
of whether or not the shedding or disruption of separated flow regions occurs will 
go unanswered, and the lack of a diastolic phase means that questions of the valve's 
ability to close and of phenomena such as regurgitant jets (associated with high shear 
stresses) will not be addressed. In addition, Roshcke and Harrison[ 102] found from their 
approximate calculations that the shear stresses which occur during the accelerating 
and decelerating flow phases, before and after the quasi-steady flow phase in pulsatile 
flow, are markedly greater than those measured in steady fl ow [811. 
3.2.2 Animal models 
In the absence of established, reliable in vitro methods for implant thrombogenicity 
assessment, an obvious avenue open to investigators is the experimental placement of 
implants in the intact animal cardiovascular system, which allows test materials and 
implants to be assessed under more clinically relevant situations than in vitro systems. 
Certain anatomical and physiological similarities exist between human and numerous 
animal species which suggest that experimental results obtained in animal trials 
can be extrapolated to predict certain physiological and pathological phenomena in 
humans [103]. Animal trials are currently used to assess the adequacy of substitute heart 
valves for humans, usually by measuring the amount of thrombus present at some point 
in time after surgical placement, and have been used to study the flow dependence of 
thrombosis, using a wide variety of axi-symmetric test-bodies inserted into the large 
arteries or veins[104ll105). Of the numerous parameters that may be considered when 
selecting an animal model[2J[106l[107], such as species type, health, age, sex and size, 
experimental design and cost, the two basic criteria used in choosing an animal are the 
flow parameters termed the Reynolds number (Re) (evaluated for mean or maximum 
flow in the cardiac cycle) and the frequency parameter (a), defined earlier. Table 3.1 
gives the mean values of the frequency parameter, evaluated at the aortic root in several 
mammalian species. 
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Generally, ex vivo experiments, where blood is drawn directly from the animal's 
vascular system into the experimental flow chamber, tend to be conducted for 
biocompatibility studies. Biocompatibility in such experiments is generally measured 
by platelet adhesion, quantified by means such as radiolabeffing of platelets, and 
scanning electron microscopy[108]. While ex vivo experiments generally examine short-
term interactions, in vivo studies allow long-term analysis of the impact of implants 
and their thrombogenicity. 
Species I Pulses/mm Radius (mm) a (fundamental) 
mouse 600-730 0.3-0.1 1.19-1.74 
cat 180 2.0 4.4 
dog 72-125 5.5-6.0 8.27-10.68 
man 	- 55-72 10.8-11.1 13.5-16.7 
Table 3.1: Mammalian characteristics [2] 
Whilst animal trials are currently the best technique available for predicting implant 
thrombogenicity in humans, they have numerous shortcomings. Not only are such 
experiments undesirable, regarding animal sacrifice, but there are also uncontrolled 
variables that seriously compromise their quantitative usefulness, including loss of 
thrombus by embolizatiort and/or fibrinolysis [109] ; differences in effects of surgery; 
timing of observations; biological variability from animal to animal[04];  and species-
related variable haemodynamic characteristics of the test system. For example, the 
contact activation system varies between species, so the undesirable effects caused 
by an implant in humans could possibly be missed if certain animals are used. For 
instance, dogs, rabbits, seals and cows possess a contact activation system in which 
activation of factor XII is slower and the efficiency of plasma protease inhibitors is 
greater than that in humans. Thus the use of these animals could lead to erroneous 
conclusions concerning the efficacy and safety of the biomaterial in question[ °l. The 
above limitations make it difficult to infer from the behaviour of a device in an animal 
its response in a human. Another shortcoming of animal trials is that since each in vivo 
study generally allows only one experimental observation period with little certainty 
that all system variables are controlled, statistical requirements demand performance 
of a relatively large number of experiments, the cost of which is considerable. Ex vivo 
methods can enable a more controlled dynamic picture of thrombosis and embolization 
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to be made, but such experiments do not eliminate all of the shortcomings; for example, 
studies have shown that, as with in vivo trials, platelet deposition on biomaterials is 
highly dependent upon animal species[' 1011981 . 
Given the difficulties and major problems encountered using physical and animal 
models for implant assessment, it is natural to enquire whether a more 
fundamental approach to blood clotting effects might not prove more advantageous. 
Experimentation at a basic level to discern the relative roles of haemodynamic variables 
in thrombosis may be the way forward. By measuring the extent to which a prosthesis 
is associated with hydrodynamic factors predominant in clotting, it should in principle 
be possible to infer its likely propensity to cause clotting. However, the relationship 
between each of the flow phenomena associated with prosthetic valves and thrombosis 
is uncertain, as the ability to isolate each phenomenon has not yet been achieved. The 
remainder of this chapter is a discussion of what flow characteristics are believed to 
affect thrombosis, with reference to results obtained by researchers using physical and 
animal models. 
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3.3 Flow phenomena and thrombosis 
3.3.1 General principles 
When flowing blood contacts a foreign surface and thrombi form, their development 
involves adhesion and aggregation of platelets on the surface, which is promoted by 
the release of aggregation-inducing chemicals from both blood and endothelial cells, 
followed by the development of a fibrin-mesh between aggregates, which traps red cells. 
Although the flow conditions may not solely determine the degree to which activating 
species are released, they do appear to determine whether or not a thrombus develops 
following activation of the coagulation cascade [60]E79][40]. The flow characteristics which 
contribute to the interaction of cells with the vessel wall and prosthetic implants, 
and are thought to influence the formation of thrombi in circulating blood, include 
stasis, separated flow, surface contact duration, mass transfer rate, turbulence and 
shear stress level. These haemodynamic phenomena are frequently associated with each 
other and may occur simultaneously at sites which are found to be highly conducive to 
the deposition of platelet thrombi; consequently, their relative importance for thrombus 
formation has not yet been established. A review of some of the findings regarding the 
relationship between thrombosis and haemodynamic conditions is presented here. 
A region of stasis, in which the local fluid residence time exceeds the mean fluid 
residence time, can occur adjacent to a step or inhomogeneity in a surface or distal 
to a sudden flow constriction or expansion. The fluid in such a region can exist as 
a 'quiet pocket' or as a closed vortex (recirculating fluid), depending upon the bulk 
flow conditions and size of the flow disturbance. Flow separation and recirculation can 
occur when a flowing fluid is suddenly accelerated and then immediately decelerated, 
as occurs when passing through an abrupt flow constriction (e.g. artificial heart valve); 
streamlines separate from the vessel wall slightly downstream of the constriction, and 
reattach further downstream. The contents of regions of stasis are mainly excluded 
from convective exchange with the mainstream. 
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Since branchings and bends of the human circulation are often associated with 
separated flow[hhl] but not necessarily thrombi, it appears that certain conditions 
other than stasis must be satisfied at such sites for thrombi to form. Perhaps trauma, 
sufficient to damage blood or endothelial cells so that they release activating species, 
is necessary. In the presence of such trauma, regions of separated, recirculating flows 
adjacent to a foreign surface can promote aggregation, if platelets are trapped and 
activating species are secreted or trapped in these vortices. Prosthetic surfaces, which 
are adjacent to slow flow, stagnant zones or flow separation, have been linked to 
observed sites of thrombus in vivo and in vitro [66][81][112-114]. In the case of haemolytic 
mechanical heart valves, the platelet-activating chemicals released from lysed cells could 
be trapped and thoroughly mixed in nearby vortices, as regions of elevated shear are 
followed, almost invariably, by 'deadwater' zones. Diffusion between the bulk flow and 
these vortices is slow and so dilution is poor, hindering both the clearance of activated 
coagulation factors and their mixing with inhibitors[h 15][h 16], possibly allowing the local 
concentration of aggregation-inducing species to rise above some threshold value (figure 
2.2). In addition, vortices promote aggregation and deposition, by increasing the 
number of collisions between cells and between cells and the surface (i.e. increased 
blood-surface contact time) [80111111 . The lifetime of the vortex and its supply of platelets 
and activating species may be the factors limiting the level of thrombosis incurred. 
It appears that the combination of separated flow and high mass transfer rate may 
provide a site favourable to thrombus deposition, when the coagulation cascade has 
been triggered. Increased mass transfer to a foreign surface will increase the interaction 
of platelets with that surface, and if a region of stasis is present, which allows released 
activating species to increase in concentration, then the coagulation cascade is likely 
to escalate. Using electrochemical techniques and an electrolyte solution, Galanga 
and Lloyd[h17] studied the flow-induced mass transfer distribution in the vicinity of 
two prosthetic heart valves in vitro, and correlated their findings to thrombus growth 
in vivo. They found that large mass transfer coefficients occurred in the vicinity of 
flow impingements or regions of high shear stresses, and in regions of flow separation, 
upstream of and distal to the sewing ring as well as immediately downstream of the 
valves, where shear stresses would be low. In vivo studiesLhlS][h19],  with the same two 
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artificial heart valves, have revealed that the regions found by Galanga and Lloyd to 
consist of high mass transfer and low shear-stresses correspond to common sites of 
thrombi. The regions of both high mass transfer and high shear stresses may have 
been thrombus-free due to short blood-surface contact times and/or the adverse effect 
of high shear stresses on cell-cell and cell-surface bonds (figure 3.4). 
Turbulence is another flow phenomenon which may influence thrombosis. It provides 
elevated shear stress levels and increased mass transfer rates, which can either inhibit 
or favour thrombosis according to the circumstances. 
From in vitro and ex vivo studies it has been recognized that platelet-surface 
interactions are sensitive to the velocity of blood 9811120 , and that increasing shear 
rate can either inhibit or promote thrombus growth, depending upon the conditions 
present. 
High flow rates and high values of shear at the surface of a boundary (short of 
that necessary to damage red cells) have been found to minimize the incidence of 
thrombosis 1 , while low flows have been associated, both clinically and experimentally, 
with early thrombosis [120]. For example, vascular implants are found to maintain 
patency more often when in arteries (high flows) than when in veins (low flows )[12 h]. 
An increase in flow rate reduces the blood-surface contact duration and increases the 
rate of supply and removal of cells adjacent to a surface, so unless the fluid is readily 
coagulable so that aggregation can occur on contact, such sites are unlikely to be 
favoured for deposition. High shear rates at the surface may also overcome the adhesive 
forces between blood elements and the surface, as mentioned above. In addition, high 
surface shears can inhibit coagulation by damaging the species involved in the clotting 
mechanism [122 ]E1231 and fragmenting the fibrin network as it forms [124]. 
In some circumstances high shear rates can promote thrombus b uildup [17][125 _ 1271. 
Subjecting red cells, platelets and the endothelial lining to shear stresses sufficient 
to cause damage, results in the release of aggregating agents into the plasma which can 
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Figure 3.4: Deposition of cells depends on the balance between adhesive, cohesive and 
shear forces [125]. 
render blood hypercoagulable (i.e. highly likely to coagulate). Further complicating 
matters, increasing the shear rate can increase the red cell collision frequency and 
tumbling, enhancing mixing and increasing the rate at which platelets diffuse to a 
surface and thrombosis occurs[128][129]3. Therefore, no simple or universal relation exists 
between shear stress and thrombosis. 
Both the magnitude and duration of the stresses to which cells are subjected (i.e. the 
'shear exposure') influence the severity of cell damage. Haemolysis has been found to 
occur when erythrocytes are exposed to viscous shear stresses of over 4x10 3 N/rn 2 for 
0.01 rns['']; of 450 N/rn 2 for 1 ms[132];  and above 150 N/rn 2 for a 2 minute exposure 
time'. Wurzinger and Schmid- Schonbein[' 3°] have found that the lysis rate of red 
blood cells and platelets subjected to high shear forces correlate in a linear fashion to the 
duration of exposure. Human platelets have a substantially lower tolerance to shearing 
than erythrocytes; the first signs of platelet lysis, based on lactic dehydrogenase (LDH) 
release, have been found to occur immediately at or above a 10-16.5 N/rn 2 range of 
shear stress [134]. Wurzinger (171[135] found that a shear stress of 170 N/rn 2 , acting for 
3 1t follows that an increase in haematocrit would further improve platelet diffusivity, and this has 
been found to be the case experimentally [125). 
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7 ms, made available procoagulant phospholipids from platelets, which accelerate the 
clotting process. For longer exposure times, such as 113 ms, a shear stress of 57 N/rn 2 
was able to produce the same effect on platelets. A typical stress duration time for a 
blood cell experiencing a prosthetic valve flow field has been said to be of the order of 
10 ms[81]E1361,  but the actual time will depend on the specific valve flow field. While 
formed elements of the blood will pass through heart valves many times during their 
lifespan, such that their total shear exposure increases on every pass, the endothelium 
adjacent to a valve is continuously subjected to the heart valve flow field. F ry [126]E137] 
has reported that exposure of the endothelium of the thoracic aorta of dogs to shear 
stresses greater than 37.9 ± 8.5 N/rn2 , for as little as one hour, resulted in marked 
deterioration. 
Due to the different equipment and fluid treatments used when assessing the critical 
shear exposure of blood cells, there is disagreement regarding the. exact values of shear 
stress required to cause cell lysis[138].  Nevertheless, it is generally found that mechanical 
heart valves cause shear stresses sufficient to lyse cells. 
3.3.2 Measurement of flow characteristics of prosthetic valves 
Yoganathan et al.(1 conducted steady flow in vitro experiments, using a blood analogue 
fluid, a laser-Doppler anemometer (LDA) and a mock flow loop, in order to measure 
velocity profiles in the vicinity of five different types of aortic prostheses. At flow rates 
corresponding to peak systolic flow rates of about 2.5 and 5.5 1/mm, the experimentally 
observed wall-shear stresses and turbulent-shear stresses were respectively about 100 
N/rn2 and 10-100 N/rn 2 ; such stresses are capable of damaging the endothelial lining 
of the ascending aorta, cells adhered there and formed elements in the flow. Figliola 
and Mueller(8h)  conducted similar steady flow studies, and also found the shear stresses 
caused by four different types of prosthetic heart valves to be large enough to cause 
cellular damage, based on the results of haemolysis-shear tests carried out by others. 
It must be realized that valve performance results obtained from steady flow in vitro 
studies cannot provide the investigator with a thorough idea of how a valve will perform 
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position of the reattachment point of the separated flow region depends on the flow 
rate, and so is likely to oscillate back and forth in pulsatile flow, the "activated" blood 
may be released into the circulation from the faltering vortex[130]. 
Given the above findings, mechanical heart valves of the types examined 4 all appear to 
be traumatic to the blood flow, and concomitant formation of regions of stasis adjacent 
to such valves could be fatal. The observations reported below further elucidate the 
relation between flow and thrombosis. 
3.3.3 Deposition experiments in specially designed blood flow 
systems 
Gott and co-workers have conducted a large number of material compatibility tests 
with flowing blood and various in vivo screening techniques involving the insertion of 
"flags", "swords" and "rings" in the canine circulation[5911621[139].  The most consistent 
of these techniques was found to be that in which a ring constructed of the material 
of interest and of dimensions 9 mm long, 8 mm o.d. and 7 mm i.d. is inserted in the 
canine vena cava. The reasons for this may be that the smooth tube not only protects 
the deposit within it from vessel wall movements but may also promote more controlled 
flow patterns. 
The testing sequence adopted by Gott and his colleagues was to conduct a two-
hour duration ring test and, if the material was promising with regard to its 
thromboresistance, a second test similar to the first procedure but for a two-week 
duration. Gott et al. (6h],  however, found that they needed an even more severe screening 
test, as several materials enabled the ring to be thrombus-free for the duration of their 
two-week implantation tests. In order to categorize further these materials with respect 
to their thromboresistance, they introduced a flow disturbance in the middle of the ring 
in the form of an orifice plate or 1 mm wide circumferential "curbstone" (figure 3.5)[601. 
They found that flow separation and recirculation occurring behind the "curbstone" 
'The work reported here and conducted by Yoganathan et al. and Figliola and Mueller included 
the study of the Starr-Edwards 1260 and 2320 (bail), Bjork-Shiley tilting disc, Smeloff-Cutter A-5, 
Cooley-Cutter A-25, and Kay-Shiley caged disc valvesl8ll95j(h13j. 
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Figure 3.5: Cross-sectional view of the "Gott ring" with a "curbstone", which was 
implanted in the vena cava of dogs for evaluation of material th rombogenicity [60]. 
promoted thrombosis; non-ridged rings that remained free of thrombus after two weeks 
of vena caval placement were heavily thrombosed after 30 mm, when a ridge of 0.6 
mm height or greater was present. Rounding the sharp leading edge of the ridge was 
found to eliminate thrombosis when the ridge was 0.6 mm in height, but not when it 
was 1 mm high. These results indicate that thrombus formation is affected not only by 
the surface chemical properties but also by the flow conditions near the surface, and 
that a flow disturbance associated with flow separation and recirculation can promote 
thrombosis, when occurring adjacent to a foreign material, even when that material is 
highly thromboresistarit. 
Vorhauer and Tarnay E 1 O 5lu414h] conducted two sets of experiments in dogs, to evaluate 
the effect of prosthesis shape on thrombus extent. Nine models (illustrated in figure 
3.6) consisting of a body of revolution of 7.6 mm diameter mounted on a support rod, 
both constructed of aluminium and coated with polyurethane, and extending from 
a thin-walled cylindrical stainless steel support sleeve, which fits closely inside the 
artery, were individually implanted in the canine descending aorta. In the first set of 
experiments, the weight of thrombus on the test-body was of interest, so the model was 
weighed before and after each 45 min experiment, with any coagulum adhered to the 
cylinder being removed prior to the final weighing. In the second set of experiments, 
the aim was to correlate the thrombus extent in the cylindrical steel support to the 
level of turbulence caused by the different test-bodies, so only the thrombus within the 
steel cylinder was weighed. In order to avoid the test-bodies themselves accumulating 
thrombus, which would alter their shape and thus the turbulence intensity they cause, 
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(a) First study 
Flow 
direction 
(b) Second study 	 I 
Figure 3.6: Profiles of the models tested by Vorhauer and T arnay [140]. 
each implant was subjected to only 20 minutes of blood flow in the second set of 
experiments. 
36 dogs were used for each set of experiments, with each dog having successive 
implantations of three different models before sacrifice. Each test-body shape was 
tested 12 times and the order in which they were implanted (i.e. first, second or third) 
equally distributed, in order to obtain a mean thrombus weight value and to allow 
comparison of the thrombus extent on the different test-bodies without interference due 
to changes in blood properties during the three experiments in each dog. The ordering 
of test-body shapes was found not to be of consequence, however, as the results of a 
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statistical cross-analysis indicated no significant correlation between thrombus weight 
and order of implantation for each test-object. 
The results of the first set of experiments, using the test-bodies illustrated in figure 
3.6(a), appear to indicate that implant thrombogenicity, as measured by deposition 
on the body itself, is related to the size of associated areas of stasis and turbulence; 
streamlined test-bodies that induce little turbulence and have small wakes, such as the 
teardrop, accumulated the least extent of thrombus. 
In the second set of experiments, the long teardrop-shaped test-body once again proved 
to be the least thrombogenic profile, with regard to thrombus extent in the steel cylinder 
downstream; but for the other test-bodies there was no obvious explanation for the 
pattern of relationships found between the turbulence intensity and thrombus extent 
at the wall of the steel cylinder. Vorhauer found that the steel cylinder, without a 
test-object attached, accumulated a larger quantity of thrombus than when any of the 
test-objects were in place, with the sole exception of the test-body at the bottom of 
figure 3.6(b). The explanation for this result may be that the presence of a test-object 
generally inhibits thrombus formation by disturbing the region of stasis at the cylinder 
wall (i.e. the boundary layer), by redirecting flow towards this wall, but may, in the 
exceptional case, promote deposition, by increasing diffusion to, and cell collisions with, 
the cylinder wall. 
The results of Vorhauer and Tarnay's experiments seem to imply that minimizing the 
size of areas of stasis and the level of disturbance adjacent to a foreign surface (i.e. 
by streamlining an object) will reduce the extent of thrombus formed, and perhaps 
that the effect on thrombus deposition of varying the turbulence level depends on the 
system conditions and the mechanism by which the turbulence acts. 
To determine the effect of turbulence on thrombus extent, Smith et al.[142]  conducted 
experiments in dogs. Two arteriovenous shunts were implanted in each dog from 
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identical in shape, surface area and material, except that one shunt contained a tapered 
constriction, reducing the flow diameter from 4.8 mm to 1.6 mm, producing turbulent 
flow, while the flow in the other shunt was laminar. Electromagnetic flow meters were 
used to monitor the flow rate in both shunts. In order to maintain similar flow rates 
in both shunts, when the flow rate dropped in one shunt (due to thrombus deposition) 
the flow rate was decreased accordingly in the other shunt. Flow was stopped and both 
shunts removed, once the flow rate had diminished to a certain value; this procedure 
resulted in each shunt being subjected on average to 19 min of blood flow per test. 
While no gross deposits were found upstream, thrombi were observed downstream from 
both the turbulence generator and the laminar flow shunt, with the extent of thrombus 
being much greater in the former shunt. 
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Figure 3.7: Diagram of the turbulent and laminar flow shunts, used by (a) Smith et 
a l.[142] and (b) Stein and Sabbah[ 13], through which blood flowed from a femoral artery 
(FA) to a contralateral femoral vein (FV). 
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Stein and S abbah[143] conducted experiments of a similar type to those of Smith et 
al. [142], but with a few differences: the turbulent and laminar flow shunts were of 
similar size but different design (figure 3.7(b)), the dogs used were larger, the mean 
flow rates and Reynolds numbers were lower, and each experiment lasted about 7, as 
opposed to 19, minutes. In addition to their canine studies, Stein and Sabbah used 
heparinized canine blood and a hot-film anemometer, in in vitro flow studies, in order 
to determine the turbulence intensity within the turbulent flow shunt and correlate 
this to thrombus extent. They observed a marked increase in thrombosis when a flow 
disturbance was introduced to the laminar flow field, as did Smith and his colleagues, 
and found that increasing the Reynolds number in the turbulent flow shunt increased 
both the turbulence intensity and weight of thrombi within this shunt. The increase 
in thrombus extent, when going from the laminar to turbulent flow shunt, and when 
increasing the turbulence intensity, may have resulted from the concomitant increases 
in shear stresses, mass transfer of species to the wall, and the number of cell-cell and 
cell-wall collisions. 
The stagnation point flow experiment (SPFE), developed by Dr. Harry Petschek, has 
been used to study thrombus formation both as a function of haemodynamics and 
material surface properties [144][145], as it provides a technique for directly observing 
the interaction of blood elements and thrombus formation on artificial surfaces [146]. In 
this experiment, blood flows directly from the carotid artery of an anesthetized dog 
into a flow chamber (figure 3.8), where the first foreign surface it contacts is a 25 mm 
diameter microscope cover slip on which it impinges and assumes a radially symmetric 
flow pattern. The flow rate through the chamber is variable, and controlled by a 
withdrawal system. The blood flows radially outward, between the cover slip and the 
bottom of the chamber, into a collecting trough from which it is withdrawn at a steady 
rate and discarded. Experiments of up to 3 hours' duration are usually possible, during 
which the interaction of the cellular blood elements, fibrin formation and thrombosis on 
the coated cover slip are directly observed and recorded non-invasively, using dark-field 
illumination and cinematography. The shape of the test-surface (cover slip) and/or 
the blood velocity can be altered to facilitate haemodynamic studies. A more detailed 
[66][146]. description of the system and experimental procedure has been given elsewhere  
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Figure 3.8: Schematic diagram of the flow chamber devised by P et schek[661. 
Petschek and co-workers [39](40][66][h12)(147I(148]  have conducted stagnation point flow 
experiments, during which they have observed white cells both flowing over and 
settling on the surface of the microscope cover slip, individual platelets depositing 
on this surface, the formation of platelet aggregates, red cell entrapment, and the 
flow disturbances caused by platelet aggregates forming on the cover slip. Their 
observations, made both during blood flow and of the stained cover slips, enabled them 
to construct diagrams of thrombus development (figures 3.9 and 3.10), where a number 
of phenomena occur in a definite time sequence, as found in part by others[3h1[h14],  some 
of which are dependent upon the flow and surface conditions. 
Before reporting the results obtained from using the SPFE, it is worthwhile noting 
that the net rate of deposition of blood particles on a surface is dependent upon the 
rate at which the particles are brought to the surface, as well as other factors such as 
surface properties, adhesiveness of the particles and surface shear. The local velocity 
gradient determines the relative diffusion rates of species 5 which may either inhibit or 
Red blood cells tumble at a rate proportional to the velocity gradient, and this tumbling enhances 
platelet diffusion to the surface(h121(1281. 
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Figure 3.9: Sequence of events observed when fresh canine blood impinges on a 
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Figure 3.10: Growth profile of a thrombus as a function of time (t); where t1 < t2 < 
t3 < t4 < i5, W denotes the thrombus width, and r represents the distance from the 
stagnation point(. 
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be essential to the growth process, and is indicative of the shearing stress on any surface 
element. In the case of a jet impinging perpendicularly on a surface, the shear stress at 
the central stagnation point is zero and rises radially outward, unlike the mass transfer 
coefficient which remains constant throughout this region [149]. The following sequence 
of events have been found to occur on the surface of the cover slip in the SPFE. 
Within a few seconds of first blood contact, all artificial materials acquire a rapidly 
thickening film of protein, but no formed elements adhere until about one minute 
after first blood contact, irrespective of the flow rate. At this point, arriving platelets 
begin to adhere to the surface, at a rate dependent on the flow velocity but roughly 
independent of the surface material (i.e. whether or not it is a thrombogenic surface is 
inconsequential), and a monolayer of platelets is formed. However, the morphological 
changes and aggregation potential of the first adherent platelets differ on different 
materials [3h] ; subsequent deposition is dependent upon the surface properties of the 
test-material and the haemodynamics. 
With high blood flow rates and a relatively nonthrombogenic cover slip surface, the 
uniform layer of platelets remains intact, adhered platelets experience no visible 
changes, and the only thrombi that form are wedge-shaped thrombi that originate 
at surface imperfections as small as 20 or 30 pm. The wedge-shaped thrombi have 
their apex pointing toward the stagnation point, grow in different directions at 
different rates (figure 3.10), and their shape, size and structure are dependent on 
local flow conditions[40][112]. The reason why growth of the wedge-shaped thrombi 
is predominantly in the downstream direction may be that the species released from 
the adhered platelet aggregates preferentially collect in the wake of the deposit. 
On surfaces of moderate thromboresistance and/or at lower flow rates, white cells attach 
to the surface within a roughly circular region near the stagnation point. The centre 
of the "white cell circle" (WCC) lies at the stagnation point and its radius decreases 
with increasing flow rate. Since the blood velocity and surface shear increase with 
distance from the stagnation point and with increasing blood flow rate [146], the mass 
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transfer coefficient is constant in the impingement zone [149], and leukocytes only adhere 
below certain shear rates (i.e. white cells attach to polyurethane for shear flows below 
5.5/s, in the SPFE1112]), it appears that the radius of the WCC is shear limited[112]. 
Sometimes, platelet aggregation within the WCC, and wedge-shaped thrombi inside 
or outside the WCC, are observed also. The explanation for white cells adhering in a 
circular pattern, but the other cells not doing so, is not known; perhaps it is because the 
white cell-surface bonds are more sensitive to shear and/or the white cells experience 
a greater force than red cells and platelets, since white cells are larger. 
Under extremely low flow conditions and/or on relatively thrombogenic surfaces, white 
cells may adhere over the entire surface, as well as large, symmetric platelet aggregates 
or thrombi. 
The SPFE can be used to determine relative haemo compatibility of different materials, 
by comparison of platelet population density, the diameter of the WCC, and/or the 
flow conditions below which extensive platelet aggregation routinely forms on the test-
surface. This will not be discussed further, as the effect of haemodynamics on the 
development of thrombi is of most interest here and so is discussed below. 
Assuming that the surface imperfections which initiate thrombi cause local platelet 
aggregation, and that the aggregated platelets release species which can cause further 
aggregation (section 2.2), it has been suggested that platelet aggregate growth occurs 
by an unstable diffusion-limited mechanism °1 , involving diffusion of platelets and the 
chemical species responsible for aggregation. When a platelet encounters a critical 
concentration of activating species near the surface, it sticks to the surface and joins in 
the aggregation, releasing more of the species to activate other platelets. The growth 
of the aggregate can be limited only by a shortage in the release rate of the activating 
species or a shortage in the arrival rate of platelets (figure 2.2). This is in agreement 
with the growth pattern of wedge-shaped thrombi (figure 3.10). 
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The effect on thrombosis of introducing a separated flow region to the SPFE has been 
studied. The SPFE has been performed, using a cover slip with a circular cavity, 
such that the blood flows radially outward from the stagnation point and encounters 
a forward-facing step, which is 250 jim deep and at a radius of approximately 1 mm 
from the stagnation point[148]. The separated flow region, formed upstream of the step, 
was found to contain freely floating platelet aggregates, which were observed forming 
and growing (by collisions with other aggregates) and on some occasions embolizing. 
Presumably, the chemical reactions which cause platelets to aggregate were initiated by 
the agents released on interaction of plasma proteins and cells with the surface material, 
with subsequent mixing of the products throughout the volume of the separated region 
leading to the formation of freely floating aggregates. While extensive symmetric 
aggregation was observed only at the lowest flow in the normal SPFE, all experiments 
with a step present produced symmetric platelet aggregation immediately distal to 
the step, indicating the thrombus-promoting affect of flow separation. Goldsmith and 
Karino[80] have studied cell motions in annular vortices formed at the corner of a tubular 
expansion, using suspensions of human red cells and platelets. They too found that 
freely floating aggregates form in a vortex. 
The results obtained by Petschek and his colleagues indicate that as the flow rate 
is reduced, the chemical properties of the artificial surface become more significant 
and thrombus formation is more likely (as is found when comparing the incidence 
of thrombosis on implants in arteries and veins [12h]).  Under high flow conditions, 
the success of an artificial surface may be more dependent upon the elimination of 
microscopic imperfections than upon the gross properties of the bulk material, provided 
that the material is not extremely thrombogenic. Although increasing the flow rate 
favours thrombus deposition, in that it increases the velocity gradient and consequently 
the diffusion rate of species, it also acts to increase the surface shear and decrease the 
blood-surface contact time, so that thrombus formation is less likely. In areas of low 
shear, such as those occurring adjacent to surface steps or at low flow rates, the blood-
surface contact time is greater and thrombus deposition is more common, even though 
the rate of diffusion to the surface is lower. 
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Figure 3.11: Schematic diagram of the apparatus used by Hiadovec and Riha, and the 
thrombus formed in their in vitro experiments['°]. 
Hladovec and Riha 1501 conducted experiments to simulate the development of a 
thrombus in vitro. They recirculated citrated whole blood, platelet rich plasma (PRP) 
or platelet poor plasma (PPP) through a system comprising a 50 cm long tube, of 3 
mm i.d., with a glass pipe of equal diameter housing a net at its outlet, a pressure 
transducer and manometer, and a peristaltic pump (figure 3.11). Both the entrance 
and exit of the tubing were placed in a siliconized glass cuvette, with a nylon net 
(mesh about 0.25 mm) fixed to the end of the tubing through which blood entered the 
cuvette. The small volume of fluid (about 7 ml) was circulated at 55 ml/min and 300 
pulses/mm, at 37°C or room temperature, with changes in the pressure drop (due to 
thrombus growth) being continuously recorded. 
White thrombus formed on the downstream side of the net only (figure 3.11), at a 
rate which increased with increasing temperature and was unaffected by increases in 
mesh size (from 0.25 to 0.4 mm) and tube diameter (from 2.7 to 4.4 mm). The formed 
thrombus occupied less than 1% of the circulating fluid volume. The plot of pressure 
against time, denoting thrombus development and its resistance to flow, indicated 
the occurrence of three different phases: no noticeable change, followed by a gradual 
pressure rise and some aggregation, and ending with an abrupt increase in pressure 
corresponding to a mass of thrombus formed on the net. All three phases were observed, 
but were of different duration, when using whole blood, PRP and PPP. Although the 
3 Thrombosis and Flow Conditions 	 54 
initial rate of thrombus growth was very small with PPP, relative to blood and PRP, 
all experiments did produce thrombus after about 60 to 70 s. 
The trauma experienced by the fluid constituents, when contacting foreign surfaces and 
being subjected to the stresses caused by the net, is likely to be the cause of aggregation-
inducing species being present in the flow system. The small regions of stasis, in the 
wake of each wire of the mesh, might be expected to trap some of these activating 
species, since these wakes are adjacent to sites likely to cause trauma. Activating 
species would also be released into, and would recirculate with, the bulk flow, but 
no caking of thrombi occurred on the upstream face of the net. Given the concept 
depicted in figure 2.2, regarding platelet stickiness and some threshold concentration 
of activating species, the explanation of thrombus forming on the downstream side 
of the net only, not on the upstream side of the net or in the bulk flow, might be 
that the concentration of activating species exceeds the threshold value in the wake 
of the mesh wires but not in the bulk flow. This would mean that platelet-platelet 
collisions would only result in significant aggregate growth in the wake of the net. 
Another relevant factor might be the shear stress level; while in the bulk flow the 
stresses may be degradative to aggregates, inhibiting their growth, the relatively low 
shear region behind the net is more favourable to aggregation. Lewis[20]  proposed that 
if an increase in the size of the thrombus was accompanied by a larger wake region, 
then with time larger particles might be trapped in this region. This indeed appears 
to be the case, as Hiadovec and Itiha reported that the size of the particles composing 
the thrombus increased with the direction of the flow, as found in vivo. The shape of 
the pressure profiles and the duration of their three phases is as would be expected, if 
a dependence of thrombus growth on species concentration and wake region size did 
exist. The initial build-up of thrombus is slow, more so when less platelets are present 
to supply activating agents, possibly as a result of the dependence of thrombus growth 
on the concentration of activating species and platelets in, and the size of, the region of 
stasis. An increase in wake region, which appears to occur, would explain the abrupt 
increase in thrombus growth rate, as more species and collisions are able to occur in 
this region. These findings appear to illustrate that stasis, which by itself does not 
initiate thrombosis[151],  is essential for thrombosis. 
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3.4 The next step 
An in vitro method for determining the influence of configurational changes on 
thrombogenicity would be of great value to the heart valve designer. It is clear that 
there exists a complicated relationship between thrombosis and the haemodynamics, 
where more than one particular flow condition requires to be present for thrombus 
formation to succeed. The shear stress level, mass transfer rate and regions of stasis 
have all been shown to be influential, but their relative importance to thrombosis 
remains uncertain. It is also apparent that whilst in vitro testing of artificial heart 
valve configurations is an essential tool for refining a given design, and the only route 
to assessing the thrombogenicity of a valve is by collation of experimental results 
for different valves in sequences of animal trials, neither of these methods of testing, 
whether used separately or in conjunction, is completely satisfactory for assessing the 
adequacy or biocompatibility of implants intended for human use. Consequently, a 
nonthrombogenic mechanical heart valve has yet to be designed. In order to improve 
on the present methods of valve testing, one must continue to try different methods 
of analysis. Rather than trying to design a complicated protocol, which enables total 
assessment of the numerous requirements of a heart valve, it may be wise to target 
specific performance criteria and keep the tests simple, feasible and reproducible. It is 
with this in view that the idea was pursued of using a coagulable blood analogue fluid 
in in vitro experiments. 
A coagulable blood analogue fluid, which coagulates in a similar way to blood but not as 
uncontrollably, could potentially be used to predict the thrombogenicity of heart valve 
prostheses. A model which employs such a fluid may also provide experimental insight 
into the effects of valve design modifications and the relative importance of different 
flow phenomena to thrombogenicity. In the cardiovascular flow system, disturbances 
are introduced by the motion of the heart, the valves, and the arterial wall which, 
in turn, affect the flow phenomena occurring. The inability to duplicate such aspects 
of this system means physical models may enable only comparison of valves but not 
prediction of their individual thrombogenicity. If the elevated shear stresses caused 
by the valve are capable of triggering blood coagulation but not the analogue fluid's 
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coagulation mechanism, complementary tests for evaluating the potential of valve-
induced haemolysis and initiation of thrombosis could be combined with tests using the 
coagulable blood analogue fluid to aid in the assessment of prosthetic valves. It is most 
likely that a combination of complementary tests will always be used to evaluate new 
heart valve prostheses, and hopefully progress will take a path away from distasteful 
animal experimentation. 
Promising work has previously been conducted, whereby a coagulable blood analogue 
fluid has been used to identify flow characteristics likely to be conducive to thrombus 
formation. This work, as well as the analogy on which it is based, is described in the 
following chapter. 
Chapter 4 
Milk Clotting and its Analogy 
with Blood Clotting 
The use of blood in in vitro coagulation tests is associated with considerable 
inconvenience and is impractical for many reasons (section 3.2.1). While the use of a 
coagulable blood analogue fluid is unlikely to provide information regarding the effects 
of biochemistry and surface properties on thrombosis, such a fluid could provide a more 
convenient means of studying the hydrodynamic causes of thrombosis. 
Lewis [20] and Christy [211 have noted the numerous criteria that a coagulable blood-
analogue fluid should satisfy: it should be readily available, of reproducible properties 
and composition, inexpensive, safe to use, and as similar as possible to blood in respect 
of its essential clotting propensities and in the adhesiveness and rheology 1 of the 
formed clot. The coagulation of blood is a complex cascade of reactions, probably too 
'Thrombus formation is a cumulative process whose later course is partially dependent on the 
rheology of the clot itself. 
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intricate to be mimicked exactly; however, for the assessment of hydrodynamic effects 
on thrombosis, the effects attributable to blood chemistry and surface chemistry do 
not necessarily have to be replicated. The cascade of reactions leading to coagulation 
can be initiated by damage to the endothelium lining and/or the presence of a foreign. 
material. These two causes are always present when a mechanical heart valve has been 
implanted - the endothelium lining is damaged by the stitches which fix in place the 
sewing ring, and the valve provides the foreign surface. Therefore, the blood passing 
the valve may already be in a hypercoagulable state. Christy and M acleod[24] have 
suggested that if this is an accurate representation of what is occurring it may be 
sufficient for the analogue fluid to mimic only the final stage of blood coagulation, 
that is the action of thrombin on fibrinogen and the subsequent formation of a fibrin 
thrombus, not necessarily the whole cascade of reactions (of the intrinsic pathway) 
leading to the formation of thrombin. 
Several substances undergo coagulation reactions: gelatin, myosin and albumin 
form gels under the action of heat, while other proteins, such as ovalbuminl151 1, 
procollagen [152] and caseinEl 53] (found in milk) undergo enzymic coagulation under 
protease treatment. The analogue fluid considered here is milk. 
Milk is a fluid which satisfies the above blood analogue fluid criteria and has many 
advantages over the use of blood in vitro. Milk is not only more convenient to handle 
than blood (with no infection hazard), but is also inexpensive, readily available and of 
reproducible clotting behaviour over an extended series of experiments. The amount 
of enzyme present in enzyme-induced milk coagulation can be controlled, whereas the 
relevant enzyme present in blood (prothrombin) is present as a precursor and varies 
in quantity from donor to donor. J olles [19] has compared the clotting of milk and 
blood, indicating a number of similarities between enzymic coagulation of milk and 
the final stage of blood coagulation. Other researchers have found that heated milk 
flows, to which cheesemakers' rennet and calcium chloride are added, show clotting 
behaviour and clot morphology resembling those for flowing blood, at three levels. On 
a microscopic scale, Petschek's stagnation point flow experiment with milk" 54 gave 
4 Milk Clotting and its Analogy with Blood Clotting 	 59 
deposition results that were remarkably similar to those obtained with b1ood 39 . On 
a visible scale, the milk curd deposition observed in a system similar to Hladovec's 
net experiment [20] was similar to the in vitro thrombus formation observed with blood 
by Hladovec and Riha[1501. On a gross scale, Bjork-Shiley and Starr-Edwards heart 
valves were tested, in a specially designed heart-valve chamber, and the sites and 
pattern of milk curd deposition were found to be similar to those reported for thrombus 
deposition in Subsequent experiments, performed by Christy 
[21],  produced 
results implicating stasis as a prerequisite for milk curd deposition, but indicating that 
it was not sufficient by itself; agitation was suggested as a necessary concomitant flow 
characteristic for clotting. Whilst these experiments have indicated the suitability of 
milk as a blood analogue fluid, and have highlighted certain flow characteristics thought 
to promote thrombus deposition, there are numerous questions still to be answered in 
this field of work. 
In this chapter milk and its clotting are described, with reference to its analogy to 
blood and thrombosis, and previously conducted work with milk in the capacity of a 
blood analogue fluid is reported. Since development of Christy's work is the goal of my 
research, the difficulties that arose during his use of coagulating milk are outlined, 
and ideas of how to resolve them are discussed. This is followed by a review of 
the dependence of milk coagulability and rennet activity on various factors, which 
is intended to assist workers trying to achieve reproducible milk clotting. 
4.1 Milk 
About 4000 mammalian species secrete milk with characteristics specific to species 
type and geographical position[']. Bovine milk, namely cow's milk, is the milk type 
considered here. 
Milk is an aqueous suspension containing both fat globules and protein-rich 
microparticlesEl 56], called micelles; these micelles are roughly spherical, have a diameter 
between 20 and 600 nm[157], and contain a calcium caseinate-phosphate complex and 
about 80% of the protein in milk. The composition of milk is approximately, by 
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weight, 87% water, 5% sugar, 4% fat, 3% casein and 0.4% other protein[158_160],  with a 
calcium ion concentration of about 30 mM, of which about 27% occurs in the micelleE 11 
(table 4.1). Whole casein is a heterogeneous group of phosphoproteins, with the major 
fractions designated a- fi- and 7caseins[161],  and cr-casein is a complex containing a 3-, 
ic- and Acaseins[162].  The caseins have different numbers of phosphate groups: a 31 -
and a 32-ca.seins have about 8 or 9; /3-casein has about 5; and ic-casein generally has 
one phosphate group. The micelle contains two groups of casein components, one 
soluble and the other insoluble in the presence of Ca2+  at room temperature; the 
insoluble components are a 3-casein and /3-casein, to which calcium ions bind strongly, 
and the soluble protein is ,c-casein, which does not bind Ca 2+  to the same degree 
as the other caseins(155].  The amphiphilic2 ic-casein molecule contains 169 amino 
acid residues[19];  the weakly positively charged N (amino)- terminal two-thirds (para-
lc-casein) are hydrophobic, and the negatively charged C (carboxyl)- terminal third (ic-
caseino(glyco)peptide) is hydrophilic. 
Component Content (g/ 100g micelles) 
a 31 -casein 35.6 
a,2 -casein 9.9 
/3-casein 33.6 
c-casein 11.9 
whole casein 93.3 
calcium 2.87 
inorganic phosphate (PO 4 ) 2.89 
total inorganic material 6.6 
Table 4.1: Average composition of casein micelles in cow's milk at room 
temperature( 163 _ 167 1 
4.1.1 Micelle structure 
There has been considerable debate about the structure of milk micelles, in particular 
the location of i-casein. It is thought that the location of ,c-casein in the micelles 
has a pronounced effect on clotting behaviour, since c-casein acts as the main agent 
for preventing aggregation of the formed micelles and is the casein cleaved during the 
primary phase of enzymic coagulation (section 4.1.2). 
An amphiphile is a molecule which possesses distinct, separate regions of hydrophilic and 
hydrophobic character. 
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A number of models of casein micelles have been proposed, which can be divided into 
three categories: coat-core models; internal structure models; and models in which the 
micelle is considered as an aggregate of submicelles. 
In the coat-core model a core of a 3- and /3-casein is completely covered by r.-casein, and 
thus prevented from flocculation by calcium. It appears that r,-casein does indeed reside 
at or close to the micelle surface, as D algleish[168] found little difference between the 
amount of r,-casein hydrolyzed by immobilized and soluble preparations of chymosin 3 . 
However, Ashoor et al.[169] obtained results that oppose the concept of a coat-core 
model. They added to the milk cross-linked papain, which cannot penetrate into the 
interior of the micelles, and found that all of the micellar caseins were hydrolyzed at 
nearly the same rate as molecularly dispersed sodium caseinate, indicating a mixed 
surface composition. 
An internal structure model was proposed by Rose[17O], in which the micelles were built 
of 13-casein polymers to which a31-  and r,,-casein were attached by hydrophobic bonding 
and which were interconnected by CCP (colloidal calcium phosphate) bridges. Because 
of the dissociation of /3-casein at low t emperatures [171], such a model would imply that 
micelles disintegrate completely upon cooling, which is not observed. 
Several investigators have postulated models consisting of casein submicelles. Pessen 
et al. [172] performed small-angle X-ray scattering on whole casein. They obtained 
results which indicate the micelle consists of two concentric regions of different electron 
density, such as might correspond to submicellar inhomogeneous particles containing 
hydrophobically stabilized inner cores existing within the colloidal micelles (figure 4.1). 
An interesting model is that by Schmidt' 57 , who proposed that a number of small 
subunits, casein submicelles, are linked together by Ca 9(PO4 )6 to form micelles (figure 
4.2). In this model, the submicelles consist of an average weight ratio of a 31 -, a32 -, P_ 
and r.-casein of 3 : 0.8 : 3 : 1, except at low temperatures, where /3-casein dissociates 
from the micelles. The submicelles may be built as shown in figure 4.2a, being 
'This conclusion is based on the belief that diffusion of caseins within the micelle is not fast. 
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almost spherical and having a non-uniform number of r.-casein molecules. Schmidt and 
B oth[180] carried out electron microscopic studies on artificial micelle systems, showing 
that c-casein is almost exclusively located at the m.icellar surface whereas cr 31 - and 
/3-casein are scattered throughout the whole micelle including the surface. Daigleish 
and his colleagues[""] conducted light-scattering studies of milk and discovered that 
the casein micelles have a 3 -caseins composing about half of their surface layer and half 
of their interior, while /3-casein appears to be located almost exclusively in the interior 
of the micelle. They too found c-casein to reside predominantly at the micelle surface, 
and additionally that the hydrophobic portion of ,c-casein is just beneath the micelle 
surface, and is 10 nm long, while the other half assumes an outer 'hair' position 
(figure 4.1). 
fhydrophilic & relatively  












Figure 4.2: Schematic representation of a subnilcelle (a), and a casein micelle (b) 
composed of subrnicelles(1571. 







This end (or hair') of K-casein is cleaved off by the action of chymosin. The amino 
acids on the caseino(glyco)peptide are mostly negative and so this Phe-Met bond 
breakage reduces the micellar net negative charge (-1 8mV to -11 mV, approximately). 
Figure 4.3: r,-casein cleavage[155]. 
The remarkable colloidal stability of the casein micelles is believed to be due primarily 
to electrostatic repulsion and steric stabilization [ 182], and the two constituents: r,-casein 
and colloidal calcium phosphate (CCP). Micellar stability is at least partly governed 
by the fact that micelles possess an overall negative charge on their surface, causing 
them to repel one another and assume spaced out positions [183]. At the natural pH of 
fresh milk, pH 6.6, r.-casein has a -3.9 mV charge, a 31 -casein -20.0 mV, and ,8-casein a 
-12.8 mV charge[' 55], and the native casein micelles have a high negative zeta-potential 
of about _l8mV[184][185]. The hydrophilic C-terminals of K-caseins act like hairs on the 
surface of the micelle [186] (figure 4.1), tending to make it more difficult for micelles to 
come together, taking up space and carrying an appreciable part of the negative micelle 
surface charge. In addition, ic-casein is thought to give stability to the protein micelles 
in milk '87 , by interacting both with water and the hydrophobic a 3-casein 11 ; r,-casein 
is able to stabilize c 3-casein against precipitation with calcium In spite 
of its low proportion, CCP plays a key role in maintaining the integrity of the casein 
micelles [188a][188 . The mechanism by which it does this is, however, uncertain [189,][189b]. 
When chymosin removes the stabilizing macropeptide tails of the r.-casein (figure 4.3), 
it reduces the steric effects and the micelle zeta-potential by 5-7 mV[ 183][184] making 
aggregation more likely. 
4.1.2 Milk clotting 
The enzymic coagulation of milk involves r.-casein (the substrate on which the enzyme 
acts) and the proteolytic enzyme, chymosin, which is the predominant protease in 
the fourth stomach of the young call and catalyzes this clotting reaction with a high 
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degree of specificity. The coagulation of milk by chymosin can be divided into primary, 
secondary and tertiary stages[190],  as outlined below. 
During the primary or enzymic stage, chymosin destabilizes the micelles by shaving 
off the ic-casein 'hair', producing a differently 'coated', more hydrophobic, micelle. 
Chymosin attacks the ,ccasein[187],  specifically cleaving its phenylalanylmethionine 
(Phejo5-Met jo6) bond, with the amino acid groups adjacent to this bond apparently 
promoting the attack at this specific site[191][192].  This yields two peptides of differing 
properties: the hydrophilic, soluble caseinomacropeptide moiety (residues 106-169)(11 , 
which will diffuse away from the micelle after i-casein cleavage, and the para-ic-
casein moiety (residues 1-105), which is strongly hydrophobic and remains with the 
micelle. The progressive hydrolysis of the ic-casein during the primary stage leads 
to the alteration of the properties of the casein micelles, such as rearrangement of 
hydrophobic sites, which increase in number and density on the surface of the casein 
micelles. The efficiency of micelle fusion appears to depend on the number of sites 
activated per micelle, which in turn will be proportional to the enzyme concentration. A 
certain extent of ic-casein proteolysis, about 80%[194),  appears necessary before effective 
aggregation is possible. Each micelle is a large assembly of thousands of individual 
casein molecules, containing a few hundred or thousand ,c-casein molecules, and the 
enzyme needs time to orientate itself onto the ic-casein molecule. This phase is therefore 
a relatively slow one, dependent on the chymosin concentration, and is termed the lag-
phase, during which no solid particles are present. 
The aggregative phase is the secondary or non-enzymic stage of the reaction, during 
which the formation of coagulum occurs as the destabilized casein micelles aggregate 
in the presence of calcium ions. Ca2+  ions accelerate this stage, probably because 
they help neutralize the already weakened micellar negative charge (section 4.4.5). 
The milk clot is made up of the three proteins para-ic-casein, c-casein and /3-casein. 
The secondary step is accompanied by an increase in the milk's turbidity and viscosity, 
with the probable formation of linear chains. Subsequently, linear casein chains start to 
cross-link and this leads to a sol-gel transition, where milk changes from a viscous fluid 
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to a viscoelastic solid. The curd becomes firmer as casein hydrolysis, more cross-links 
and structural rearrangements continue to occur[195]. 
The tertiary stage [196]  involves processes such as syneresis (the expulsion of liquid by 
the curd) and non-specific proteolysis of the caseins in the curd. 
4.1.3 Milk clotting time and reaction order 
By the criterion of the visible appearance of clots in enzyme-treated milk, the rate 
of the milk clotting reaction, to a first approximation, is directly proportional to the 
concentration of clotting enzyme11971.  However, the appearance of visible clots is the 
result of two different reactions, the enzymic attack on ,c-casein and the aggregation of 
micelles, which are not separable[194],  since aggregation is initiated before conversion 
of the ic-casein substrate by the proteolytic enzyme(s) is complete. The time required 
to complete these two phases (t 0 ), when milk is renneted4 , is generally referred to 
as the rennet coagulation time (RCT) and can be represented by the two-term loIter 
relationship[198_ 201 ] : 
IC 
t 0 	- + t2 .. . (4.1) 
'- enz 
where Ce, is the rennet concentration, t2 is the time between the end of the primary 
enzymatic reaction and the onset of the clotting and K is a constant. The first term on 
the right-hand side of this equation corresponds to the time taken for the primary phase 
of milk coagulation, and the second term represents the duration of the second phase 
(aggregation). This equation can be improved, if the enzymic stage is defined and if 
both the state of the system at which visual clotting is observed, and the relationship 
between the enzymic and coagulation stages are es tablished(1 90]. Equations[202][203] 
more complicated than equation 4.1 have been formulated, but how well these and 
equation 4.1 fit experimental results is determined by the system conditions (section 
4.4.5). For example, a drop in pH, or a change in Ca2+  concentration, may alter the 
basic premise on which an equation is based. 
"Milk can be coagulated by the addition of cheesemakers' rennet, which contains chymosin (section 
B.2). 
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The two phases of milk coagulation have varying degrees of dependence on different 
system variables. The enzymic (lag) phase appears to be chemically limited, with 
factors such as the temperature and enzyme activity and concentration dictating the 
rate of micelle destabilization [201,], while diffusion and C a2+ concentration are very 
important in the aggregation phase [206b]. Therefore, system conditions will play a large 
part in determining which of the two stages will be the rate determining step (R.D.S.) 
and thus the apparent reaction order. 
The activation of micelles is such a slow process that the degree of mixing need not be 
very large for the enzymic phase to be the R.D.S. To determine the effect of agitation 
at different stages during the coagulation of milk, a modified version of the Lee-White 
test was conducted by Christy [24][21]. The Lee-White test is a simple test that was 
previously devised for blood clotting analysis [211];  1 ml of blood is placed in a 8 mm 
i.d. test-tube, which is then plugged and inverted every 30 s, and the end-point taken 
as the time when the blood no longer flows. Christy's tests also involved inversions 
every 30 s, but had one 30 s period chosen, for each test, during which the test-tube 
was shaken vigorously. Christy used a mixture composed of 5 ml of unpasteurized 
milk and 0.4% (vol.) of both cheesemakers' rennet 5 and saturated CaC1 2 solution, at 
33°C. No matter at what stage during these tests agitation was performed, the clotting 
time was always 2.5 minutes. Agitation during the lag-phase did not enhance clot 
formation. However, when agitation was carried out at the stage when particles first 
became visible to the naked eye, a preferential deposit of coagulum occurred at the 
wall of the test-tube whose adhesivity to the surface was greater than if no agitation 
had occurred. The interpretation of these observations may be that during the early 
enzymic stage there are no precipitated particles which agitation can induce to collide 
and the diffusion of enzyme to the micelle surface may not be the limiting aspect of 
this stage. On the other hand, in a region where the fluid has spent a time long enough 
to develop incipient particles, agitation aids clotting by increasing the collision rate 12081  
between activated micelles and promoting their intimate contact with the solid surface 
to which they bond. No reduction in clotting time is observed, either because this test 
5 Rennet contains the enzyme chymosin. 
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is performed in such a way that the clotting time is very approximate (solidification 
being checked for only every 15 s) and/or because the second phase is so fast at this 
temperature and Ca2+ ion concentration that agitation, whilst enhancing collisions, 
may not be able to make a marked difference in the clotting time. 
4.1.4 Comparison of milk and blood, and their coagulation 
The fluid mechanical properties of milk are substantially different to those of blood, 
but this does not seem to be a significant factor in the comparison. Milk is known to 
show a very slight increase in viscosity with falling shear rate[ 209],  while the viscosity 
of blood increases much more rapidly (figure 3.3). Even at shear rates which are 
high enough to make blood behave in an approximately Newtonian manner, milk and 
blood still possess several fluid mechanical differences. For example, whole blood and 
milk have a density of approximately 1059 kg/m 3 [78] and 1030 kg/m3 [210] at 25°C, 
and a Newtonian viscosity of about 0.0033 kg/ms[82] and 0.0013 kg/msE2121  at 37°C, 
respectively. In addition, non-Newtonian flow properties exist in blood due to red cell 
spin and migration, which lead to increased diffusion rates [213];  rennet causes a small 
reduction in milk viscosity [214], which increases diffusion in milk; and the fat globules 
and micelles in milk will affect its flow properties. Such fluid mechanical differences 
between milk and blood do not appear to invalidate the inferences drawn from results 
obtained using milk as a coagulable blood analogue fluid (section 4.2). 
Although blood and milk are markedly different constitutionally (milk being a 
suspension of micelles and fat globules which have little in common with platelets, 
erythrocytes and leukocytes present in blood), it has been found that the. enzymic 
coagulation reaction of milk resembles the final stage of blood coagulation (figure 4.4). 
Jolles [19] compared the structural aspects of the clotting of milk and blood, and showed 
that although there are obvious differences between the two there is an overall similarity. 
Both reactions occur as a result of the action of a proteolytic enzyme on a soluble protein 
to yield an insoluble protein, which undergoes a second order polymerisation reaction 
to form a fibrous mesh; and furthermore, the kinetics of the two reactions appear to 
be the same [215]. Both clotting reactions exhibit an induction period during which no 
	
4 Milk Clotting and its Analogy with Blood Clotting 	 ITM 
In Milk: K - casein 	
Chymosin 	Para - K - casein (insoluble) 
pH 6.8 + caseino(glyco)peptide (soluble) 
Thrombin 	Fibrin monomer 	> Fibrin gel 
In Blood: Fibrinogen 	 + 
Fibrinopeptides 
Figure 4.4: The milk clotting reaction and latter stage of blood coagulation[19] 
solid material is visible, and the duration of this lag-phase is inversely proportional to 
the enzyme concentration and reduced by an increase in temperature. The lag-phase 
of both clotting processes is followed by the appearance of particles which rapidly 
coagulate to form a structured clot, and the final stages, syneresis and fibrinolysis, 
both act to break down the formed clot. 
The causes of the lag/induction phases in blood and milk coagulation may be different, 
although both are likely to be due in part to a difference in reaction order between 
the enzymic and polymeric reactions[216].  In blood, the formation of a cross-linked 
mesh appears to require the removal of both fibrinopeptides, FPA and FPB, from the 
fibrinogen substrate, with the removal of FPA occurring first[217][218].  In experiments 
in which the rate of release of these fibrinopeptides is measured, a delay is apparent 
before any FPB is released. The delay in the coagulation of milk appears to be due 
to a threshold value of the extent of ,-casein cleavage, below which micelles cannot 
aggregate[168](219], as several active sites on a micelle are needed before collisions will 
lead to coagulation[215](220]. 
Both thrombin and chymosin are proteases, which have very high specificity, causing 
limited proteolysis of specific linkages in the fibrinogen (Arg-Gly) or ,c-casein (Phe-Met) 
molecule respectively, resulting in each case in the liberation of soluble acid peptides 
(fibrinopeptides or caseino(glyco)peptides) and an insoluble portion (fibrin or para-i- 
2+ casein) which polymerises, in the presence of Ca. 
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The amino-acid sequences surrounding the thrombin- and chymosin- sensitive linkages 
of milk #c-casein and human fibrinogen determine in part the susceptibility of 
these linkages to thrombin and chymosin hydrolysis [19][191][192][22 ]. The length 
[222], 
composition and sequence [221] of peptide substrates have been found to be important 
determinants of enzyme-substrate interaction prior to hydrolysis. In particular, there 
are indications [221] that hystidine residues of both r,-casein and human fibrinogen play 
an important part in the interactions between these two proteins and their respective 
proteases. Several long sequences in r.-casein, corresponding to 80% of the molecule, 
have 31-42% homology with the fibrinogen moleciile [155], indicating an additional 
commonality. That the two fluids are genetically related is supported by work done 
by Fiat et a l.[225], who found that there is an immunological cross-reactivity between 
bovine fibrinogen and bovine K-casein. 
The above mentioned similarities between milk and blood coagulation prompted 
experiments to compare the adhesion of clotting milk to surfaces and the behaviour of 
blood under similar circumstances. Some of these experiments are described in section 
4.2, indicating the similarities between deposition from milk and blood flows. 
4.2 Experiments demonstrating the milk-blood analogy 
If milk is to serve as a blood analogue in clotting studies, where the location and growth 
characteristics of deposition are of interest, it must be capable of depositing clot in 
identical locations and in similar relative amounts to thrombus formed in vivo, under 
the same flow conditions. This implies either a clotting reaction kinetically similar 
to that of fibrin, if kinetics are dominant, or similar diffusive behaviour of clotting 
elements if the reaction is diffusion-limited. The formed clot should also adhere to 
surfaces and have rheological properties similar to those of thrombus. 
4.2.1 Clot adhesion 
It appears that the adhesiveness, and thus the extent, of milk and blood deposits at a 
flow boundary, are partially dependent on the type of surface material. The stronger 
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the adhesive bond between the clot and the surface, the greater the potential for a 
large deposit to develop. 
Berridge [116][2271 has examined the adhesion of milk coagulum to a number of different 
surfaces under similar conditions. To allow the enzymic phase of the rennet action 
to be completed prior to experiments, Berridge treated raw milk with 0.024% (vol.) 
rennet, at a temperature of 2-4 °C, 18 to 24 hours before each experiment. This cold 
renneted milk was pumped (at about 200-250 ml/min) via a heat exchanger (which 
elevated its temperature to 30'C) to a mixing cell where it was mixed with a flow of 
CaC12 (usually 1 ml/min, corresponding to approximately 0.45% (vol.)) sufficient to 
ensure immediate coagulation on the test-material 6 . A film of the milk mixture, on the 
point of clotting, flowed down a strip of material (usually 25x l.OxO.l cm) suspended 
vertically by one end from a balance, producing adhered clots of varying weight. The 
weight of the strip, and any attached clot, was recorded at intervals until the clot fell 
off. A strip coated with cholesterol gave by far the best adhesion (a clot of 9 g was 
achieved after 2.5 hours, with no clot loss), whereas coating the strip with lecithin or 
viscose gave poor clot adhesion (reaching at most 1.5 g of clot before clot dislodgement). 
These results and those he obtained from other material tests led Berridge to conclude 
that the extent of curd adhesion could be reduced to very low levels, if not zero, when 
the surface is very hydrophilic and a compound of carbon, hydrogen and oxygen only, 
and a sink for C a2+. Withdrawal of C a2+ reduces the rate of the clotting reaction. 
The curd adhesion being more extensive when on hydrophobic surfaces, as opposed to 
hydrophilic surfaces, agrees with the known importance of hydrophobic interaction in 
clotting [189a][195]. A hydrophobic surface might promote coagulation of micelles at the 
surface, because the tendency for milk to clot in the bulk, as opposed to at a surface, 
will depend on the interaction forces between the destabilized micelles themselves and 
that between these micelles and the surface. If the surface is more attractive to the 
micelles, then the micelles will adhere to the surface preferentially. 
6 Renneted milk at 4°C will remain a fluid for h ours [228], but at 37°C will clot in less than a minute. 
If extra calcium is added clotting will take place in seconds. 
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The experiments of Gott [61][59]  (reported in section 3.3.3), in which rings of different 
materials were implanted in the venous circulation, and BerridgeE 2271 , with milk 
(reported above), illustrate the importance of surface chemistry in coagulation. The 
protective action of lecithin, when used to coat the surface of a milk test piece, is very 
similar to that of heparin coating a Gott ring. This similarity in the material-dependent 
nature of both coagulation reactions is perhaps attributable to the influence of material 
properties on protein adsorption, given that the initial stage in the adhesion of both 
thrombus and milk curd appears to be the adsorption of a protein layer on the surface. 
Before a protein molecule can be adsorbed to a surface it must approach the surface 
closely enough to allow interaction between the molecular forces involved. This 
approach is governed by diffusion, so flow and/or stirring or agitation, as opposed to 
stasis, might be expected to enhance mass transfer and thus the deposition rate. Results 
have been obtained which imply flow[2261  and agitation[241  increase the extent and 
adhesiveness of milk clot. Berridge (226]  found that renneted milk, which is about to clot 
and that is continuously passed over a surface, forms clot which has stronger adhesion 
than a clot formed in static milk. He stated, "adhesion in the system milk+rennet 
occurs most markedly when milk on the point of clotting is moved continuously over 
a surface(227l.  This may be due to the increased mass transfer rate of micelles to an 
attractive surface, and enhanced collisions /fusion of deactivated micelles. The results 
of the modified Lee-White tests, conducted with milk by Christy(24]  and described in 
section 4.1.3, indicate that agitation can result in a tendency for solid-liquid boundary 
clot formation as opposed to coagulation of the bulk fluid, and improved clot adhesion. 
4.2.2 Clot rheology 
Scott B1air[209]12291E230]  has shown that there is a general similarity between the setting 
process of bovine (and human) blood coagulated by plasma geloplastin, and of milk 
coagulated by chymosin, and between the rheological properties of the formed clots. He 
conducted experiments using 50 ml samples of blood or milk in a U-tube gelometer[209], 
with air pressures being applied alternately to each side of the column of setting fluid. 
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The changes in rigidity of coagulating milk and blood with time follow a similar pattern, 
as illustrated in figure 4.5. However, rigidity moduli (G) of even the very soft blood 
coagula were many times greater than those of a well-established milk gel. The formed 
coagulum is simpler for blood than for milk, thrombus behaving like a Maxwell body  
and milk curd as a Burgers b ody8 C2291(230]. Scott Blair found blood coagula to show 
extremely simple rheological behaviour, except in the earliest stages of coagulation 
when the blood gels resembled those of milk. Unlike milk gels, blood coagula gave very 
simple "creep" curves and almost immediate elastic recovery when the applied pressure 
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Figure .4.5: Plots for coagulation of milk (by rennet) and blood (by plasma 
geloplastin)1209]. 
Although the viséoelastic behaviour of blood clots and milk gels are not similar, 
they are not drastically different, with the rigidity modulus of both blood and milk 
clots during the initial stages of clotting being in the region of 0-200 N/rn 2 [2091 . 
The above mentioned differences in rheology between blood and milk clots could 
T A Maxvç,eli body is like a single elastic spring attached in series to a single viscous dashpot. 
Burgers body is like an elastic spring and a viscous dashpot attached in parallel, connected in 
series with a Maxwell body. 
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cause some variation in the behaviour of clot, especially in oscillating high shear 
flows; to compensate for this, the rheology of the clot deposited from milk could be 
controlled over a wide range by adjustment of added electrolyte concentration [2311 and 
temperature J2321 (section 4.4.5). 
4.2.3 Milk experiments by Lewis and Christy 
With the desire to establish an in vitro means for determining the effect of implant 
configuration changes on the clotting tendency of prototype devices, Lewis and 
Christy devised milk experiments with previously performed in vivo and in vitro blood 
experiments in mind. The milk mixture they used comprised heated unpasteurized 
milk and small amounts of commercial cheesemakers' (calf) rennet essence and calcium 
chloride. They concerned themselves with deposition patterns and not with the full 
sequence of reactions that lead to blood becoming hypercoagulable, starting the analogy 
at the stage where blood and milk have coagulating species present and are in the 
vicinity of a solid object. The assumption on which their work was based was that the 
presence of a heart valve or other foreign body will initiate the sequence of clotting 
reactions which lead to the blood becoming hypercoagulable and, since the lag-phase 
of blood is very short, any stasis or regurgitation could enable blood to remain in 
contact with the sewing ring and artificial valve for a time in excess of the lag-phase. 
Accordingly, having assumed that the blood is in a hypercoagulable state, which is likely 
if it is passing over a rigid, foreign material[233], their intention was to determine under 
what hydrodynamic circumstances the activated milk and, by inference, blood will clot 
on that surface. The lag-phase of milk coagulation enabled milk flow experiments to be 
conducted, where bulk coagulation does not occur until the milk leaves the test-section. 
Thus, any clot found on a test-object in the flow is not due to bulk coagulation of the 
milk at that point. The experiments conducted by Lewis and Christy, their limitations 
and the implications of the results obtained are considered here. 
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Experiments by Lewis 
To determine whether or not deposition from activated milk and blood is affected 
in similar ways by the same fluid mechanical phenomena, a series of experiments, 
executed previously with blood, were performed by Lewis [20][22][154]: the Lee-White 
test; the stagnation point flow and net experiments; and a test for assessing heart 
valve thrombogenicity, based on hydrodynamics. His results indicate that the clotting 
behaviour and clot morphology (he clot form and structure) of coagulating milk flows 
resemble published results for flowing blood, at three levels: microscopic, visible and 
gross. 
Lewis's first milk test was the Lee-White test, which was briefly described in section 
4.3.1. In these tests, Lewis used 5 ml of unpasteurized milk and 1% (vol.) of rennet 
and saturated aqueous CaC12, at room temperature, and found milk to behave in a 
manner apparently identical to blood, forming a stationary plug of clot after a definite 
time delay. Lewis also used the Lee-White test for the assay of clotting activity of 
rennet and milk, to check for inconsistencies prior to tests. It is noteworthy that these 
Lee-White tests provide only approximate clotting times, as 30 s between inversions is 
a relatively long time. 
Lewis investigated deposition from a milk mixture flow at different times, temperatures 
and levels of shear stress, in a stagnation point flow chamber, similar to that used by 
Petschek 1  with canine blood (described in section 3.3.3 and depicted in figure 3.8). 
The results of this work, which allowed comparison of the microscopic deposition of 
renneted milk impinging normally on a glass cover slip with the blood deposition studies 
by Petschek et al.[66][114], signify similitude of clotting behaviour for milk and blood. 
There was a striking resemblance between the microscopic appearance of the milk and 
blood deposits forming at and around the stagnation point, and between the sequence 
of events during these depositions. In medium and low shear flows, Lewis observed 
wedge-shaped deposits that, as with blood, appeared to be initiated at imperfections 
on the cover slip. Lewis also found, as did Petschek, that clots did not form at all in 
high shear flows. 
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Lewis constructed a replica of Hiadovec and Riha's 150' net apparatus, described in 
section 3.3.3 and illustrated in figure 3.11, to simulate the development of a thrombus, 
using milk. Ten ml of the milk mixture was circulated by a peristaltic pump at 
75 ml/min, through a 50 cm long, 3 mm i.d. tube containing a net at its outlet. 
Remarkable similarities were found between the results obtained with blood and milk. 
Milk clot was found to form downstream of the net, and the pressure variation upstream 
of this net revealed three distinct phases of deposition similar to those observed with 
blood. Furthermore, microscopic examination of the sectioned milk coagulurn formed 
revealed a similar structure to that reported for blood. The milk clot comprised a 
protein network in which the size of the trapped constituents (fat globules) increased 
with distance from the net, and calcium deposits were at its most downstream end. 
The time of clot formation was found to be unaffected by variation in mesh size and 
decreased with increasing temperature, as found by Hiadovec and Riha with blood. 
The shearing effect of the flow was found not to dislodge clot from the net, indicating 
a well adhered clot. This is not surprising, given Berridge's observations12271  (section 
4.2.1) and Christy's findings [211  that sufficient stasis and agitation will promote the 
formation of well adhered clot. 
Lewis further extended the range of this experiment by assessing the effects of varying 
mesh material, milk temperature, and the rennet and CaCl 2 concentrations on clotting 
time and clot extent. Variation of the net material type did not appear to alter the 
clotting time, but did alter the final quantity of clot adhered to the mesh; this is in 
agreement with the findings of Berridge[227],  that adhesion of coagulating casein differs 
on different surfaces. The relationships between clotting time and temperature, rennet 
concentration and CaC12 concentration are shown in figure 4.6, where the clotting times 
correspond to the time taken for a 30 mmHg increase in pressure drop to occur(2l.  The 
effect of fluctuations in rennet and CaC12 concentrations could be minimized in future 
experiments, by adopting reagent concentrations which lie on the plateau of the plots 
for these reagents; however, no temperature-independent region appears to exist, so no 
choice of experimental conditions can reduce the importance of temperature control. 
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Figure 4.6: Variation of milk clotting time with varying temperature, and rennet and 
calcium chloride concentration[20]. 
The results of the Lee-White test, together with those of the net and stagnation point. 
flow experiments, indicated fax reaching physical similarities between milk and blood 
deposition. These justified Lewis's next step, which was to investigate milk deposition 
on prosthetic heart valves using milk and an artificial heart chamber. 
Unpasteurized milk was pumped at a fixed rate from a 140 litre reservoir to a degassing 
vessel, via a heat exchanger- which elevated its temperature to between 36 and 43 ° C. 
The degassed milk was pumped to a constant head tank, from which it was drawn by 
the pulsations of a hydraulically driven diaphragm pump of an artificial heart system 
through the prosthetic valve(s) under test. These valves were housed in rigid, perspex 
heart chambers situated at the diaphragm pump's entrance and exit, respectively. The 
heart chambers had circular cross-section and the same hydraulic diameters as the 
respective flow areas adjacent to the mitral and aortic valves in the human heart. 
Upstream of this artificial heart system about 1% (vol.) of rennet and CaC12 were 
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continuously injected into the milk flow. The milk flow was at a rate in the range 1.5 
to 3 1/mm, giving experimental durations between 45 to 90 mm, and had a pulsatile 
frequency of 60 to 70 beats/mm. At the end of each experiment, the valves were 
removed for examination and their clot formations were photographically recorded. 
The aim of the valve test was not to provide information on blood chemistry or surface 
chemistry effects but to determine whether or not valve sites prone to thrombus 
deposition could be identified by trials with milk more readily than by existing 
techniques. Lewis was unable to rank the valves relative to one another with respect 
to their thrombogenicity, due to obvious deposition variation resulting from the valves 
available being constructed of different materials. He did, however, obtain results 
that indicated the promise of renneted milk as a blood analogue fluid. Lewis found 
that the location and appearance of the clots forming on the valves with renneted 
milk were similar to thrombus found in clinical practice, and that the results were 
reproducible. Curd deposited on the struts and sewing ring of the Bjork-Shiley valve 
(figure 1.2(d)), which are locations prone to thrombus deposition in vivo, and sometimes 
a more generalised clot formed on the disc. Milk curd formed inside the sewing ring 
and on the struts, but not at all on the ball, of the Starr-Edwards prosthesis (figure 
1.2(c)). These locations of curd deposition are common sites of thrombus in vivo, with 
the exception of the valve struts, which seem to accumulate very little thrombus in 
vivo. Lewis suggested that this difference might be due to the walls of the ventricle 
or aorta contacting the struts of the caged-ball valve, as the thrombus found on these 
cage struts in vivo, if any, is on the inside rather than outside of the cage. 
Lewis also studied the effect of varying a few aspects of the system conditions. A 
reduction in the flow rate resulted in greater deposition on the valves (as is found 
with blood in vivo [121]); this may have been due to lower shear, greater fluid-surface 
contact time and/or the extended time interval from when milk is first renneted to when 
it contacts the valve. The earlier the milk is renneted, the more imminent clotting 
becomes. This was made obvious by the finding that all valves placed in the aortic 
position in the artificial heart chamber experienced much greater clot extent than when 
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in the upstream mitral position. An increase in rennet concentration, or slight increase 
in temperature (i.e. 2 11 C), were also found to increase clot extent, acting to reduce the 
clotting time. 
The assumptions on which the milk-blood analogy experiments were based have proved 
to be acceptable, as the milk clotting results Lewis obtained from several experiments 
correlated well with the location and appearance of thrombus formed with blood under 
similar flow conditions. It is, therefore, apparent that renneted milk shows great 
potential as an analogue fluid for use in assessing flow-related implant thrombogenicity. 
The only warnings that appear at this stage are the variations in appearance of 
milk deposits due to bubble impingement and that, in order to avoid misleading 
indications due to surface chemistry variations, comparisons of clot extent between 
different implants should be restricted to implants that are prepared in a similar way 
and are either constructed of or coated with similar materials. 
Experiments by Christy 
Given the promising milk clotting results obtained by Lewis, Christy[' 11 endeavoured 
to devise a milk experiment allowing identification of flow characteristics conducive 
to thrombus formation. A simple flow chamber and determinate, identifiable flow 
patterns offer at the outset a plausible way of attempting to differentiate the effects of 
different flow phenomena, so Christy did not develop a model designed to mimic the 
heart but rather developed an easily characterizable test-chamber for these pioneering 
experiments. Christy and M acleodE23l[24] constructed an apparatus (figure 4.7), which 
allowed them to examine curd deposition from steady and pulsatile milk flows on four 
simple bodies of revolution axially located in a cylindrical test-chamber, and compared 
their results with those obtained by Vorhauer and Tarnay' °1 for blood deposition on 
similarly shaped test-bodies suspended in the canine descending aorta (section 3.3.3). 
In the milk experiments, 15 to 30 gallons of fresh, unpasteurized milk was drawn by 
a peristaltic pump from milk containers through a plate heat exchanger, where it was 
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Figure 4.7: Schematic diagram of Christy's apparatus. 
heated to 37°C, then through a degassing vessel containing ceramic balls, and into 
an elevated header vessel. The milk then flowed at 2 I/min to the 18" long, vertical 
test-section, either steadily under the influence of gravity or in a pulsatile manner (70 
pulses/mm) by means of a diaphragm pump. Immediately prior to the test-section, 
the milk stream was divided into two equal streams to allow continuous injection of 1% 
(vol.) cheesemakers' rennet into one and saturated aqueous calcium chloride into the 
other stream. The two streams were then recombined near the entrance to the test-
section, ensuring that the calcium chloride and rennet were well mixed with the milk, 
and a diffuser nozzle at the mouth of the test-chamber provided a gradual increase 
in the flow cross-section, from 10 mm to 32 mm. An axisymmetrical test-object was 
mounted axially in the test-chamber, fixed at its downstream end to a vertical 50 mm 
long stainless steel rod. The milk stream leaving the test-section was sent to a drain 
which was copiously flushed with water. The four test-bodies used in these studies were 
the teardrop, sphere, disc and upstream-apex cone depicted in figure 4.8, all of which 
were fabricated of P.V.C., with the exception of the sphere, which was nylon". At the 
9 Christy apparently assumed that the effect on clot deposition of this compositional difference is 
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Figure 4.8: The four test-body shapes used by Christy (flow direction upward). 
end of each milk experiment, which had a duration of about 35 mm, the test-object 
was removed, photographed and weighed. 
The mean residence time of the bulk milk mixture, on passing the test-object, was 
kept much less than the estimated lag-phase time for coagulation. The time required 
to achieve a non-flowing plug in a modified Lee-White test at 37°C (with inversions 
every 15 s), lay between 30 and 45 s. The residence time of the renneted milk prior to 
encountering the test-object, determined by Christy using water intermittently injected 
with dye, was 9 ± 3 s. 
The main purpose of the milk clotting system devised by Christy and Macleod, with its 
rigid, cylindrical test-section, was not to mimic a heart but to assess the relationship 
between flow characteristics and deposition. However, if comparisons were to be made 
between deposition in this milk system and that occurring in vivo, dynamic similitude 
would be desired. Nerem 1  has shown that the onset of turbulence in pulsatile flow 
depends on both the Reynolds number (Re) and the frequency parameter (a) (defined 
in section 3.2), and these quantities were also suggested by Schu1tz 235 and others[2]  as 
the standard ratios for ensuring dynamic similarity in pulsatile flows. Thus, in order 
to correlate the clot formations occurring in the milk experiments described above to 
those expected in dog or man, the Re and a values of the respective systems should 
ideally be similar. 
negligible. This assumption will be used here, for discussion purposes, but it is suggested that one 
should endeavour to use similar materials whenever possible. 
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Schultz 1235  reported that for large, 20 kg dogs, the diameter (d) of the aorta in the 
neighbourhood of the aortic arch is between 1.5-2 cm; the kinematic viscosity (ii) 
is 4x10 6 m2 /s; the mean flow velocity (ii) is 0.125 m/s; and the heart beat rate is 
between 150-200 pulses/mm. Where Re = and a =these values for a dog 
correspond to a Re = 470-625 and a = 15-23. Vorhauer's test-bodies had a diameter 
of 7.6 E140], so their Reynolds number, Re 3 _b0d, would have been about 240, in 
dogs with the above cardiovascular characteristics. 
The human adult aorta has a diameter of about 25-30 mm' 3]; the viscosity and density 
of blood (at 37°C) and the cardiac output of an average healthy adult at rest are 
approximately 0.0033 k g/ms [82], 1054 and 5 l/min [237], respectively; and 
the pulse rate in man is about 55-100 pulses/min L 235li2l. The above values for man 
correspond to a Re = 1120-1340 and a = 17-27. 
The viscosity and density of unpasteurized milk are 0.0013 kg/ms (at 35°C) [2121 and 
1030 kg/M3  (at 20°C)[210] , respectively. Christy chose to use a test-chamber of 32 mm 
i.d., a milk temperature of 37°C, and a milk flow rate and pulse rate of 2 I/min and 
70 pulses/mm, respectively. He also employed a systole diastole ratio 10 of 1 : 1 1  
to give a simple sinusoidal pulse and for ease of analysing the flow. These conditions 
approximately correspond to" a Re 2 1051, Retest -bo dy = 328, and a = 39. 
The consequences of the values of Re (1051) and a (39) in the milk flow being much 
greater than those of the Re (470-625) and a (15-23) of blood flow in dogs and different 
to the values in man (Re = 1120-1340 and a = 17-27), are that comparisons of 
results obtained from the milk experiments to results from in vivo studies of thrombus 
deposition might not be appropriate. Increasing the Reynolds number may increase 
`Typically a systole : diastole ratio of 3: 5 occurs in humans [2h1;  some investigators have conducted 
in vitro studies using this ratio, and others have adopted values such as 3 : 
4(3) and 1 : 2 1901 . 
"I have discovered that Christy published miscalculated values 
(241, writing that "the mean pipe 
Reynolds number is 700, the mean Re based on the projected diameter of each test-object is 220, and 
ct is 25". The incorrect values of Repipe and Ret e st—body were apparently due to the use of an incorrect 
milk viscosity of 0.002 kg/ms and a slightly high value for the density of milk. The value of a is 31.1, 
when using the value 0.002 kg/ms for milk viscosity, so some additional mistake was also made by 
Christy to obtain a value for a of 25. 
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both the size of the flow disturbance caused by the test-bodies and the duration for 
which this disturbance lasts. Increasing the frequency parameter might increase the 
propagation of disturbances and make the flow less stable; however, Christy 
[241  has 
found that varying a by about 12% appeared to have no influence on the overall 
structure or behaviour of the flow in dye experiments conducted using water in place 
of milk, indicating that the results of clotting experiments may not be very sensitive 
to variation of a. 
Christy found that the coagulum deposited on the upstream face of each test-body 
varied more in extent from one experiment to the next, was generally more randomly 
distributed, and had a more coarse-grained spongy appearance than that deposited 
on each test-body's downstream side (figure 4.9). The deposit on the upstream face 
possibly arose for reasons not related to the shape of the object, perhaps due to 
bubbles adhering to this part of the test-body or impinging clot dislodged from the 
test-chamber wall further upstream. The downstream coagulum, however, indicated a 
more reproducible, less random deposition pattern. Accordingly, the character of the 
downstream deposit was the quantity further analysed. 
Christy chose to compare his milk deposition results to Vorhauer's thrombus deposition 
results, which were obtained using similarly shaped test-bodies implanted in dogs 
(section 3.3.3). Figure 4.10 allows a comparison of the deposition results obtained 
by Vorhauer to those obtained by Christy, indicating that there are both differences 
and similarities between the two sets of results. In pulsatile flow milk experiments, 
Christy's ordering of the test-body shapes, based on the extent of deposit adhered 
to the test-objects, is the complete opposite of that based on the results of Vorhauer's 
work; in the steady milk flow experiments, however, a close similarity exists between the 
relative extents of canine thrombus and milk clot. With the exception of the teardrop, 
which was associated with the second largest extent of milk clot but the least canine 
thrombus, the order of clotting propensity for the test-bodies was the same for steady 
milk flows and canine blood flows. 
I.: 	(iii 1,-,l 	 Illc I.\('. 	II)jI( t 
after a milk experiment: (a) & (e) feature the teardrop; (b) & (f) 
are of the sphere; the cone is in (c) & (g); and (d) & (ii) are of 
the disc, where the left colunin corresponds to steady flow tests 
and the right coluirin to pulsatile flow studies. 
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(0.0301g) (0.0658g) (0.0831g) (0.1478g) 
Vorhauer: Teardrop < Sphere .< Disc < Cone 
(0.043g) (0.071g) (0.080g) (0.095g) 
Christy, (Steady flow): 	Sphere < Disc < Teardrop < 	Cone 
(17sec) (8sec) (>l8sec) (12sec) 
(0.006g) (0.027g) (0.073g) (0.200g) 
Christy, (Pulsatile flow): 	Cone < 	Disc < 	Sphere <Teardrop 
(1 sec) (isec) (8sec) (14sec) 
Figure 4.10: Ordering of test-body shapes, based on the weights of thrombus or clot 
formed. Vorhauer's results correspond to test-object thrombus weights, while Christy's 
clot weights are those of clot recorded on the downstream-side of the test-bodies. 
Approximate residence times of vortices trapped downstream of each test-body in the 
milk experiment apparatus are also shown. 
The differences between the ordering of test-body shapes, with regard to clot extent, 
could have occurred for a number of reasons: 
The Re and a were different in the milk experiments and the dogs, as indicated 
above, but how different and to what effect cannot be ascertained. Vorhauer did 
not measure the kinematic viscosity, flow rate or pulse rate of the canine blood, 
and these values can be very different from one dog to the next. For instance, 
Darke [238] quoted a mean canine blood flow rate of 3 I/min and pulse rate of 
70-140/min for a resting dog of about 20 kg weight; based on the aortic diameter 
used in the above calculations for a dog, these values correspond to i = 0.2 m/s, 
mean Reptpe = 910, Retest—bod y  = 385, and a = 10-19, which are very different 
from the values for dogs calculated earlier. 
It is possible that the extent and shape of clot differed due to the different extents 
of occlusion caused by the test-bodies used by Vorhauer and Christy. Vorhauer's 
test-bodies occluded about half of the cross-sectional flow area in the canine aorta, 
whereas in Christy's milk experiments only -1 th of the flow area was occluded. 10 
The greater local flow acceleration due to the test-body in the canine studies 
would cause greater shear stresses and strongly influence the wake region's size 
and turbulence intensity. Given the large size of test-objects used by Vorhauer, 
they may even have contacted the wall of the aorta. 
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3. Christy noted that this large degree of occlusion (resulting in a high pressure 
drop), and the distensibility of the aortic wall, may have had such a damping 
effect on the flow in the canine descending aorta, that this flow may have been 
largely steady with only a small oscillatory component[24]. This would explain the 
deposition similarities between the canine experiments and steady, as opposed to 
pulsatile, flow milk studies. 
Although the values of Re and a used by Christy do not lie directly in the range 
expected to occur in man or dog, his results do shed light on the effect of implant 
configurational changes and flow phenomena on deposit extent. 
Large differences in the extent of coagulum deposited in the test-body wake regions 
occurred on changing the flow regime from steady to pulsatile. Such differences are 
presumably due to changes in local fluid residence times, levels of agitation and sizes of 
wake regions. Accordingly, Christy conducted dye experiments to determine whether 
or not a correlation exists between the weight of clot formed in the wake region of each 
test-body and the fluid residence time in, and size of, this region. For each test-body 
shape, the wake region vortex residence time (figure 4.10) and size (figure 4.11) were 
estimated, by studying the behaviour of the dye and time taken for it to dissipate from 
this region, in a water flow(24]  injected with dye 12 . 
In steady flow milk experiments, regions of stasis were associated with curd deposition 
but the extent of curd did not appear to be directly related to the fluid residence 
time in, or size of, these regions. Christy observed that in steady flows past test-
bodies (where Ret e3 t_body 330) a trapped vortex formed downstream of each test-body 
(figure 4.11) - the site where all four test-objects developed deposits. In steady flow, 
the smallest vortex was observed for the teardrop yet this object developed the second 
largest downstream clot. This might be partly because the vortex formed behind the 
teardrop was the most long-lived compared to the other test-bodies, but this would not 
"Since Christy's dye experiments were conducted using unfouled test-bodies and water, and water 
has a kinematic viscosity of about 3/4 that of milk, the predicted residence times and relative sizes of 
regions of stasis are approximations of the initial conditions only. 
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explain why the sphere, which had a similar vortex residence time and larger vortex, 
accumulated about half the amount of clot formed in the wake of the teardrop. In 
addition, although the vortices behind the sphere, disc and cone test-bodies were of 
similar size in steady flow, the relative length of their residence times did not seem 
to determine their ordering with respect to clot extent. The second most long-lived 
vortex was found to occur behind the sphere, but this test-body developed the least 
downstream clot. 
In half-wave-rectified sinusoidal (pulsatile) flow, the duration of stasis appeared to be 
the dominant factor determining the extent of deposition. The dye-study revealed 
long-lived trapped vortices oscillating within the wake region of the teardrop (lasting 
for 14 s) and sphere (lasting for 8 s), while no vortex remained trapped downstream 
of either the disc or cone for more than one cycle of the flow. While the wake regions 
behind the teardrop and sphere were smaller than those behind the disc and cone, the 
wake region clot extent was greatest for the teardrop, followed by the sphere, while the 
wake of the cone and disc remained virtually free of clot. It is, however, apparent that 
factors other than residence time are also relevant to clot extent; the extent of clot was 
much greater in the disc's wake region relative to that behind the cone, although the 
"7) 	Systole 	 Diastole 
() 	 Systole 	 Diastole 
Systole 	 Diastole 	 I 
(7) Systole 	 Diastole 	 I 
Figure 4.11: Christy's postulated flow patterns for steady and pulsatile flows past 
24] unfouled testbodiesE. 
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residence times of the vortices trapped behind the cone and disc-shaped test-bodies 
were both about 1 s, and the wake regions were of similar size. The explanation might 
be that a change in the level of mixing, due to a change in test-body shape, may alter 
the aggregate collision rate and thus curd adhesion. 
During both steady and pulsatile flow dye experiments, Christy observed dye residing 
adjacent to the test-chamber wall for 20-25 s, indicating that curd deposition at 
this wall is likely. Wall clot did indeed form in all milk experiments, and its final 
thickness was said to be greater in steady than in pulsatile flow experiments. The 
greatly increased level of agitation in pulsatile flow might be expected to produce a 
well adhered clot, given Christy's findings with regard to curd adhesion and agitation 
(section 4.1.3); however, the high peak shear stresses and transient boundary layer 
occurring in the pulsatile regime may limit clot growth. Another possibility is that wail 
clot loss occurred, making comparison of the final wall clot thicknesses meaningless. 
Christy's results indicate that there is no simple relationship between clot extent and 
the size of a region of stasis or its residence time; other factors, such as the level of 
mixing, may also influence the extent of clot formed. Merely making an object more 
streamlined does not guarantee it will accumulate less deposit when flow separation still 
occurs. Christy's findings suggest that deposition tends to occur where regions of stasis 
occur and that, while no one flow phenomenon always controls deposition, variation in 
local flow conditions can affect deposit extent. For instance, sometimes the influence of 
local fluid residence time may predominate over that of the level of agitation while in 
other circumstances the order of these influences is reversed. In Christy's experiments, 
the vortex trapped behind the sphere had a much smaller residence time in pulsatile 
flow than in steady flow, yet the clot weight was much greater in the former experiment. 
This was also the case for the teardrop. The disc and cone also had much smaller vortex 
residence times in pulsed flow, but accumulated less clot in pulsatile flow than in steady 
flow experiments. Apparently the increased agitation when changing from steady to 
pulsatile flow did not compensate for the reduction in the residence times of the vortices 
behind the disc and cone. The different wall clot extents in steady and pulsatile flows 
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may have reflected differences in agitation and shear stresses, since the fluid residence 
times at the wail appeared to be similar. Stasis and agitation may combine to enhance 
coagulation when both occur at sufficient levels, while very short fluid residence times 
may limit the extent of clot formation, particularly when accompanied by elevated 
shear stresses. 
Discussion 
The analogy between deposition from milk and blood flows appears to be satisfactory. 
The phenomenon of platelet thrombi exuding a particular species, which in turn diffuses 
and promotes more aggregation, is very different from the milk clotting system, where 
the source of the activating species (rennet and CaC12) is well upstream and these 
species are mixed throughout the fluid. However, a critical concentration of activated 
platelets or destabilized micelles appears to be needed in both cases, in order for 
collisions to result in fusion and a deposit to develop. Fulfilment of both 'concentration 
requirements' and agglomeration/ adhesion appears to need stasis and collisions near a 
foreign surface. This similarity in deposition mechanisms is exemplified by comparing 
the results of net experiments with blood and milk. Both fluids had activating species 
present in their bulk yet deposited clot/thrombus only at the same particular sites, 
those associated with both stasis and mixing. 
While the previously reported milk clotting results are promising, with regard to the use 
of renneted milk to investigate the relationship between haemodynamics and thrombus 
deposition, the limitations of this work with milk should be realized. 
There are a number of differences between thrombosis in vivo and the milk clotting 
occurring in this system, in particular with regard to the effect of fluid phenomena; 
the sensitivity of blood, milk, thrombi and milk clots to shear stress, with regard to 
degradation and embolization, may differ such that deposit extent in one system does 
not indicate the extent that would occur in the other system; diffusion is enhanced 
by red cell tumbling in blood flow, but not in milk flow; while the release of clotting 
agents into the blood is likely to be highly localised, the active enzyme in the milk 
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experiments is added to the bulk milk mixture, so that all of the milk clots after 
a known time and the possibility exists that milk coagulation will occur in regions 
of stasis not associated with the test-object. In addition, processes exist in vivo for 
deactivating the proteolytic enzyme, but not in the milk experiments, and the extent 
of curd and thrombus deposition may differ on the same material. It is thus important 
to realize that the milk flow model is not intended to provide an estimate of the extent 
of thrombus that would form, but to indicate sites prone to thrombus deposition. 
The large differences between the results from Christy's steady and pulsatile milk 
flow experiments add fuel to the long-term debate over the usefulness of steady flow 
experiments. The effects of vortex shedding and elevated shear/agitation can be absent 
in steady flow experiments, but these experiments can still be used to study the effect of 
those flow phenomena that occur in both steady and pulsatile flows. In flow situations 
where the flow is damped, being only weakly pulsatile, correlation with steady flow 
experiments becomes more appropriate. 
4.3 The challenges 
The goal of my research was to extend and improve upon Christy's milk experiments, 
making them more fruitful. The usefulness of Christy's pioneering studies was perceived 
to have been limited by experimental uncertainties and the absence of a way to 
continuously observe the events occurring during these experiments. 
4.3.1 Wall clot 
Christy, and Lewis before him, showed concern about the presence of bubbles and wall 
clot in their experiments. The effect of these on the test-body clot was uncertain. 
Reduction of the quantity of vapour bubbles present in the milk flow is an issue 
addressed in section 6.1.3, while the potentially more significant problem of wall clot 
formation, and ways to prevent or minimize it, has been considered here. The formation 
of wall clot can cause flow irregularities and, when the volumetric flow rate is kept 
constant, can result in an increase in the milk flow velocity by reducing the flow cross- 
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section, leading to increased shear stresses and a shorter mean fluid residence time 
in the test-section. Wall clot can also make it difficult to remove the test-object, for 
examination at the end of an experiment, without loss of its deposit by contacting this 
clot. The biggest concern, however, lies with wail clot loss. There is the possibility 
that all, or portions of, the wall deposit may become detached and impinge on the test-
body, either adhering to or dislodging clot already formed there, rendering uncertain 
the origin of any clot deposit then found on it. 
Methods that have been adopted to tackle adhesion of coagulating milk to solid surfaces 
include calcium removal via a membrane[239];  the coating of surfaces [227](2401;  periodic 
back surging(24hI and use of pulsed fiow[242];  and provision of a layer of non-coagulating 
fluid at the solid boundary(2431.  Each of these approaches to inhibiting wail clot 
formation are considered below, with the conclusion that a method which inhibits 
clot growth altogether is most suitable, but that if this is not possible, the wall clot 
extent should be minimized and its loss prevented. 
The endothelium stays patent by being permeable to certain chemicals and by it 
synthesizing prostacydin(244],  a potent inhibitor of platelet aggregation. Using a 
'calcium sink', as opposed to injecting a clot inhibiting chemical, may be a way to 
achieve a patent test-chamber in the milk experiments. Berridge (227](2191  found that a 
cellulose dialysis membrane containing EDTA acts as a Ca2+ sink, providing a curd-free 
surface. 
If such a Ca 2+  sink could not be established here, :one could search for clot-inhibiting 
materials by firstly looking at the materials used in the dairy industry. In the dairy 
business, stainless steel surfaces tend to be used [245]  for ease of cleaning and for rust 
prevention but, according to Berridge's results[227],  use of stainless steel will promote 
adherence of coagulum; Berridge found that curd of about 5 to 9 g adhered to his 
test pieces of stainless steel, after 90 min of the milk clotting experiment described 
in section 4.2.1. The low clot extent and curd-releasing tendencies of lecithin-covered 
surfaces have led many to adopt this composite in order to minimize curd adhesion. 
4 Milk Clotting and its Analogy with Blood Clotting 	 91 
However, wail clot loss is not acceptable here; a strongly adhesive curd bond is needed. 
Unfortunately, Berridge found that when the bond of curd to surface was stronger 
than the cohesive curd bond (as for copper and stainless steel), the extent of curd 
was substantial. A compromise may be feasible; materials assessed in Berridge's 
experiments that did not experience large amounts of curd adhesion or curd loss, within 
the first 40 mm (i.e. within the duration of a milk experiment), might be adequate. 
The candidate materials tested by Berridge [227]  which fail into this category 13 and 
which had less than 1 g of clot adhered to them during this time, include a film of 
lecithin, a film of an equimolar mixture of cholesterol and lecithin, and regenerated 
cellulose (viscose). Achieving a uniform layer of these films, and maintaining them 
during experiments and post-experiment cleansing, may be difficult. Alternatively, 
hydrophilic regenerated cellulose looks worthy of a trial, as Berridge found it to have 
the lowest rate of deposition (0.2 mg min - ' cm -1 ) and only about 0.5 g of curd adhered 
after 60 mm, up to which point no clot loss had occurred. 
Whilst pulsation (212][2461  and momentary reversal of flow 211 have been reported as 
methods for preventing blockage, they appear to be ways of minimizing, as opposed to 
preventing, wall clot buildup by intermittent clot dislodgement, which is undesirable 
here. Lipatov and Fridenberg [242] passed acidified milk through fiat and round cross-
section channels, at a pulsation frequency of 0.6-3.0 Hz, because they found this 
'prevented' curd from adhering to the coagulator channel walls. Whether or not clot 
actually formed and was dislodged, or did not form at all, was not made clear in this 
document. Although a correlation between Lipatov's and Christy's experiments might 
be informative, with regard to the potential of wall clot loss occurring in Christy's 
pulsatile flow experiments (in which the pulsation frequency was about 1.2 Hz), this 
was not attempted. The reason was that the channel dimensions in the former's work, 
and thus the Reynolds number and shear stresses occurring, were not available. Also, 
acid curds are more easily displaced from surfaces and are known to be softer than 
enzyme-induced curds [2471. 
"The flow conditions in Berridge's experiments are very different from those in Christy's tests, but 
this is a starting point. 
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Hain and Jacob (113]  used an approximately similar configuration to Christy's test-
section for the continuous production of milk curd from upward flowing renneted 
milk, and they too observed curd deposition at the wail. In order to overcome this 
wall clot formation, they used a thin fluid film of milk or whey to act as a lubricant 
between the walls of the vessel and the curd. Four slits, each extending round the 
whole circumference of the cylinder near its base, allowed milk or whey to be pumped 
into the cylinder. The walls of the cylinder were heated, possibly because this would 
reduce the viscosity and density of the lubricating fluid and thus promote its steady 
rise up the wa111 2481. 
Preliminary research into wall clot prevention has been conducted in this laboratory. 
An undergraduate Honours research project was conducted by Stuart Williamson and 
myself, in search of a way to eliminate or limit the occurrence of wall clot whilst causing 
minimal interference to the milk flow. Several new designs or modifications of Christy's 
test-section were considered. Of the ideas mentioned above, coating of the test-chamber 
wall and use of an annular film of fluid were further considered. Coating of the wail was, 
however, not attempted, due to the difficulties involved with coating (stated above) and 
because coating the wall would not remove the clot-promoting stagnant layer of fluid 
adjacent to the wall and so may permit the formation of a weakly adhered wail clot. 
During the course of the undergraduate project, a concurrent liquid/liquid core-annular 
flow column was designed and constructed and preliminary tests with this column were 
performed. The purpose of this column was to provide a stable flow of inert, immiscible 
fluid at the test-chamber wall, in order to inhibit contact of the coagulable core fluid 
with the wail whilst causing negligible interference with the core-flow of renneted milk. 
The preliminary results, obtained using steady flow, were encouraging: with water as 
the core-fluid, and C2 C13F3 as the film fluid, a continuous annular film was established 
and no entrainment into the core fluid occurred. 
Further core-annular flow work was conducted by myself during my postgraduate 
research. A computer model, intended to act as a guide for evaluating the flow 
parameters most likely to permit continuous core-annular flow, was developed and 
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based on several assumptions: the flow in the column is fully developed; there is 
smooth annular flow with no waves forming at the liquid/liquid interface; there are 
only axial pressure gradients; and laminar flow occurs. This model enabled evaluation 
of velocity profiles, interfacial shear stresses, interfacial velocity gradients, axial pressure 
gradients, fluid film thicknesses, and film and core fluid Reynolds numbers, indicating 
what values of such parameters as density (p), viscosity () and flow rate (Q) of the 
two fluids would be most likely to provide a 'stable' core-annular flow regime for steady 
flow experiments. The velocity profile of a stable column of this type would probably 
be characterized by a maximum velocity at the centre-line of the tube, with a gradually 
decreasing velocity with distance from the centre. Therefore, if the velocity profile was 
found to contain negative velocities or an inflexion, for a given set of conditions, then 
instability was predicted. The ratios indicated as being the most feasible and practical 
for the core (c) and film (f) fluids, in steady flow, were Pf/Pc = 1.0, Qf/Qc = 0.01, and 
= 0.5, which were in agreement with expectations based on the experimental 
findings obtained during the undergraduate research. Most of this work is detailed in 
a paper [2491  reproduced in Appendix A. This core-annular flow regime has yet to be 
tried in milk experiments; it may not be feasible for pulsatile flow studies, as there is 
acceleration and deceleration in this flow and an inflexional profile is created in the 
decelerating phase, making instability and entrainment more likely [27] . 
4.3.2 Clot growth analysis 
Christy's milk experiments were limited to providing a single measurement of clot 
deposited after a fixed time period and were unable to provide information on the 
deposition process, such as test-body clot growth rates and concomitant wake region 
changes. If by some real-time imaging technique one could study what is occurring 
during the milk experiments, not only could more deposition information be obtained 
but a thorough investigation of reproducibility could be performed. Clot deposition 
rates and the extent of the effects of bubbles and wall clot could be quantified, and 
methods for inhibiting wall clot formation could be assessed. Furthermore, if the 
imaging technique allowed observation or measurement of the deposition at earlier 
stages of the experiment, the cost of milk experiments could be reduced by shortening 
their duration. Shortening the experiment might also reduce the probability of wall clot 
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loss, if this dislodgement occurs only above a critical curd weight or thi ckness [227]. An 
assessment of a visualization technique, intended for continuous imaging of deposition 
in Christy's milk experiment, is given in chapter 5. 
Attempts at recommissioning Christy's equipment were met with many problems, 
including extensive clotting. Duplicating his pre-run consistency tests, such as modified 
Lee-White tests, did not provide all the answers to these problems. In order to achieve 
reproducibility, equipment tests (reported in chapter 6) and a study of the dependence 
of enzyme-induced milk coagulation on system conditions were carried out, with the 
findings of the latter work reported in the following section. 
4.4 Variation of milk, rennet and coagulation 
In order to obtain truly reproducible results and allow comprehensive comparisons 
of results obtained in different laboratories, details of the dependence of milk and 
rennet properties on their source, composition and pretreatment were sought, as well 
as information regarding the influence of system conditions on rennet-coagulation of 
milk. 
4.4.1 Milk source 
The type of herd from which milk comes can make a difference to the curd it forms. 
For instance, milk from a Jersey herd has been found to give firmer curd than that 
from a Holstein-Friesian herd, when formed under similar conditions [250]. 
4.4.2 Milk composition 
Milk composition [232] is dependent upon the stage of lactation, age of cow, month of 
sampling, somatic cell count, and genetic variants, and its variation can influence the 
coagulating properties and curd firming rate of milk[250255]. 
Hamdy et al. [256] studied the effect of varying some milk constituent concentrations 
on chymosin-induced coagulation of cow's milk. They found that increasing the fat 
4 Milk Clotting and its Analogy with Blood Clotting 	 95 
content of cow milk, by adding cream or butter-fat oil, extended the coagulation time, 
whereas Bastian et al. [150]  found that the milk clotting time decreases with increasing 
protein and fat content. Hamdy and his colleagues also found that the clotting time was 
lengthened when either the %SnF (solids-not-fat) was elevated or the milk was diluted 
by water. Addition of CaC12 , so that the soluble calcium in the milk increased from 
0.118% to 0.175% (wt.), had the most significant effect - a reduction in the coagulation 
time by more than four-fold. 
r,-casein is the only casein that contains sugars; it has been found that these sugars 
play a role in milk clotting, possibly by retarding the rate of chymosin action on K-
casein[257]. Wheelock and Knight [ 2581 have observed that peptides which lack sugar are 
released much more quickly by the action of chymosin on compared to 
sugar-richr,-casein [257] . 
The molar ratio of a,/r. and /3/K is also relevant to precipitation of para-k-casein. The 
cr8 - and /3-caseins accelerate precipitation at low concentrations but are inhibitors at 
high conceutrations [194]. 
'Heat stability' is the length of time required for the onset of flocculation of a 
milk sample at a given temperature, and can be altered by artificially adjusting 
the concentration of various salt and protein f actors [260]. Most of the colloidal and 
soluble constituents individually modify the heat stability of milk [ 165]. For instance, 
removal of colloidal calcium phosphate (CCP) from the casein micelle results in 
drastic changes in micellar properties, including an increase in heat stability 261 . The 
heat coagulation time (HCT) varies with pH, and inter-species differences (including 
composition differences) result in considerable differences in the shape of the HCT/pH 
curve[1886]. Whilst heat stability characteristics of cow's milk have been found to be 
relatively consistent throughout a lactation (excluding very late lactation 14 ) and over 
consecutive l act ations [263], these stability characteristics are influenced by seasonal[264] 
and dietary [261] changes. The results of an extensive surveyE2661  of the heat stability of 
14 The protein concentration of milk increases significantly with advancing lactation 
[188b]  
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bulk Scottish milk indicate that milk produced during July—November is most stable, 
while milk that has very poor heat stability is produced during May and June; the 
increased stability of milk from cows on pasture was associated with a compositional 
difference: an increase in the concentration of urea. Webb and H olm [267] also found 
a relation between milk composition and stability; a solids-not-fat (SnF) content of 
about 13% was found by them to be the critical value determining whether pre-heating 
has a stabilizing (greater than 13% SnF) or destabilizing (less than 13% SnF) effect. 
4.4.3 Milk pretreatment 
The properties of milk and milk products are determined to a high degree by the 
functional properties of the casein micelles, and are thus influenced by the micellar 
changes induced by processing conditions. Milk pretreatment is necessary because raw 
milk is not very stable" at its milking temperature of 37'C, being susceptible to rapid 
spoilage by naturally occurring enzymes and contaminating micro-organisms. The best 
or least alterative way to preserve milk is debatable. 
To prevent property changes and inhibit the growth of contaminating micro-organisms, 
many workers choose to store raw milk at a reduced temperature of about 2-6°C' 6 ; 
however, the resultant milk is considered by some to be 'processed milk[268]. The 
microflora of raw milk can be altered by bulk storage at this temperature 
[2691, as can 
the rennet coagulation time (ItCT) and curd firmness 17[270][271]. Berridge 
[2271  has found 
that stale milk, or milk kept at 4°C for 3 to 5 days before adding rennet, tends to 
produce more adhesive clot when renneted than when fresh milk is renneted. On 
the other hand, Davies and White [2601 and others [2721  have found that cow's milk can 
be stored at low temperature, such as 4°C, for up to one week in the absence of 
pretreatment or preservatives, without significant change in ItCT or any other aspect 
of clotting. 
"Davies and White 2601  have found coagulability of some individual-cow milks to be altered even by 
exposure to light. 
16 Milk is destabilized by freezing and many chemical preservatives[216. 
17 	in RCT and curd firmness can result from cold storage, due to it causing reversible changes 
in the physical and chemical status of the raw milk (involving protein and sa.ltE210]). 
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Modification of many factors, including pH and calcium phosphate/ citrate and casein 
solubility, can occur during cold storage and affect the protein equilibrium in milk 
and micelle stability. The salts equilibrium and heat stability [183b] are much affected 
by changes in milk pH (table 4.2), which is about 0.3-0.4 units higher at 2-6°C 
compared with 37°C 2731 . Davies et a l.[274] and others [271][275] have found that the 
calcium and phosphate content of serum increase on cold storage. Soluble casein 
concentration increases substantially during cold storage, with up to 42% of the total 
casein being dissolved after storage for 48 hours at 4°C 2771 . The equilibrium of a 3 -
casein between serum and micelles is almost independent of temperature, unlike /3- 
casein which dissociates from the micelles into milk serum at low temperature[171]. 
This is illustrated in figure 4.12, where values were recorded after 4 hours of storage. 
During longer storage times the a-/- casein equilibrium is also affected and both 
caseins are dissolved to some extent into milk serum [ 277], but at lower concentrations 
than /3-casein. 
Component pH 5.0 pH 6.6 pH 7.5 
casein (%) 15.5 19.6 15.8 
calcium (%) 0.16 0.67 0.66 
phosphorous, inorganic (%) 0.05 0.25 0.22 
phosphorous, total (%) 0.09 0.42 0.41 
water (%) 79 	-- - 74 78 
(lemperature: u-oW u) 
Table 4.2: Casein micelle composition variation with pH[189a1 
Component 0 - 5 °C 35 - 40 °C 
casein (%) 20 28 
calcium (%) 0.7 1.0 
phosphorous, inorganic (%) 0.24 0.29 
phosphorous, total (%) 0.45 1 	0.63 
water (%) 76 62 
Table 4.3: Casein micelle composition variation with temperature [189,] 
Attempts have been made to re-establish the properties of the original raw milk after 
cold storage [278][2791. Heat treatment can cause readsorption of solubilized casein by the 
micelles [21101  and has a considerable effect on the distribution of calcium in milk, which 
inevitably affects the RCT[ 281]. Morr [189a] found that cooling freshly drawn milk to 
0-5°C causes transfer of calcium and soluble casein (table 4.3), mainly 0-casein, from 
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Figure 4.12: The concentration of a 3 -casein (unshaded) and /3-casein (shaded) in milk 
serum after storage for 4 hours at various temperatures. The micellar protein was 
sedimented by ultracentrifugation (190 kg, 2 hours) at the storage t emperatures [171 ]. 
the micelles [1 S9 l, and that upon warming this process is reversed; at 0-5°C, miceilar 
casein/total casein is 75-80%, whereas at 25°C this percentage increases to 95-98%. 
The duration over which Morr cooled and heated the milk to achieve these changes 
is unknown, but Reimerdes (282] found that maintaining milk at 60°C for 30 mm, that 
has undergone changes in serum and micelle composition due to cold storage, can 
re-establish a protein content in the serum equal to that in the original fresh raw milk. 
Another way of limiting quality changes caused by contaminating microorganisms 
is heat treatment, but this can cause changes in milk properties (283) Heating 
milk at 60°C and below, even for prolonged periods, has been found to have little 
effect on the rennet coagulation time l8 [272], but this is not the case at much higher 
temperatures. While whey proteins are sensitive to temperatures above 600C(189a1,  and 
undergo complete denaturation in 5 min at 90°C 284 , isolated r.-casein experiences 
thermal denaturation at 90°C 285286 . Heat treatment of milk can increase the 
rennet coagulation time (RCT) to varying extents, depending upon the severity of 
the heat treatment [18861. In the UHT (ultraheat treatment) sterilization of milk, milk 
"'While changes do occur in milk at these temperatures, such as loss of lipoprotein lipase activity 
when stored at 37°C for 4-24 hours 1289 , the properties related to RCT appear unaltered. 
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is sometimes heated at 132°C for 1 [287] resulting in a longer RCT than for raw milk. 
Rollema and B rimkhuis [188a] have found, using NMR spectroscopy, that elevating the 
temperature, especially in the range 60-98°C, causes the rigid structure of the casein 
micelle to disintegrate, giving increased solubility to most of the micelle proteins. Milk 
is normally pasteurized at or above 72.5°C, for 15 [287],  altering milk reactivity but 
not causing denatmration [245]. 
One way to avoid the need for milk pretreatment would be to have a few cows in the 
laboratory, but this option itself poses a few problems and is not practical. 
4.4.4 Rennet 
The origin, preparation and storage of chymosin, as well as the physical and chemical 
conditions of the medium, influence chymosin activity. 
Rennet can come from a whole range of natural sources, such as plants and mammals, 
with its reactivity and response to changes in the physical and chemical conditions of 
the medium being dependent on its origin. According to their origin, their optimum 
temperature and their heat stability vary, they are more or less sensitive to alkalis, 
and are more or less activated by acids or by calcium salts. Vegetable rennets of 
different properties exist, yet none are identical to those obtained from ruminants, 
each possessing a distinctive behaviour towards exterior agent S[290];  vegetable rennets 
resist the action of heat better, have an optimum temperature that is higher and, in 
general, act on a scale of temperature more extended than animal rennet s [232]. 
There are several proteolytic enzymes present in rennet obtained from the stomach 
of a calf, so special procedures have to be followed to isolate the specific protease - 
chymosin. Unless calf rennet is prepared in a very precise fashion (section 13.2), it will 
contain other proteolytic enzymes 19  and foreign substances which influence the effect 
"Most commercial rennets contain pepsin 11 , the proportion of pepsin depending on the age of the 
calf when sacrificed [2911. Chymosin appears to be more specific in its attack, with pepsin showing a 
1 ' 1 . more general proteolytic activity 
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of temperature on its activity and thus the RCT. 
The storage conditions of rennet in solution can alter its activity. Rennet in solution 
maintains its activity at 0°C for a very long time. However, at warmer temperatures 
(i.e. 20-30°C), a perceptible diminution of enzymic activity is perceived, more so at 
higher t emperatures (232]. Aguhlon[291 ] found rennet to be considerably influenced in an 
unfavourable way by ultra-violet rays in the presence of oxygen or in a vacuum. 
The activity of rennet in solution is strongly influenced by the solution temperature 
and pH. Most enzymes work best within narrow ranges of pH and temperature, with 
both the pH-activity and temperature-activity profiles tending to be bell-shaped 2921 . 
For the interaction with ic-casein, chymosin has a pH optimum between 5 and 551 2931 
and a temperature optimum between 40 and 41°C. The activity of chymosin decreases 
as the pH or temperature are increased above their optimum value, ultimately being 
irreversibly denatured, although sufficient activity remains for the enzyme to be 
effective at the normal pH of milk (' 6.6). 
4.4.5 The effect of certain system conditions on milk coagulation 
There are several physical and chemical conditions, such as pH, temperature and Ca 2+ 
ion concentration, which can influence the primary and secondary phases of the overall 
milk clotting process (2941  and, in turn, affect the properties of the final curd [194](232]. 
The coagulation of milk by calf rennet occurs more rapidly in an acid milk than in a 
normal milk. Small amounts of acid produce very obvious results; a decrease of pH 
from 6.8 to 6.3 accelerates the aggregation of renneted micelles by a factor of 2( 2951, 
acting on casein in such a way as to make it more apt to coagulate(2321  and increasing the 
activity of the rennet. The general importance of pH is related to a reduction of micelle 
repulsion and increased enzyme activity, except at low pH (i.e. less than 6) where the 
acidic nature has similar cleavage action as chymosin (i.e. acid coagulation) [2481.  One 
result of the reduced micellar charge, in acid coagulation, is a reduction in both the 
micellar calcium and the contribution of calcium to gel-strength, hence the finding that 
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acid coagulation gives softer cheese[2 47] • 
Temperature variation not only modifies the micelle composition (table 4.3), but also 
alters the rapidity of both phases of the milk clotting reaction and the clot rheology[2321. 
Sharma et al.(20601,  using a vibrating sphere viscometer and skimmed milk, found that 
the initial rate of ic-casein hydrolysis (determined by measuring the amount of free 
amino acids per gram of protein per minute), the rate of aggregation and the curd 
firmness increased with increasing temperature. 
For most single enzymic reactions, the reaction rate is approximately doubled by a 10°C 
rise in temperature [292] ; however, the temperature coefficient varies somewhat from one 
enzyme to another, depending on the activation energy of the catalyzed reaction and 
the influence of temperature on the enzyme activity. The milk clotting reaction has at 
least two stages occurring at the same time, which have different activation energies 
and different levels of dependence on temperature, so there is a combined temperature 
effect on the whole system. For instance, Effront(2321  found that coagulation occurs 
quickest at 41°C, whereas at 15°C and 66°C, no coagulation occurs. At 66°C, the 
rennet deteriorates, losing its ability to coagulate casein. At temperatures below 
15°C(29711232] , enzymic degradation of ,c-casein can occur, but without concomitant 
coagulation of milk [206b](183];  subsequent heating of the treated milk, after the rennet 
action is completed, causes clotting to occur rapidly (at 30°C) or instantaneously (at 
45'C). Chymosin can complete its action of cleaving about 90% of ic-casein on each 
micelle within 18 to 24 hours ( 1211 at low temperatures, and the second phase is an 
even longer process at low temperatures. The heat-induced acceleration of the lag-
phase and the second phase of milk clotting is possibly respectively due to chymosin 
activity increasing with temperature and increasing thermal motion and hydrophobic 
interaction [247] . 
Addition of Ca2+ ions to renneted milk improves curd firmness and reduces the clotting 
time. The effect calcium ions have on the rheology of the clot is possibly linked to the 
rate of reaction; a high concentration of Ca2+  gives a fast rate of reaction, and this may 
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make the chains link in a much more favourable way to form strong crosslinks. The 
effect of Ca 2+ addition on each of the phases in milk coagulation is not fully understood. 
Ca 2+  may or may not act as a catalyst or coenzyme in the first phase of milk 
coagulation, affecting chymosin action on the Phe-Met bond. Whether or not it 
enhances chymosin activity and the mechanism by which it would do this is uncertain; 
there are results that indicate that Ca 2+  addition does affect the primary phase of milk 
clotting and other results that indicate the opposite. 
Wheelock and Penney (291] observed that the initial rate of chymosin action on milk is 
directly proportional to the amount of peptide released. Based on this observation, 
Wilson and Wheelock [212]  investigated the possibility that addition of Ca2+  to milk 
could alter the primary phase of milk clotting; the RCT was found to decrease, on 
addition of Ca 2+, but the number of peptides released by chymosin did not change, 
indicating that addition of Ca 2 does not alter the initial rate of the enzymic phase. 
Contrary to these findings, it has been reported that the addition of Ca2+  does influence 
the rate of the enzymic reaction; addition of Ca 2+  appears to increase the affinity of 
rennet for the micelle. Although the number of peptides released was similar with and 
without Ca 2+  addition, Green and Marshail 13001 found marked increases of enzymic 
as well as clotting activity when up to 5 mM Ca2+ was added to milk. The RCT, 
and plots of macropeptide released against incubation time with rennet, when different 
amounts (0 to 5.0 mM) of Ca 2+  were added to simulated milk ultraliltrate, indicate 
that addition of Ca 2+  slightly accelerates the initial rate of the enzymic action of rennet 
and has a more marked effect on the latter part of. this phase. 
While there is doubt regarding the effect that Ca 2+ addition has on the enzymic 
phase, much more research has been done on the aggregation (2nd) phase than on the 
proteolytic stage of milk clotting. Chymosin can cleave c-casein but cannot coagulate 
milk at temperatures below 15° C, but if the milk is sensitized by increasing the amount 
of alkaline-earth salts present renneted milk can coagulate at such t emperatures [232] ; 
this clearly indicates that Ca 2+  addition does affect the aggregation phase. This effect of 
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Ca 2+ on the aggregation phase appears to be due to a reduction in the activation energy 
of the second phase, so that an increase in temperature is not essential for coagulation 
to occur; this may be achieved by the Ca 2+ ions increasing the hydrophobicity of the 
micelles [30301] and reducing micellar repulsion. 
Chapter 5 
Ultrasound and its Feasibility 
for Imaging Curd Growth 
In order to extract more information from Christy's milk experiment, with regard 
to the course and mechanism of clot formation, a method which allows continuous 
quantitative measurement of curd deposition on the test-objects was sought. From 
the various techniques that could be used for studying this growth, ultrasonic imaging 
was chosen. This chapter attempts to provide a basic understanding of ultrasound, 
including its nature, how it can be generated and used for imaging, the factors leading 
to improvement or degradation of images, and the use of ultrasonic imaging in relevant 
applications. Results are provided of analyses of ultrasound-induced phenomena and 
of preliminary tests, aimed at determining the feasibility of this ultrasound application 
and how it can best be implemented. 
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5.1 Deposition measurement techniques 
The nature of the system to be interrogated places limitations on the type of 
imaging technique that will be suitable. Since the milk mixture is opaque 
and its clotting is sensitive to both temperature and flow disturbances, optical, 
thermal and invasive imaging techniques are inappropriate. However, one can 
consider non-invasive techniques currently used in the diagnosis of thrombosis, such 
as radioactive labelling [302], computed tomography (C.T.) 1303), magnetic resonance 
imaging (M.R.I.) [304]  and ultrasonography°]. Pl atelets [306], or enzymes that bind 
to flbrin [307], can be marked with radioactive tracer and studied using a scintillation 
counter; regions of high radionuclide concentration correspond to thrombus. Similarly, 
in the study of milk clotting, a constituent of milk that is found throughout curd could 
likewise be labelled. How accurately the deposit dimensions could be measured using 
this method is uncertain, however and, since the milk is not recirculating but is used in 
large quantities, much tracer would be needed. C.T. scans have been used for diagnosis 
of deep venous thrombosis (DVT), where the X-rays produce shadow images which 
broadly represent the electron density of thrombotic structures. A less hazardous and 
more accurate technique for measurement of deposit is M.R.I., where the body under 
investigation is subjected to a magnetic field of a non-hazardous intensity and the 
energy transferred to the protons of the medium is returned in the form of radio waves; 
however, the high equipment cost (about $ 2 Million) and unavailability of magnetic 
resonance machines is discouraging. Ultrasonic scanning was chosen for further study, 
since this imaging technique offers a rapid, reliable [ 309], relatively inexpensive and 
easily conducted way of constantly monitoring the progression of thrombus position 
and size[3101, while producing no known side effectsl312l. 
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5.2 Ultrasound production and its use for imaging 
5.2.1 Ultrasound 
Ultrasound is energy propagated through a medium by cyclic pressure variation, with 
high and low pressure regions occurring at frequencies above the range of human hearing 
(i.e. > 20kHz). This sound can be thought of as high frequency longitudinal waves, 
with the motion of the particles of the transmitting medium being parallel to the 
direction of wave travel, and can be transmitted continuously or in short, regular pulses 
through any substance, solid, liquid or gas, which possesses elastic properties. The push 
and pull action of a vibrating sound source, in the pulsed form, results in a short burst of 
vibration travelling through the medium and influencing a limited number of particles 
at any one time. These vibrating molecules, in turn, collide with their neighbours and 
pass on some of that energy, so that a sinusoidal variation in the pressure along the 
medium occurs. The wave of acoustic pressure flows away from the source, with the 
part of the wave where the particles are crowded together (the compression region) 
having a pressure higher than normal, and the region where the particles are furthest 
apart (the rarefaction region) having a pressure lower than normal (figure 5.1(a)). For 
simplicity, a sound wave is generally depicted as an oscillatory trace (figure 5.1(b)), 
where its wavelength ) is the distance between two adjacent bands of compression 
or rarefaction, and its amplitude (P 0 ) is the magnitude of the maximum change in 
pressure caused by the wave. 
5.2.2 Ultrasound Transceivers 
Ultrasound transducers that both generate and detect ultrasound waves are called 
transceivers, and can have one or many crystals. A basic ultrasonic single-crystal 
transceiver takes the form of a small cylindrical tube covered at one end by a disc-
shaped crystal, which has thin metallic-film electrodes evaporated on its front and 
back faces. Multi-element array transducers are commonly 4 to 10 cm long and contain 
64 to 256 such crystals that measure 1 to 2 mm wide by 5 to 10 mm long E'. The 
crystals employed in ultrasonic transceivers exhibit the property of piezoelectricity; 
they produce a voltage when deformed by an applied pressure, and conversely change 
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Figure 5.1: Sound waves can be depicted as (a) a series of vertical lines, whose spacing 
represents intensity, or as (b) a sinusoidal continuous wave, where the amplitude (P 0 ) 
denotes intensity and the wavelength (A) is the distance between adjacent regions of 
rarefaction or compression[313]. 
shape when a voltage is applied. On applying a high frequency oscillating electric signal 
to a piezoelectric element, a sequence of crystal contractions and expansions will occur 
at the same frequency, such that the electric signal is converted into high frequency 
pressure waves (ultrasound). A piezoelectric crystal can also be used to detect pressure 
fluctuations, as these cause the crystal to expand and contract which generates an 
oscillating electric signal[3051 [313] . The operation of piezoelectric transceivers is optimum 
at the natural resonance frequency of the crystal(s), which depends upon the crystal 
thickness [314]. 
5.2.3 Ultrasonic imaging 
Reflection is the primary mode of interaction with matter which enables ultrasound 
images to be achieved. Pulsed ultrasound transceivers 1  can be used to obtain images by 
use of the echo information received from interfaces which reflect sound. The percentage 
of the ultrasound beam reflected back to the transceiver from an interface depends 
on the angle of incidence of the beam and on the difference between the acoustic 
impedances (Z 1 and Z2) of the media on either side of the interface (figure 5.2). With 
'Pulsed, rather than continuous wave, ultrasound is used for imaging with a single probe, as a 
transceiver cannot produce and detect sound waves simultaneously. 
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Figure 5.2: A schematic representation of the redistribution of energy in an ultrasonic 
wave incident on an interface (B), where Z2 Z1. Generally, when sound waves strike 
a surface, the energy may be divided into three portions: the incident (i), the reflected 
(r) and the transmitted (t) energy. "s" represents the small shear wave and surface 
wave components that sometimes occur [315]. 
current equipment, the operator must align the transceiver so that the ultrasound 
beam strikes the interface of interest as close to perpendicular as possible, as almost no 
reflected sound will be detected if the angle of incidence is more than 
3o[312] away from 
the normal. A medium's acoustic impedance, Z, is a property related to its density 
and elasticity, and is obtained by multiplying its density by the speed at which sound 
travels inside it. To be able to get an echo at an interface, the acoustic impedances of 
the two media forming the interface must be different. If this difference is large, much 
of the sound will be reflected, whereas if the acoustic impedances of the two media 
comprising the interface are the same all the sound is transmitted. 
For normal incidence at a flat interface, the percentage of the incident beam energy 
reflected (K) is expressed by the equation [305][3151: 
R = 	x 100%= 
( Z2 Z'  )2 x i00% ... (5.1) z2+z1 
where I, is the intensity of the reflected wave, li is the intensity of the incident wave, 
and Zi and Z2 are the acoustic impedances of the media on either side of the interface, 
respectively. The calculation of It becomes more complex when the angle of incidence 
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is not 900[305]. 
Using information from the backscattered ultrasound signal, diagnostic ultrasound 
instruments can permit essentially instantaneous, real-time images of both static and 
moving structures. Similar to the echo-return technique used by bats and dolphins, the 
ultrasound imager measures three things of importance: the time between transmission 
and reception of a wave, the direction from which the echo came, and the intensity of 
the echo. The lapse of time between sending and receiving echoes allows the depth 
of reflective tissues to be evaluated, using a simple range equation and the average 
velocity of sound in the medium 2. The direction in which the echo is travelling 
provides information on the interface alignment, relative to the ultrasound beam, and 
the amplitude of the echo signal represents the acoustic impedance change across the 
reflective interface. The two-dimensional cross-sectional representation of structures, 
deducible from such information from an array of ultrasound beams, is usually displayed 
on a cathode ray tube synthesized line by line, with each line of the image corresponding 
to the echo information from an individual pulsed beam. 
The part of the ultrasound beam that is of high enough intensity to be effective in 
producing detectable echoes corresponds to the 'effective beam'. The intensity of the 
beam corresponds to the rate at which energy is transported by the wave per unit 
area, and falls off with distance along the axis of the transducer, more rapidly so in the 
direction at right angles to the central axis. Considering a multi-element transducer to 
be composed of a large number of small ultrasound sources, each emitting a spherical 
wave, the intensity at each point in the field, at a given time, is the algebraic sum of 
the hundreds of individual positive and negative pressure waves arriving at that point. 
Proceeding along the ultrasound beam, away from the transducer, a great variation 
in ultrasound intensity from wave front to wave front occurs, with a series of pressure 
maxima and nulls occurring along the beam axis (figure 5.3). The difference in the 
path length from different parts of the transducer becomes smaller and smaller, until 
at the last axial maximum (depicted by X in figure 5.4) nearly all of the acoustic waves 
'Most  ultrasonic imaging monitors that are intended for medical use are programmed to assume 
the velocity of sound to be that in soft tissue (i.e. 1.54 km/s). 
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Figure 5.3: A diagrammatic representation of parts of the heterogeneous acoustic beam 
emitted by the transducer, T. The transverse beam plot at position X shows the last 
axial maximum and marks the transition between the highly non-uniform near field 
and the diverging beam of the fax field 3151 . 
arrive in phase, and the acoustic intensity is highest (if none of the energy has been 
absorbed en route). This point is termed the beam focus or focal point, at which the 
the beam width is a minimum and the best imaging is achieved. The effective beam has 
a gradually narrowing conical region, which leads up to the focal point and is termed 
'the near field', and a diverging region, which occurs beyond the focal point and is 
called 'the far field' (figure 5.4). 
The resolution of an ultrasonic real-time scanning instrument corresponds to the 
smallest detail that it can depict. More specifically, the contrast resolution defines the 
smallest detectable difference in tissue reflectivity, while the axial and lateral resolution 
Focal point at 
minimum beam width 
beam axis 
Lnf 	 Farfield or 
Near field or Fresnel zone 	 Fraunhoer zone 
Figure 5.4: Simplified field shape from a sinusoidally excited transducer element 
generating a continuous wave. 
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determine the minimum size of structure detectable. 
Contrast resolution is the minimum change in a physical quantity depicted in an image, 
characterizing the effectiveness of the instrument to display small changes in grey 
shade/reflectivity of neighbouring tissues, and is not as affected by frequency variation 
as are the axial and lateral resolution. 
The axial resolution is the minimum separation of two targets that lie on the beam axis, 
for which separate echo signals can be detected, and in theory is equal to half the pulse 
length[313]. This resolution is improved when the spatial pulse length is reduced, the 
ultrasound source is 'damped' (which makes the emitted and received pulses sharper), 
and when the ultrasound frequency is increased. Most ultrasound pulse-echo systems 
emit pulses of 3 to 5 cycles in duration and cannot be altered by the operator; however, 
for a fixed number of cycles in a pulse, increasing the frequency reduces the wavelength 
and thus the pulse length (equation 5.2). As a result better axial resolution is achieved, 
but a reduction in the depth of penetration also occurs, as ultrasound is more easily 
absorbed at higher frequencies (section 5.3). 
The minimum separation of two structures that are side by side, lying in a plane 
perpendicular to the ultrasound beam axis, for which two separate echo signals can 
be obtained, is the lateral resolution. The lateral resolution is usually the parameter 
that limits image quality, as it is always worse than the axial resolution [312][314], and 
is approximately equal to the effective beam width, which varies with distance from 
the transducer and is best at the focus. Consequently it is dependent on the operating 
frequency of the transducer, and on the element size or focusing ability. Beam width and 
focusing are strongly related to frequency since they are both determined by diffraction. 
The only way you can improve the focusing independently of the frequency is to increase 
the diameter (i.e. size) of the transducer (section 5.3.3). This is likely to give a bulky 
transducer which is difficult to work with. Another option is to use a linear-array 
transducer whose focusing can be controlled electronically (section 5.2.4). In general, 
increasing the ultrasound frequency results in a longer near field and less divergent 
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far field (equations 5.3 and 5.4), producing a narrower beam deeper into the tissue 
and consequently better lateral and axial resolution. These ideas apply equally to 
multicrystal and single crystal transducers. A group of small crystals is equivalent to 
a single crystal of the same size [314]. 
The velocity of sound, c, depends on the medium through which it is transmitted, is 
a constant for a given uniform medium, and has a relationship with the frequency, f, 
and wavelength, A, of sound which is denoted by the equation [316] : 
c= fA.. . (5.2) 
For versatile, high resolution imaging it is desirable to generate a beam with a long, 
narrow near field and focal zone. The focal zone is the region extending along the beam 
axis near the focal point, over which the beam width is less than twice that at the focal 
point. At a given ultrasound frequency, the length of the near field (L1) varies as the 
square of the crystal radius, r, and the angle of divergence in the far field, 9, varies 
inversely with that radius, denoted by [305][313]: 
f = r2 
sin 9 	
O.61A(54) 
5.2.4 Electronic and mechanical focusing 
Focusing is very useful for enhancing ultrasonic imaging, and can be achieved 
electronically and/or mechanically. An increased maximum intensity and a smaller 
width of the ultrasound beam can be achieved by focusing, giving stronger echoes and 
better lateral resolution on the beam axis. The more extreme the focusing, the better 
the lateral resolution at the focal point but the smaller the focal zone, as the field 
strongly converges/diverges on either side of the focal point. 
(a) Defocusing lens 
	
(b) Focusing lens 
c1 
(d) Curved crystal(s) transducer 
(c) Fixed acoustic lens 
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A directional, focused beam can be achieved by activating the strip elements in a multi-
crystal transducer with slight time delays between each activation, called 'electronic 
focusing'. By controlling the delay between excitation of the different elements, the 
degree of focusing and the focal length can be controlled 3 . The pressure waves coming 
from the elements can be made to arrive in phase at one particular point, at which 
constructive interference provides a high intensity focus, with the position of the focal 
region being determined by the sequence of delays chosen. Large transducers, which 
contain many strip elements, provide a very sharp focus, as the greater the ratio of 
transducer width to the wavelength of ultrasound the better the focusing ability of the 
probe 
Ultrasound can be focused by means of lenses. While electronic focusing in the plane 
of the array of a rectangular probe does not appreciably affect the width of the beam 
in the direction perpendicular to this plane, focusing in both directions can be achieved 
by using annular elements and a circular as opposed to rectangular probe face, or by 
using concave crystals or an acoustic lens 
[305][313][317] (figure 5.5). 
3 Control of crystal activation can also be utilized to change the beam direction without 
physically 
moving the device. 
I 	\ 
Figure 5.5: Effects on ultrasound of different lenses. 
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5.3 Ultrasound attenuation 
Reduction of the intensity of an ultrasonic wave as it propagates is described as 
attenuation. It may arise as a result of the wave energy being absorbed, refracted, 
diffracted, scattered, or reflected. The size of the energy loss is dependent on the 
strengths of these attenuating processes, and determines the depth and quality of an 
ultrasound scan. The attenuation coefficient, j, represents the fraction of energy lost 
due to the various attenuative processes, and is expressed as the rate of decrease 
of intensity in units of decibel per cm depth of tissue (dB/cm) and given by the 
equation (313] : 
ki = 2 1og10(E) ... (5.5) 
where I is the intensity level at a point in the beam a distance x from the source, and 
10  is a reference value. 
5.3.1 Absorption 
Absorption of ultrasound is due to internal frictional forces that oppose the vibration of 
molecules and cause the conversion of some of the wave energy into heat, reducing the 
intensity of the particle vibrations and the size of the 'effective beam'. The absorption 
coefficient, a, is the fraction of wave energy absorbed in unit path length and is 
defined by an equation of the same form as equation 5.5, in which It is replaced by 
when attenuation is by absorption alone[318].  The amount of ultrasound absorption 
increases with increasing viscosity of the medium, 'relaxation time' of the molecules and 
frequency of the ultrasound. Elevating viscosity increases the internal friction of moving 
molecules so that energy absorption and heat production are increased. The time for a 
molecule to return to its equilibrium position after it has been moved by the ultrasound 
wave is termed the 'relaxation time'. If this time is long, such that the molecule does 
not return to its original position before the next compression wave arrives, extra energy 
is required to stop and reverse the direction of such a molecule, resulting in increased 
absorption. The higher the frequency of ultrasound transmitted through a viscous 
medium, the more rapidly the molecules vibrate and the quicker the compression waves 
arrive, giving molecules less time to relax between cycles, resulting in more absorption. 
The upper limit of frequency, for ultrasound propagation, is approximately 5 MHz in 
gases and 500 MHz in liquids and solids. 
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5.3.2 Refraction 
Refraction is the deviation of an ultrasonic beam from its original direction as it strikes 
an interface between two media, in which the velocity of ultrasound differs. When 
the ultrasound wave strikes this interface perpendicularly, no change in beam direction 
occurs. However, when the incident wave strikes this boundary at another angle (figure 
5.6), the transmitted wave does not continue along the same line of propagation as it 
originally occupied in the first medium, but is refracted. Refraction can cause objects 
to appear to be in a different location than they actually are, or may cause the shape of 
an object to be incorrectly depicted by ultrasound, giving rise to refraction artefacts 4 . 
The relationship between the incident angle, 9,  and the refraction/ transmission angle, 
92, when ultrasound strikes an interface comprising two media where c 1 and C2 are the 
velocity of sound in the first and second medium, respectively, is given by Snell's law: 
sin 01 	! 	(56 
sin 02 c2 ' 
The degree to which the beam is bent or refracted at an interface depends on the 
difference in the velocity of sound in each medium comprising the interface. As this 
difference in velocity increases, so does the degree of refraction. When an ultrasonic 
wave crosses an interface, into a medium in which sound travels more slowly (i.e. c 1 > 
C2), the beam bends towards the normal, and conversely, the beam bends away from 
the normal when c 1 < c2. When ultrasound strikes a soft tissue/bone interface at an 
angle of incidence greater than 22°, the ratio of cl/c2 for these media is such that the 
angle of refraction is larger than 90° (i.e. the beam does not enter the bone but is 
reflected back into the soft ti ssue)(313]. 
5.3.3 Diffraction 
Diffraction is the spreading of an ultrasonic wave, after it interacts with an obstacle, and 
strongly affects the lateral resolution. It can occur when small openings or apertures, 
which act as small 'secondary sources' of sound, are present in the medium scanned. 
4 An artefact is any information on an image that is due to a spurious signal, and does not truly 
represent the physical conditions existing within the scan field. 
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Normal 
interface 
Figure 5.6: Beam deviation caused by refraction at an interface. 
The extent of diffraction of an ultrasound beam, as it moves away from a 'secondary 
source', is dependent on the size of this source relative to the wavelength of the 
Ultrasound wave transmitted. For any given frequency, the larger the sound source, 
with respect to the wavelength of the sound, the more directional the sound beam 
becomes. If the wavelength of the sound wave is larger than the source that produced 
it, the sound will proceed in the form of a spherical wave away from that source [3 l 5]. 
5.3.4 Scattering 
The size and shape of reflectors affects the amplitude of the echoes reflected back to the 
transceiver. Scattering causes ultrasound energy to be dispersed in many directions, 
increasing beam attenuation, and occurs when the ultrasound waves interact with 
obstacles which have surface irregularities, are obliquely aligned to the beam axis or are 
of a size similar to (or less than) the wavelength (figure 5.7). Small objects which give 
very weak echoes, such as the filaments of fishing nets, are difficult to detect sonically 
and that is why dolphins tend to get caught in these nets. The overlap of scattered 
echoes generates wave interference patterns and results in a speckle-pattern on the 
ultrasound image. 
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Figure 5.7: Scattering by (a) a non-smooth surface, and (b) discrete reflectors [305]. 
5.4 Ultrasound uses and associated phenomena 
To facilitate the adaptation of ultrasonic imaging to Christy's milk clotting system, 
by determining which ultrasound beam and transceiver characteristics are most 
appropriate for this application, reviews of ultrasound-induced phenomena and 
ultrasound applications, and preliminary tests (reported in section 5.5), were carried 
out. 
5.4.1 Ultrasound-induced phenomena 
Certain forms and applications of ultrasound can induce phenomena, such as acoustic 
streaming, standing waves, cavitation and temperature rise, capable of disrupting the 
milk clotting experiment. 
Acoustic streaming is the circulation of fluid induced by radiation forces [319][3201. When 
induced near a bubble, the bubble dynamics lead to eddying movements that are 
of microscopic proportions yet can produce high viscous shear stresses capable of 
damaging or changing fluid constituents [321]. Acoustic streaming is less likely to occur 
when the intensity and frequency of the ultrasound are reduced. If this conversion 
of sound energy to kinetic energy occurs in the milk experiments, where bubbles are 
present in the milk flow, the improved mass transport might enhance the aggregation 
phase of the milk clotting process, and the shear stresses might cause deterioration of 
clot and the constituents of the milk mixture. 
Standing waves occur when two waves travelling in opposite directions overlap. For 
example, a reflected wave can be superimposed on an incident wave, resulting in a 
standing wave which consists of high and low intensity regions fixed in space relative to 
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the reflective interface. This can result in a higher local intensity than in the absence of 
reflection. The creation of a standing wave can impede or even arrest the movement of 
small particulates or cells in a liquid, trapping them at pressure nodes and promoting 
particle separation and agglomeration 
[3O5] [322][323] Standing waves are less disruptive 
when the Ultrasound intensity is low, and are less likely to be generated when the 
Ultrasound beam axis is not perpendicular to the reflective interfaces, the applicator 
or reflective interfaces are not stationary and when pulsed, as opposed to continuous 
wave, ultrasound is used (since in the pulsed regime the superimposition of waves can 
only occur when the pulses overlap). Standing wave formation might interfere with the 
milk clotting process, when ultrasound is applied to the milk experiment, as bubbles 
and aggregates might be trapped and made to resonate and agglomerate, respectively. 
Cavitation [3241 is a phenomenon (which may be hydrodynamic, thermal, or acoustic in 
origin) that results in the formation, and in some cases enlargement and implosion, 
of gaseous and vaporous cavities in a liquid. Cavitational activity occurs in two 
forms under the influence of the pressure fluctuations of a sound wave; the stable 
type of cavitation involves the enhanced oscillation of bubbles, whereas the transient 
form involves the growth and violent collapse of bubbles, which causes localized high 
shear stresses, temperatures and pressures. The 'cavitation threshold' corresponds to 
the intensity of ultrasound above which cavitation occurs in a fluid. High intensity 
ultrasound imposes large pressure fluctuations on the medium in which it is travelling; 
the compression cycles exert a positive pressure on the liquid, pushing the molecules 
together, while the expansion cycles exert a negative pressure, puffing the molecules 
away from one another. When a sufficiently large negative pressure is applied to 
a liquid, such that the average distance between the molecules exceeds the critical 
molecular distance necessary to hold the liquid intact, the liquid will break down and 
cavitation bubbles will be formed and in some cases collapse. The acoustic streaming 
and extreme conditions arising from cavitational activities would no doubt interfere 
with the milk experiment. In order to reduce the likelihood of cavitation occurring 
one should choose values of certain system and ultrasound features which increase the 
cavitation threshold. 
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The cavitation threshold is a function of a number of physical parameters, including 
solution properties (viscosity, surface tension, vapour pressure, type and concentration 
of dissolved gas and solid particles), temperature, the external pressure, and the 
intensity, frequency and attenuation of the ultrasound [ 325]. 
Cavitation is more difficult to generate when the vapour pressure of a liquid is reduced 
and its viscosity or surface tension is increased. The pressure in the rarefaction cycle 
must be lower than the vapour pressure and overcome the natural cohesive forces 
acting in a liquid, in order to induce cavitation. When the fluid viscosity is increased, 
not only do these cohesive forces increase but the amount of ultrasound absorption 
also increases (section 5.3.1), reducing the intensity of the ultrasound beam and the 
likelihood of cavitation. For example, the threshold intensity varies between 0.5 to 2.0 
W/cm2  for tap water, but can be tens of W/cm 2  for higher viscosity liquids[326][327] 
Degassing and filtration have been found to increase the cavitation threshold. Estimates 
of the acoustic pressure necessary to cause cavitation in water have been approximately 
1500 atm.; however, in practice cavitation usually occurs at considerably lower values, 
because most liquids are sufficiently contaminated by gas molecules or particulate 
matter (with gas-filled crevices), both of which lower the cavitation threshold 
[3281.  For 
example, in tap water an acoustic pressure of only a few atmospheres will form bubbles. 
Roy et ct l.[329] found that the smaller the filter size used for ultrafiltrating a medium 
prior to its irradiation, the greater the cavitation threshold. Figure 5.8 illustrates the 
effect of degassing on the threshold intensity, at different ultrasound frequencies. 
Increasing the temperature of a liquid allows cavitation to be achieved at lower acoustic 
intensity, because it reduces the liquid's viscosity and surface tension and increases 
its vapour pressure. Pressurizing the system, above atmospheric pressure, makes 
the formation of bubbles more difficult to achieve and thus increases the cavitation 
threshold [3301  
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Figure 5.8: Variation in threshold intensity with ultrasound frequency, when (a) aerated 
and (b) air-free water are i rradiated[318]. 
The intensity is the main factor determining whether or not cavitation occurs. Cavity 
growth also is largely dependent upon the intensity of sound. High intensity ultrasound 
can expand the cavity so rapidly during the negative-pressure cycle that the cavity never 
has a chance to shrink during the positive-pressure cycle, resulting in cavities growing 
rapidly in the course of a single cycle of sound (transient cavitation). For low intensity 
ultrasound the size of the cavity oscillates in phase with the expansion and compression 
cycles, and over many cycles the cavity may grow gradually. At intensities above the 
cavitation threshold, an increase in intensity will cause more violent bubble collapse 
and thus greater mechanical and chemical effects [33h]. 
As is clear from figure 5.8, the frequency of ultrasound strongly affects the cavitation 
threshold( 332 . At lower ultrasound frequencies (kHz) cavitation is more readily induced, 
as the rarefaction phase has sufficient time to form cavitation bubbles and greater sound 
energy can be transmitted further into the medium. At higher ultrasound frequencies, 
the absorption of ultrasound is greater and the duration of the rarefaction phase shorter, 
resulting in more power being required to maintain the same cavitational effects. Even 
if a bubble were produced during rarefaction, the time required to collapse that bubble 
might be longer than is available in the compression half-cycle of a high frequency sound 
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wave. For example, using 7.5 MHz ultrasound, the rarefaction cycle lasts 0.067s 
(i), less than the necessary collapse time of a bubble of radius 10 3cm, which is 
approximately 1 ,s(318]. 
Vibrational energy can be transformed into h eat(3151. The amount of local heating 
induced by ultrasound depends on the ultrasonic intensity 5 , the type of tissue 
irradiated, the rate at which heat is dissipated, and the duration of exposure and 
frequency of the ultrasound(' 1 . The temperature rise (ST) induced by transmission 
of ultrasound of intensity I, for a time t, in the absence of any cooling mechanism, can 
be estimated by using the equation (3161: 
Pm 
where a = absorption coefficient, which increases approximately linearly with 
frequency (313)(316),  p = tissue density, and Cm = specific heat per unit mass of tissue. 
The higher the intensity of the beam and the longer the exposure time, the more 
vigorous the vibration of the tissue and the greater the tissue temperature rise. Figure 
5.9 provides a guide to the approximate ultrasound intensity necessary to produce 
a 1°C temperature rise in tissue, at different ultrasound frequencies and for a fixed 
duration. A temperature rise in the milk experiment would have a noticeable affect on 
the clotting (section 4.4.5). 
5.4.2 Ultrasound characteristics suitable for the milk application 
The test-chamber to be studied comprises a solid tube, of 32 mm.i.d. and 40 mm o.d., 
which contains an axially located curved test-object that is 10 mm in diameter at its 
thickest part. The thickness of clot over the whole test-body is of primary interest and 
may be between 0 and 4 mm. A suitable transceiver would be one which emits an 
ultrasound beam having a focal length and focal zone both of about 20 mm, and an 
axial resolution less than, say, 1 mm. The lateral resolution need not be so small, but 
'There are six intensities that can be defined: isprp, ISPTA, IspPA, 'SAT?, 'SArA and ISAPA; 
where SP = spatial peak, SA = spatial average, TP = temporal peak, TA = temporal average, and 
PA = pulse average. 
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Figure 5.9: The approximate ultrasound intensity necessary to produce a 1°C rise in 
local tissue temperature, as a function of f requency [3121. 
as close to 1 mm as possible. 
The main characteristics influencing the selection of an ultrasonic scanner for the curd 
deposition application were: the cost, the depth of penetration, the effective beam 
shape and resolution, the accuracy of the measurement system and its effect(s) on milk 
clotting. These aspects depend on the frequency and intensity of the ultrasound, as 
well as the transducer head size and shape, focusing and duration of irradiation. 
Frequency determines, to a large extent, pulse length and beam width and hence axial 
and lateral resolution. The greater the frequency the finer the resolution and the 
smaller the likelihood of cavitation for a given intensity, but the greater the cost of the 
transducer and the shallower the depth of penetration. Table 5.1 provides guidelines 
for frequencies, regarding their corresponding depth of penetration and resolution. 
A 10 MHz ultrasound probe may provide adequate penetration and an agreeable 
axial resolution for clot thickness measurements, while the lateral resolution, which 
is diffraction limited, is better the smaller the wavelength, and can be enhanced by 
beam focusing. While the great difficulty involved in constructing transducer arrays 
with very small crystals that have a resonant frequency greater than 10 MHz could 
be side-stepped by using a reciprocating single-crystal probe, the depth of penetration 
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Freq. (MHz) Penetration (cm) Axial R. (mm) Lateral R. (mm) 
1 15 4.6 / 
2 10 2.3 5.0 
3 / 1.0 3.0 
5 5 0.9 2.0 
8 3 0.65 
10 2 0.5 1.0 
15 / 0.3 / 
25 / 0.2 / 
Table 5.1: Frequency, penetration and resolution [313] 
improvement in axial resolution attainable with increasing frequency; the concomitant 
increase in transducer cost becomes less attractive above 10 MHz, as the corresponding 
improvement in axial resolution is small. In addition, the depiction of the test-body 
and clot may be impaired by scatter, and thus might not be improved markedly by 
employing a more expensive, higher frequency probe. 
Figure 5.10: The axial resolution as a function of the operating frequency, for optimally 
damped transducers [ 3051. 
Higher intensity corresponds to greater vibrational effects and likelihood of cavitation, 
but an improved amplitude of echoes returned from weakly reflecting interfaces. 
To image the region of interest and to avoid diffraction, which occurs when the 
transducer size is comparable to that of the sound wavelength, a probe length of about 
5 cm is necessary. The curved elements of the probe illustrated in figure 5.5(d) would 
probably be appropriate, allowing good coupling and focusing, where the beam is made 
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narrower in the direction at right angles to the plane of the scan. 
Focusing the transmitted pulse will result in tissue being irradiated at higher intensity 
than if unfocused, but larger echo amplitudes are achievable and better image detail due 
to an improved lateral resolution. Sequential crystal activation that allows the beam 
to be steered is also desired, as this allows echoes from interfaces aligned obliquely to 
the unsteered beam to be received at greater amplitude. 
The duration of irradiation should be kept low, to avoid the formation of standing 
waves and reduce the time-averaged intensity. 
In order to estimate the characteristics of ultrasound for which non-disruptive imaging 
of this milk system is possible, different ultrasound applications were reviewed. A few 
ultrasound applications only were looked at, because the effects and imaging ability 
of applying ultrasound to one system will not necessarily be the same for another. 
For instance, since threshold values above which ultrasound-induced phenomena occur 
depend on several of the ultrasound beam and system conditions (section 5.4.1), the 
exact effect of an ultrasound beam on each system is unique. The results obtained 
from in vivo ultrasonic studies may not provide an accurate indication of that occurring 
when the same ultrasound field is applied to an in vitro system, as the geometry, the 
occurrence and type of nuclei that provide the potential for cavitation, the mechanism 
of action and the type and response of molecules may differ considerably between the 
two systems [305][312][313][333][334] .  Reviewing in vitro results, as opposed to in vivo ones, 
may be more appropriate but can still only provide a very approximate guide to which 
ultrasound beam characteristics do not disrupt the milk clotting system. 
Ultrasonic thickness measurements of very thin films (of the order of 10 ,im)[335][336] 
have been achieved with great precision (down to 1% accuracy), but due to the high 
frequencies used (90-510 MHz) the depth of penetration has been far too shallow to be 
of use in the milk experiment. The range of frequencies used in diagnostic ultrasound  
'Diagnosis of valvular heart diseaseE34 hj, peripheral vascular disease and a range of tissue 
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are more likely to provide beam characteristics appropriate for the milk application. 
Present-day pulsed wave diagnostic ultrasound typically has a frequency of 1-20 MHz 
and SATA intensities of 5-20 mW/cm2 , with SPTP intensities up to 10 W/cm2 . 
In diagnostic ultrasound, the typical ultrasound frequency range is 2-5 MHz for 
and heart scans, and 5-20 MHz for examinations of superficial 
regions, such as the eyes[3131.  Pulse wavelengths and the corresponding resolution 
features of ultrasound images are of the order of 1 mm. 
Clark et al. (311)  used real-time ultrasonic imaging to measure the thickness of soft tissues 
over bone, an application not much different from the intended milk clot investigation, 
where clot is deposited on a solid surface. The range of soft tissue thicknesses measured 
was 4.0-37.6 mm. A linear sector 7.5 MHz ultrasound transceiver was employed, 
with an axial resolution less than 1 mm, a lateral resolution of 4 mm and a focused 
penetration of 4-5 cm deep. A soft silicone 'stand-off' block was placed between the 
transceiver and the skin to allow the area of interest to lie within the focal region of the 
ultrasound beam. While certain beam characteristics of this probe are not acceptable 
for the milk clot application, the success of this tissue/bone imaging application is very 
encouraging. A higher frequency and/or more focused ultrasound beam would provide 
better resolution and a focal length more appropriate for the milk application. For 
instance, a frequency of 20 MHz would improve axial and lateral resolution by a factor 
of 3, relative to 7.5 MHz1311 . 
The ultrasound intensities used in clinical diagnostics appear to cause no noticeable 
bioeffect s (3121. However, unlike mammalian tissues and blood flow, the milk system 
contains bubbles, making the occurrence of ultrasound-induced phenomena more likely 
(section 5.4.1). The effect of irradiating the aerated milk system depends on several 
factors, including the size and quantity of the bubbles and the ultrasound beam 
characteristics. 
11 characterizations, such as cross-sectional area, diameter, wall and plaque thicknesst 31 , as well as 
thrombus and cyst d epiction (309)(310h, are possible using ultrasonic scanning equipment. 
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Flynn [3391 and Carstensen [3401 have calculated transient cavitation thresholds for 
microsecond-length pulses of ultrasound in a gaseous solution that indicate thresholds 
are dependent on the ultrasound frequency and the size of the gas nuclei in the medium. 
They found that the cavitation threshold may be as low as 1-2 W/cm 2 , at 1 MHz, and 
20-40 W/cm 2 , at 10 MHz. These intensities are above those typically used in clinical 
diagnostics. 
If bubbles in the milk flow were to reside in the ultrasound field, they might oscillate 
with undesirable consequences. Bubbles might become trapped in the recirculating 
flow in the wake of the test-bodies or, as has been observed on post-experimental 
examination, adhere to the test-object and its clot. If this were the case, the bubbles 
might be made to oscillate and the work of Miller and his colleagues[ 1421  might be 
indicative of what to expect. Miller et al. exposed human platelet-rich plasma to 
2.1 MHz ultrasound in the presence of 4 urn diameter gas bubbles stabilized in the 
hydrophobic pores of a membrane. Two different sources (one generating spatial peak 
intensities of 8-250 mW/cm 2 , and the other, a commercial Doppler device, producing 
a spatial peak intensity of 80 mW/cm 2 ) were used to expose the plasma and immersed 
membrane for 10 minutes. The platelets gathered around the pores, forming reversible 
aggregates at 8 mW/cm 2  (spatial peak intensity) and irreversible aggregates above 16-
32 mW/cm2 . The size of the aggregates formed increased with increasing intensity. 
They also found that applying diagnostic ultrasound of a spatial peak intensity greater 
than 32 mW/cm 2  induced platelet aggregation under similar conditions. Application 
of diagnostic ultrasound to the milk experiments might thus promote aggregation of 
destabilized micelles, unless the milk is efficiently degassed. 
Ultrasonic treatment of enzymes, notably the active enzymes in rennet (pepsin and 
chymosin), has been found capable of altering their properties. The response of 
an enzyme to ultrasound is determined by several factors, including the enzyme's 
molecular weight, structure and concentration in solution, the solution temperature 
and PHI"I and the ultrasound beam characteristics. The harsh conditions resulting 
from cavitation and acoustic streaming, induced by high intensity, low frequency 
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ultrasound, have been found to deactivate or denature pepsin and chymosin 111 '. 
The use of diagnostic ultrasound is unlikely to affect chymosin in this way, as not 
only is cavitational activity unlikely but the temperature rise resulting from the use 
of diagnostic ultrasound is usually negligible and the milk flow would rapidly dissipate 
heat. 
Based upon the above findings, diagnostic ultrasound appears worthy of further 
investigation. In section 5.5, preliminary tests and their results are reported and 
discussed in the endeavour to find a suitable transducer for imaging milk clot deposition 
and to determine how best to adapt this probe to the test-chamber. 
5.5 Application of ultrasonic imaging to the milk system 
The preceding review of ultrasound has provided guidelines for the ultrasound beam 
characteristics suitable for the milk application, but certain questions remain; for 
instance: 
- Can ultrasonic imaging be used to measure the thickness of milk clot immersed in 
flowing milk? 
- Is enzymic milk clotting affected by the presence of diagnostic ultrasound? 
- How can an ultrasonic scanner be physically adapted to the test-chamber of the 
milk experiment, in order to give acceptable image quality while causing minimal 
interference? 
In order to answer these questions, preliminary tests were carried out with diagnostic 
ultrasound equipment. Many of the technical difficulties that were encountered with 
the milk apparatus, and detailed in chapter 6, were unresolved at this stage of the 
research, so models of the milk system were used. 
5.5.1 Imaging of the milk system 
The aim of the first test was to determine whether or not it is possible to image 
ultrasonically the interfaces between milk clot, aqueous milk and P.V.C. A bell-shaped 
solid P.V.C. test-body, covered in freshly prepared milk coagulum and suspended on a 
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steel rod, was immersed in a basin of milk and imaged using a real-time, multi-element, 
3 MHz ultrasound transceiver. The ultrasound probe was submerged slightly below the 
milk free surface and aligned parallel to the axis of the test-object, and a rubber strip 
was placed on the base of the basin to avoid undesirable reflections from the back 
wall. The interfaces formed by the clot and milk and the rod and milk were roughly 
delineated, but the test-body/clot interface was not depicted. A subsequent test was 
performed using the same arrangement and a 7.5 MHz probe, which provided a better, 
less hazy image of the milk/clot interface and what appeared to be the test-body/clot 
interface, meriting further research. 
A simple static model was devised (figure 5.11) for assessing the feasibility of using 
ultrasound to image milk clot. This model consisted of the test-chamber from the milk 
apparatus, with clot on some of its inner wail, plugged at both ends, and containing milk 
or water and a partially clotted teardrop-shaped P.V.C. test-body on a stainless steel 
rod. The preclotting of the test-body was achieved by fitting the test-body onto a steel 
rod and using this to stir a mixture of warm milk, rennet and CaC12, and then leaving 
it to clot. Wall clot was prepared by trying different large-scale clotting procedures, 
not much different from that of the Lee-White test, until a combination of reagents was 
discovered that allowed a well-adhered clot to be formed on the test-chamber wall. 
Since the intended application is a novel one, the type of scanner which would be 
most suitable was not readily apparent. Selection of the transducer by testing a wide 
range of probes of different design (i.e. flat or curved crystals (figure 5.5(d)), electronic 
focusing, and different frequencies (5-15MHz)) would be most appropriate, but the 
required selection of probes for such comprehensive tests was not available. However, 
three transducers were available for these tests: two 7.5 MHz transceivers (one linear 
(6 cm x 1 cm), the other convex), and a point probe with an estimated frequency of 
10 MHz. The suppliers  estimated the resolution and focal length of all three probes 
to be 1 mm and 20 mm, respectively. The 7.5 MHz linear-array transceiver proved to 
be the most appropriate of the three probes, as it was able to both couple well to the 
'Dynamic Imaging Ltd., Young square, Brucefleld industrial park, Livingston, Scotland. 
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Figure 5.11: Schematic of the static model used in preliminary ultrasound tests. 
wall of the static model and scan the full length of the test-body. However, it did not 
provide imaging of a quality adequate for test-body clot thickness measurement. 
There are various ways to improve image quality, but for further tests to be conducted 
an ultrasound scanner had to be purchased. The most suitable scanner available was 
a "Concept 2000", which came equipped with a linear-array piezoelectric transceiver 
operating at 7.5 MHz, SATA intensity of 9.6 mW/cm 2 and a beam power of 462 pW. 
This transceiver has a face that measures 6 cm x 1 cm, has 79 crystals, which are 
sequentially activated to focus the ultrasound beam to one of two optional focal lengths 
(35 mm or 60 mm), and provides pulses of ultrasound of 0.45 jis width in water, with 
a pulse repetition frequency between 2 to 8 kHz, and a fixed frame rate of 25 f/s. 
Assessments of this scanner's effect on milk clotting (section 5.5.2) and of ways to 
improve its imaging of the milk system (section 5.5.3), as well as its resolution, were 
conducted. 
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5.5.2 Investigation of ultrasonically-induced effects 
While most bubbles in the milk flow will spend very little time in the ultrasound 
beam, bubbles that are trapped in the wake and clot of the test-body, or in standing 
ultrasound waves, may be irradiated for the full duration of the test-chamber scan. 
These trapped bubbles might resonate in the ultrasound field, resulting in acoustic 
streaming and enhanced mass transfer. 
In order to investigate whether or not the purchased ultrasound system induces any 
undesirable effects, a few simple static s  tests were conducted. Any thermal, chemical 
or mechanical effects induced by ultrasound during these tests were negligible, as no 
noticeable changes in clotting, clot appearance or bubble behaviour resulted from the 
use of ultrasound. No temperature rise occurred during 80 minutes of irradiation of 
a stagnant, water-filled perspex test-chamber. Application of ultrasound through the 
wall of the test-tube, during a Lee-White test with milk, resulted in no change in 
clotting time or clot adhesion. Bubbles studied under magnification, both in a warm 
water flow and adhered to the P.V.C. test-body, were seen to behave no differently 
when irradiated with ultrasound. Irradiation of a preclotted test-body submerged in 
stagnant water caused no dissolution or disturbance of the clot, at both macroscopic 
and microscopic levels. 
5.5.3 Image enhancement 
Ultrasound transmission through the perspex test-chamber wall is associated with 
unacceptable attenuation and consequently poor imaging of the clotted test-body. This 
image degradation is a result of ultrasound reflection, absorption and refraction. While 
both the reflection and absorption of ultrasound will result simply in a reduction of the 
amplitude of echoes from the test-chamber contents, the consequence of refraction can 
be an image which incorrectly depicts the depth, thickness and shape of structures. In 
order to improve imaging, (i) redesign of the test-chamber was attempted; (ii) different 
materials of construction of the test-chamber and test-object were tested; (iii) a 'stand-
off' was tried; (iv) and the optimal settings of the machine controls were established. 
'Reproducible milk clotting in the milk rig had not been achieved at this stage of the research. 
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(i) Test-chamber redesign 
Different test-chamber designs were considered. One could seal the transducer into 
the test-chamber, with its active face flush with the surface of the inner-wall, but this 
would not allow the operator to scan different regions of the test-chamber, as is desired. 
Alternative designs included a test-chamber with a 'shaved flat' (figure 5.12(a)), and 
ones with a flat, thin window (figure 5.12(b) and (c)). 
If the site of probe application was a flat section machined on the outside of the 
test-chamber (figure 5.12(a)), the probe would not disrupt the flow within the test-
chamber, would be more easily applied and ultrasound would be transmitted through 
less attenuative material; however, refraction would still take place. 
Comparisons were made between images obtained by transmission and reception of 
ultrasound through the original perspex test-chamber wall, the wall of a P.V.C. test-
chamber, and the flat window of a test-chamber of the design illustrated in figure 
5.12(b). Transmission through the silicone-rubber window provided a better test-body 
image than that obtained with the P.V.C. pipe wall which, in turn, was better than that 
with perspex. It was, however, difficult to obtain a water-tight seal between the rubber 
window and the test-chamber, and this window was bumpy; capable of disturbing 
the flow within the test-chamber. Another problem associated with the 'windowed' 
test-chamber, that would be likely to affect the milk clotting experiment, is that it 
renders the test-chamber unsymmetrical. Compositional, as opposed to structural, 
modifications might be an easier and more versatile way of improving imaging. 
(a) Test-chamber with 







(c) Test-chamber with a 
variable window-material 
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Figure 5.12: Three test-chamber design ideas. 
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(ii) Composition 
The attenuation caused by the different media within the field of scan (i.e. the milk 
clot, aqueous milk, the test-body and its support rod, and the test-chamber wall) was 
assessed, and improved where necessary. 
The images achieved when the static models illustrated in figures 5.11 and 5.12(b) were 
used, with and without wall clot present, indicated that the wall clot does not attenuate 
the ultrasound beam markedly. Minimal attenuation also is caused by aqueous 
over the shallow depth to be scanned here. 
When the ultrasound beam interacts with the test-objects, refraction, absorption, 
reflection and scattering lead to incomplete imaging of the posterior side of the test-
body and of structures lying directly behind it, and extensive reverberation  arises due 
to the presence of the highly reflective (Z=45.7x 10 6 kg/m2 s [347]), low loss (0.43 dB /cm 
at 10 MHz[348]), 1.6 mm diameter stainless steel rod, which is aligned perpendicular 
to the ultrasound beam axis. Unambiguous imaging of the near-side of the test-bodies 
was thus the best that could be hoped for. The criteria used for choosing the material 
for construction of the test-body and its support rod were that there should be a large 
difference in acoustic impedance between it and the milk and curd, so that strong 
reflection can be achieved at both the test-object/milk and test-object/curd interfaces; 
that the material should be acoustically absorbent to avoid reverberation artefacts; 
and that it should be inexpensive and rigid even when thin. The acoustic impedance 
of aqueous milk, Zmilk = pmilkxcmuk 
1030[210]X 1540 [349]  = 1.59x 106  kg/m2 s. The 
speed of sound in curd (c rd) is believed to be 1540 m/s, similar to that in aqueous 
milk and soft tissue [313];  it was found that the scanner, which assumes the speed of 
sound to be 1540 m/s in its computations, displayed a given interface to be at the 
same depth of immersion in milk, whether coated with milk clot or not. Zrd was 
assumed to be about 1.63x 10 6  kg/m2 s (the average value for soft ti ssue)[313]. 
occurs only when the ultrasound beam is perpendicular to strongly reflective 
interfaces and the medium between them is not highly attenuative. It is manifested in the image 
by equidistant lines parallel to the strong reflector, which are caused by internal reflections between 
the proximal and distal interfaces prior to the echo returning to the transceiver. 
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The ideal material for construction of the test-chamber is one that is inexpensive, rigid 
and acoustically matched to its surroundings. Such a material would have a similar 
acoustic impedance and similar speed of propagation of sound to that of milk and the 
elastomer cover on the transceiver crystals, and cause no loss (absorption or reflection) 
of ultrasound. The acoustic impedance of the probe face is 1.63x 10 6 kg/m2 s[350]. 
A preliminary series of non-quantitative tests was carried out with readily available 
cylindrical tubes of different materials, in order to determine whether or not one of 
these materials might be suitable for construction of the test-chamber. The tubular 
vessels were filled with water and a preclotted P.V.C. teardrop test-body immersed 
within them. Glass (pyrex) containers gave the worst imaging, resulting in extensive 
refraction and reflection and an image riddled with artefacts. Perspex receptacles of 
different sizes were also found to cause unacceptable levels of beam distortion. A P.V.C. 
pipe allowed a better, but still poor, test-body image to be obtained. Transmission 
through either high density polyethylene or polycarbonate gave better imaging of the 
test-body, and transmission through polypropylene gave the best test-body imaging. 
Variation of the thickness of polycarbonate (0.75-3.0 mm) and polypropylene (2.25-4.0 
mm) did not markedly alter the quality of image achieved. 
A quantitative, more extensive and systematic approach was subsequently adopted in 
the search for suitable materials of construction for the test-body and test-chamber; 
data from the literature (given in table 5.2) and values obtained from experiments were 
used 
In table 5.2, "loss" corresponds to the reduction of ultrasound intensity as it propagates 
through a material, as given by equation 5.5. For example, if ultrasound of 1 MHz 
frequency has an intensity 1 0  of 9.6 mW/cm 2  on entering soft tissue (a medium which 
incurs a loss of 0.7 dB/cm), then T, the intensity of the wave, say, 1 cm into the soft 
tissue, would be about 8.2 mW/cm2. 
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Material cj (m/s) p (kg/m3) I Z  Loss(dB/cm) 
adiprene / 1160 1.94 / 








12 at 1 MHz 
0.018 at 1 MHz 
butyl rubber / 1110 2.0 / 
carbon (pyrolytic) / 2210 7.31 / 
carbon (vitreous) / 1470 6.26 / 
climethyl pentene polymer / 830 1.84 4.4 at 4 MHz 
Dow silastic rubber / 1250 1.30 33.7 at 4 MHz 
ethyl vinyl acetate / 940 1.69 / 
glass (pyrex) 5640 2240 13.1 / 
glass (crown) 5660 2500 14 0.17 at 10 MHz 
milk 1540 / "-p1.59 2 at 5 MHz 
neoprene / 1310 2.1 / 
nylon 2200-2680 1120-1170 2.4-3.1 2.9 at 5 MHz 
paraffin wax 2200 830 1.8 / 
perspex 2680-2730 1170-1200 3.2 4.95 at 2.5 MHz 
polycarbonate / 1180-1200 2.69 24.9 at 5 MHz 
polyester 2400-2900 1070 2.86 / 
polyethylene (LDPE) 2000 915-925 1.79-1.84 4.7 at 1 MHz 
polyethylene (HDPE) 1950 926-960 2.33 / 
polypropylene / 890-906 2.36 18.2 at 5 MHz 
polyurethane / 1110 1.96 46.1 at 4 MHz 
porcelain 5600-6200 2300-2400 13.5 / 
P.T.F.E. 1350 2140-2200 2.97 3.9 at 5 MHz 
P.V.C. 2300 1300-1450 3.27 11.2 at 5 MHz 
soft rubber 1480 900 1.4 / 
soft tissue (average) 1540 / 1.63 0.7 at 1 MHz 
stainless steel 5900 7890 45.7 0.43 at 10 MHz 











wood (pine) / 450 1.57 
ZL = acoustic impedance = pxci (xlOb) kgf 
smh;  ci = speed 01 longitudinal bulk 
waves. 
Table 5.2: Approximate material properties[210] [305] [313] [347] [348][351][352] 
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In the search for a material suitable for the construction of the test-object, it was 
found that a high percentage of ultrasound is reflected at the interfaces between water 
and aluminium (70%), carbon (43%), glass (65%), porcelain (64%) and stainless steel 
(87%), but that these materials are not very absorbent. Less reflective polymers (listed 
in table 5.3) were chosen for preliminary tests, due to the ease with which they can be 
shaped and their greater absorption of ultrasound. 
Of the materials listed in table 5.2, those which roughly satisfy the above mentioned 
test-chamber material criteria and/or were promising in early imaging tests were wood, 
polyurethane and a few of the materials listed in table 5.3. Berridge found 
[2271 in his 
milk deposition studies (described in section 4.2.1) that the rate of curd deposition on 
wood is very small (0.06 mg/mincm 2 ), so its use here might limit wall clot growth, but 
unfortunately wood is too attenuative to allow transmission of ultrasound. Michael 
Finsterwald [3501  recommended a certain type of soft polyurethane, which has very good 
acoustic properties (e.g. c = 1540 m/s; Z = 1.6 kg/sm 2 ; and is 'low loss'), but a pipe of 
this type of polyurethane might be insufficiently rigid to be practicable and was in any 
case unavailable. The different polyurethane samples available were rigid but highly 
attenuative. The remaining materials worthy of further consideration were included in 
the test described below. 
Speed of sound tests 
The values in the literature of Z, p and c, of the polymers chosen for further 
consideration, either varied from source to source or were not found. An existing 
ultrasonic measurement system, at the Royal Infirmary of Edinburgh, was thus used to 
obtain a more accurate and complete quantitative guide to which of the most promising 
materials would be best suited for construction of the test-chamber and test-object, 
with regard to the criteria listed above. 
The test system (figure 5.13(b)) consisted of a water tank, a clamp stand for mounting 
the sample perpendicular to the ultrasound beam, a 3.5 MHz ultrasound transducer 
and receiver both applied against special windows on opposite sides of the water 





Figure 5.13: (a) An A-scan trace depicting reflecting interfaces, and (b) a schematic of 
the water tank apparatus used for determining the speed of propagation of sound in 
different test-materials. 
tank, and a demodulator through which the recorded signal passed on its way to the 
oscilloscope. Flat, square samples, composed of the first six materials listed in table 
5.3, were prepared and individually mounted in the measurement tank. A pulsed-echo 
one-dimensional scan was performed, called an A-scan, in which echoes are displayed 
as vertical deflections of the trace on a CRT screen at locations corresponding to the 
interfaces which produced the echoes (figure 5.13(a)). The size of the vertical deflection 
indicated the magnitude of the echo signal, and the difference between the position of 
the deflections along the horizontal axis was a measure of the time taken for sound to 
travel through the test-material. 
The difference in sound transmission time, when ultrasound was passed through the 
water tank with and without a sample present, was used with the value of the sample 
thickness to calculate the longitudinal plane wave velocity in that specimen. The 
acoustic impedance (Z) of each material was then determined, by substituting density 
values from the literature and the empirically obtained sound speeds into the equation: 
Z = p x C; the values obtained are listed in table 5.3. Using these values, and a value 
for Zmjlk of 1.59x 106  kg/m2 s and Cmjjk of 1540 m/sE ] , the reflection and refraction of 
ultrasound caused by interfaces consisting of milk and these materials were evaluated 
as explained below. 
c = velocity of sound (found experimentally; from the literature); p = sample density; 
Z = acoustic impedance (ct.xput.; clit . X Plit. or Zia.);  and f denotes a value from 
the manufacturer. 
Material c (m/s) p (kg/M3 ) Z x 106  (kg/m 2s) 
P.V.C. 2282 ; 2300 r'.'1375 3.138; 3.162 
P.T.F.E. 1425 ; 1350 2170 3.092; 2.930 
perspex 2598 ; -.27O5 .1185 3.079; 3.205 
nylon 2517 ; 	2440 1145 2.882; 2.794 
polycarbonate 2082 ; / 1190 2.478; 2.69 
polypropylene 2303 ; / 898 2.068 ; 2.36 
polyethylene (HDPE) / ; 1950 -935f / ; 1.823 
* The percentage of the incident beam reflected when an ultrasound beam strikes the 
flat milk/solid interface at normal incidence; f dB/cm at 5 MHz. 
Material - % Reflection* Absorptionf 
P.V.C. 1.482 10.7 11.2 
P.T.F.E. 0.925 10.3 3.9 
perspex 1.687 10.2 10 
nylon 1.634 8.3 2.9 
polycarbonate 1.352 4.8 24.9 
polypropylene 1.495 1.7 18.2 
polyethylene 1.266 - 	0.5 25 
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Table 5.3: Material properties from experiment and literature 
[353][3541 
The ratio of the speed of sound in the different media to that in milk (-) were calculated 
and listed in table 5.4, to allow one to compare the different solid/milk interfaces, with 
respect to the extent of ultrasound refraction (equation 5.6) they cause. In addition, 
the empirical values of Z in table 5.3 and the value of Zm1k were substituted into 
equation 5.1, in order to estimate the relative extent of ultrasound reflection at the 
different solid/milk interfaces, and the values obtained are given in table 5.4. 
Table 5.4: Refractivity, reflectivity and absorption of ultrasound with different 
materials interfaced with milk 
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Choice of test-chamber material 
From examination of table 5.4, none of the materials considered are ideal for use in 
the construction of the test-chamber, since all reflect, refract and absorb ultrasound. 
In order to determine which of these materials is most suitable for construction of the 
test-chamber, assessment of the combined importance of (), percentage reflection and 
absorption was attempted. 
Since ordering of materials with regard to transparency to ultrasound and based solely 
on material properties is not possible without quantitative knowledge of the relative 
importance of the various properties involved, and no such information was available, 
the results of imaging tests were used here. Comparison of the results of the preliminary 
series of image quality tests reported earlier with the material properties in table 5.4 
indicates that no single property of a given material uniquely determines the quality of 
ultrasound imaging of an object enclosed by walls of that material. It was found that 
ultrasonic imaging was better when ultrasound was transmitted through the P.V.C. 
pipe wail than through the wall of the perspex pipe. The amount of ultrasound 
absorbed in, and reflected at, the P.V.C. wail is slightly greater than with the perspex 
wall; however, perspex causes more refraction (u-) and scattering than P.V.C., and 
it is the refraction and back-scattering artefacts, which riddle the images obtained 
by transmitting ultrasound through perspex, that make imaging through perspex 
worse than that through P.V.C. On the other hand, tests conducted with P.V.C. 
and polypropylene showed that imaging was best when ultrasound was transmitted 
through polypropylene. This appears to be because the greater percentage reflection 
of ultrasound at the milk/P.V.C. interface, relative , to that at the milk/polypropylene 
interface, has a greater influence on imaging than the refraction (-) and absorption 
occurring, which are greater in polypropylene than in P.V.C. The quality of imaging 
when ultrasound was transmitted through polyethylene and polycarbonate was found 
in preliminary experiments to be similar, although a greater percentage reflection and 
refraction () are likely to occur with the polycarbonate. These images were better 
than those obtained with P.V.C., although P.V.C. causes less absorption; presumably, 
the lower absorption is offset by the greater percentage reflection and refraction 
() occurring with P.V.C. Yet, it is anomalous that polypropylene allowed better 
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imaging than polyethylene; while causing less sound absorption than polyethylene, 
polypropylene is more reflective and refractive. 
In order to confirm that of the materials considered polypropylene is the best material of 
construction for the test-chamber, test-chambers were constructed of the two materials 
most likely to be of use - polypropylene and polyethylene. Comparisons between the 
quality of images obtained using these test-chambers indicated that the polypropylene 
test-chamber with a 4 mm thick wall does indeed provide the best imaging, followed 
closely by the polyethylene test-chamber with a 3 mm thick wall. 
A polypropylene test-chamber, with a bore of 32 mm and a wall thickness of 4 mm, 
was used in further tests unless otherwise stated. The choice of this pipe wall thickness 
was guided by its rigidity, as imaging was not noticeably affected when the thickness 
of this wall was varied between 2.25-4.0 mm. 
Choice of test-object materials 
Of the materials listed in table 5.4, P.V.C., P.T.F.E. and perspex are most likely to 
provide a good image on normal irradiation and observation, based on the percentage 
reflection estimated to occur at their solid/milk interface when perpendicular to the 
ultrasound beam axis. However, the surfaces of the test-bodies intended for use in 
the milk experiments are not, in most places, perpendicular to the ultrasound beam 
axis. Since this axis is also the line of observation, such surfaces are mainly viewed 
by scattered (diffusely reflected) radiation. The amount of ultrasound returned by 
diffuse reflection to the transceiver is not only dependent upon the change in acoustic 
impedance across the milk-test-body interface but also on the angle of incidence and 
the roughness of the surface'°. It was decided, therefore, that imaging tests should be 
conducted with test-bodies constructed from all of these materials, except polyethylene. 
`The size of an echo from a smooth object varies rapidly with the angle of incidence of the ultrasound 
beam; the amplitude of echoes received by specular reflection from a smooth surface perpendicular to 
the beam axis can be about 100 times greater than that of echoes received by diffuse reflection from 
E3131 the same surface obliquely aligned to the ultrasound beam axis 
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Ratingt Material Comment 
1 P.V.C. near-face depiction good, less so on oblique parts; correct shape & length 
1 P.T.F.E. near-face depiction as good as that with P.V.C. 
1 nylon near-face depiction as good as that with P.V.C. 
2-3 perspex discontinuous depiction of near face 
3 polycarb. discontinuous, poor depiction of near face 
3 polyprop. discontinuous and least well depicted near face 
Itating based on relative image quality ki. is Desi). 
Table 5.5: Relative imaging quality of unclotted teardrop-shaped test-bodies 
Tests were conducted using a milk-filled polypropylene test-chamber and a preclotted 
or clean teardrop-shaped test-body, and some of the results are given in table 5.5. 
The region of the test-body with the smallest angle of incidence (i.e. the widest part) 
produced the strongest echoes, while the more oblique areas were delineated poorly, if at 
all. Although P.V.C., P.T.F.E. and perspex all give approximately the same percentage 
reflection at interfaces with milk perpendicular to the ultrasound beam axis, P.V.C. 
and P.T.F.E. provided better images than perspex for interfaces perpendicular and 
oblique to the beam. The perspex test-body produced a glare of intense local specular 
reflection on its near-side, which made clot detection difficult, and its oblique parts were 
less well depicted; presumably the incident radiation was mostly specularly reflected 
away from the observation direction, probably due to the much smoother surface of 
the perspex test-body. On the other hand, the nylon test-body was imaged with a 
quality similar to that of P.V.C. and P.T.F.E.; though it is less specularly reflective, 
the nylon specimen used may have had a rougher, more diffusely reflective surface 
than P.V.C. and P.T.F.E. The polycarbonate and polypropylene have the smallest 
differences of acoustic impedance from that of milk, of the group of materials tested, 
so it was no surprise that test-bodies constructed of these materials were least well 
depicted, particularly on their oblique sides. Of the test-body materials providing the 
best image, P.V.C. is the most absorbent (thus the least likely to cause reverberation 
artefacts) so was chosen as the test-body material. The teardrop, cone and disc-shaped 
test-bodies used by Christy, and illustrated in figure 4.8, are constructed of P.V.C. and 
so were used in the tests reported later. 
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The depiction of the P.V.C. test-bodies within the polypropylene test-chamber was 
not ideal, particularly on the oblique sections and when clot was present. Although 
the near face of the P.V.C. teardrop could be completely delineated, the oblique parts 
were more fuzzily depicted and any clot on these parts obscured these regions of the 
test-body surface. This problem might be overcome by making the surface of the test-
bodies sufficiently rough, as is sometimes done with biopsy needles in invasive ultrasonic 
procedures E3 l3], allowing more sound to be scattered back to the transceiver. However, 
such surface modification might alter the test-body clotting propensity and would be 
difficult to do uniformly. The use of a stand-off is a recommended way to improve the 
percentage of ultrasound returned to the transceiver; tests carried out with a makeshift 
stand-off proved disappointing, however, and are reported later. 
The reverberation caused by the steel rod supporting the test-body was reduced by 
finding a replacement for steel that is more absorbent, less reflective and rigid even 
when thin. In order to determine which of the available materials was most rigid (i.e. 
has the largest Young's modulus (E)), the values of c and p (from table 5.3) were 
substituted into the equation [3551: 
and the Young's moduli calculated are given in table 5.6. 
Material E (x109 kg/ms2) dB/cm at 5MHz 
perspex 7.97 10 
Nylon 7.36 2.9 
P.V.C. 7.03 11.2 
polycarbonate 5.207 24.9 
polypropylene 1 	4.80 1 	18.2 
P.T.F.E. 1 4.41 1 3.9 
Table 5.6: Young's moduli of, and loss in, different materials 
Perspex was the material chosen for construction of the new support rod. The new 
rod is illustrated in chapter 6 (figure 6.4) and has a greater diameter than the steel 
rod (for rigidity), is of greater length, and is tapered so that it can be inserted into 
the test-bodies. This rod was found to cause less reverberation than the steel rod; 
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especially at its tapered part, since this section of the rod is not perpendicular to 
the ultrasound beam axis. Thus the region of interest, that is the test-body and its 
immediate-wake region, is now free from reverberation and even less likely to cause 
standing wave formation. 
Use of a stand-off 
A stand-off is usually used to either reduce image degradation due to reverberation, 
by increasing the distance between the reflective structure and the sound source, or 
to enable the operator to position the probe so that the object under view lies at the 
beam's focal point. Neither reverberation nor the fact that the test-bodies are not 
at the beam's focal point" was a major problem here. A simple test was conducted 
that indicated that the ultrasound beam is weakly focused and that the image quality 
is insensitive to variation in object depth; a bell-shaped solid P.V.C. test-body was 
depicted with similar quality, when 19 mm and 35 mm from the probe face in a water 
bath. A flexible stand-off could still be useful, however, as it would allow the operator to 
achieve angles of incidence closer to 900  on the otherwise oblique and poorly delineated 
test-body surfaces. 
A deaerated water balloon, coated with gel couplant on both sides and known to act 
as a good stand-off clinically, was inserted between the probe and the test-chamber 
wall. This stand-off was awkward to use and gave poorer images than those obtained 
without it. A similar result was achieved using a gel-filled sanitary probe cover. A 
more useful stand-off for this application might be a customized one; however, the cost 
of a customized stand-off is extremely high. Thus a stand-off was not used in the work 
reported hereafter. 
Instrument settings 
The image quality is highly dependent on the operator, who determines the effective 
beam shape by using sensitivity controls. Once the optimal settings of these controls 
"The focal length of the 7.5 MHz probe is about 35 mm, and the distance between the test-chamber 
outer wall and the centre-line of the pipe is only 20 mm. 
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were established (section 6.1.11), the axial and lateral resolution were estimated. The 
best axial resolution (AR) for soft tissue is denoted by [312]: 
AR = SPL. . . ( 5.9) 
where the spatial pulse length (SPL) is the product of the number of cycles in the pulse 
and A. The 7.5 MHz transceiver emits pulsed ultrasound at a speed of 1540 rn/s (in 30°C 
milk)E39] with 3 cycles in each pulse; using equation 5.9, the best axial resolution to 
be expected is about 0.31 mm. The axial resolution of diagnostic ultrasound is always 
better than lateral resolution[312] ; the lateral resolution is usually about three times 
poorer than axial resolution [3l4] and was estimated by the instrument manufacturers 
to be 1 mm. The resolution or detail, achievable when imaging a non-flat clot, may 
not be as good as these predictions, so resolution tests were conducted. 
Since extensive, well adhered coagulum on the test-body was not easy or cheap to 
achieve, a small object was taped onto the P.V.C. teardrop, and this model of the 
clotted test-body was immersed in a water-filled polypropylene test-chamber. Paper 
was rolled into a ball and taped onto the teardrop in two different places. Thickness 
measurements of the 'clot' taken from the display screen were accurate to within about 
0.4 mm, and lateral resolution was about 1 mm. 
5.5.4 Interpretation of ultrasound images 
Interpretation of ultrasonic images can be difficult, with image detail being coarse and 
some structures causing beam attenuation and misleading artefacts. An ultrasonic 
image is dependent on the equipment, the media under study and the operator. The 
operator bias can be minimized by familiarity with the limitations and capabilities 
of the ultrasound scanner, and by learning what patterns or display characteristics 
correspond to specific structures and which are artefacts in the ultrasonic images. 
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All of the systems illustrated in figures 5.14(a), 5.15(a) and 5.16(a) contain a test-
chamber, in which a. flow (from left to right in the image) of renneted milk passes a 
centrally positioned test-body, and are displayed on the ultrasound monitor as shown 
in figures 5.14(b), 5.15(b) and 5.16(b), respectively. The scale graduations on the 
perimeter of the ultrasound image are separated by 10 mm, while the grey-scale wedge 
on the left side of the image indicates the range of grey in which echoes are depicted. 
Aspects of the ultrasound images worth consideration are denoted by the letters A—G, 
and are discussed below. 
The milk clot provided diffuse reflections, arising due to scattering of the ultrasound 
beam and resulting in a speckle-pattern depiction, and was imaged better when in some 
locations than in others. The curved test-body and clot adhered to it were depicted, 
but not well enough to allow clot thickness measurements to be made. The clot on the 
wall nearest the probe was partially depicted, but was too near the probe to be imaged 
unambiguously. There exists a region next to the transducer face of about 4-5 mm 
deep1312113131, termed the 'transducer dead space', which cannot be imaged due to the 
fact that transceivers cannot detect echoes while they are transmitting. A cloudy region 
(A) occurred in this superficial region, due to echoes from structures near the probe 
face being returned to the transceiver during transmission. A consolation was that the 
milk/clot and wall/clot interfaces at the far-side of the pipe (F) were depicted well 
enough for thickness measurements to be made, except when lying directly behind the 
test-body. This wall clot was usually depicted as consisting of a bright layer adjacent to 
the wall, probably trapped bubbles, covered by a dark or speckled clot whose interface 
with the milk flow was a grey line highlighted by bubbles flowing over it. 
Nearly all of the ultrasound beam intensity was reflected or absorbed, where air bubbles 
and the test-body were present in the beam. A glare was sometimes present, due 
to strong reflection at the surface of the test-body and bubbles, which made image 
interpretation of the adjacent structures difficult. Bubbles in the flow" (B) and on the 
test-body (C) were depicted brightly and gave rise to scatter and shadowing 13 . The 
12 The frame rate was sufficient for the bubbles in the flow not to appear as if they were jumping. 
"Shadowing is an artefact that occurs when ultrasound is greatly attenuated by strongly reflective 
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highly attenuative test-body caused a shadow region (D), which made interpretation of 
images on its far-side impossible. Bubbles, and even a highly reflective brass rod (Z = 
40.6x 106 kg/ sm2 [347]) placed perpendicular to the ultrasound beam, were undetectable 
when in the shadow region of the test-body. 
Reverberation artefacts occurred due to multiple reflections of the ultrasound waves. 
'Ghost' interfaces were present in the ultrasound images, on the posterior side of the 
support rod (E), due to internal reflections between the front and back faces of the 
support rod. 
The depth of a structure is displayed, following a calculation made by the signal 
processor (using the speed of sound in soft tissue, 1540 m/s). Since the speed of sound 
in curd is similar to that in soft tissue, the curd thickness depicted on the display was 
the actual thickness. However, the ultrasonically depicted thickness of other media 
within the plane of the ultrasound scan, in which sound travels at speeds substantially 
different to that in soft tissue, was not similar to the actual thickness of these media. 
For instance, the 10 mm diameter teardrop-shaped test-body was depicted as being 
less than 10 mm wide (G in figure 5.14(b)). 
Given the fixed parameters of the ultrasound transducer, the fixed shape of the test-
bodies, the small difference in acoustic impedance between the curd and milk, limited 
time and no effective stand-off available, it was not felt that much more progress in 
image enhancement could be made. At this point, therefore, it was decided to proceed 
to the next stage : conducting ultrasonically imaged milk experiments. The results 
obtained from ultrasonic scans in numerous milk clotting experiments are reported 
and discussed in chapter 7. Chapter 6 details the apparatus, how it was used and the 
way in which technical difficulties were approached. 
interfaces and/or highly absorbent layers. Structures on the posterior side of these highly attenuative 
media can produce only weak echoes, which must cross the highly attenuative structures before reaching 
the transceiver. This can result in a dark shadow region on the far-side of highly attenuative structures. 
Chapter 6 
Apparatus and Recommissioning 
Numerous difficulties in securing controlled and reproducible operation were 
experienced when attempting to recommission a previously constructed milk clotting 
rig. A particular problem was the formation of extensive, poorly adhesive milk clots. 
This chapter provides descriptions of the various pieces of apparatus composing the 
milk rig and their inherent problems, if any, and the measures taken to overcome these 
problems. In addition, details of consistency checks, including consistency assessments 
of reagents, wall clot growth and test-body clot shape and weight, and an investigation 
of the effect of using ultrasound in the milk experiments are given. 
The experimental procedure and apparatus (figure 6.1) employed here are similar to 
that used by Christy and described in section 4.2.3, with a few exceptions. 15 gallons of 
fresh, unpasteurized milk was used in each experiment. The accumulation of clot on the 
test-object and test-section wall was visualized by applying an ultrasound transceiver, 
which was linked to a scanner, video-tape recorder and printer, to the test-section 
wall. Other equipment additions or changes are detailed below, and the experimental 
procedure is described, in full, in appendix B. 
149 
6 Apparatus and Recommissioning 
	 150 
6.1 Apparatus 
6.1.1 Dispensation of milk 
The milk was used on the same day that it was obtained, and dispensed from 
three 5 gallon P.V.C. containers with built-in taps. A manifold was employed to 
allow convenient changeover between water and milk, at the start and end of milk 
experiments, and from one milk container to the next during experiments. 
6.1.2 Heat exchanger and temperature controller 
A single-pass plate heat exchanger was used, with 6 parallel hot water channels 
alternating with 5 parallel milk channels, to elevate the temperature of the milk to 
370 C. The heat exchanger was constructed of 316 stainless steel, with Paracril gaskets 
to minimize fouling by milk proteins. Three heating elements (one single-phase 2 kW, 
one 3-phase 4.5 kW and one 3-phase 6 kW element) submerged in a water tank, which 





































Figure 6.1: Schematic diagram of the milk clotting apparatus. 
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controller was equipped with a negative feedback loop to control the water 1 and thus 
milk temperature. 
Inaccurate temperature readings and a major lack of temperature control were 
discovered, so tests were subsequently conducted to identify the sources of these faults. 
The testing of thermocouples was facilitated by implementing a pocket arrangement; 
this made removal of the thermocouples for testing easier than the original arrangement, 
as the thermocouples were previously fixed in place (in direct contact with the 
flowing fluid). Tests on all five of the thermocouples, using flasks of water at 
different temperatures, indicated these detectors were unreliable, giving inconsistent 
and incorrect values. The problematic temperature sensors were found to be made of 
a T-type alloy, which is incompatible with this specific temperature controller. The 
thermocouple wires were thus replaced with wires composed of a compatible (K-type) 
alloy. These new thermocouples were tested, in the same way as before (using water 
samples at different temperatures), and were found to provide correct temperature 
readings. 
The temperature controller was unable to provide a steady-state temperature of 37°C, 
so attempts were made to achieve temperature control. Insulation was applied to vessels 
and tubing but with little effect, indicating that the temperature fluctuations due to 
heat losses occurring through the system were not the main cause of the problem. The 
2 kW heating element was found to be faulty, but this was not of concern as this heating 
element and the 4.5 kW element, present to enable heating of flows of milk up to 6 
1/mm, were found to be unnecessary for heating the 2 I/min milk flow used here. The 
third heating element, that is the 6 kW one, proved capable of supplying all of the heat 
duty required. The temperature control system itself was studied, and it was found 
that only the 'thermal cut-off' mechanism, which limits temperature runaway, was 
operating correctly. Following extensive checking and repairs to the existing control 
'To prevent the risk of heat-induced changes in the milk (section 4.4.3), the water temperature was 
kept below 60° C. 	 - 
6 Apparatus and Recommissioning 	 152 
system further testing showed little improvement in temperature control, with the 
temperature fluctuating continuously by 3-8 °C. The controller was deemed to be of 
poor design and performance and was thus replaced. 
A "91e Eurotherm" temperature controller was chosen as the new controller. This self-
tuning PID controller, which automatically calculates the PID control parameters when 
a setpoint is chosen, provided precision control (± 0.2°C) and enabled the set-point 
temperature to be achieved with circulating water within about 15 minutes. 
6.1.3 Degassing unit 
The degassing unit illustrated in figure 6.2(a) consisted of a 5 litre stainless steel vessel 
containing j"  ceramic spheres (to improve the surface area / volume ratio and promote 
bubble coalescence), and was accompanied by two 7 litre perspex capacitance chambers, 
with vacuum supplied by use of a water-jet ejector nozzle. 
The purpose of the degassing unit was to remove excess gases from the milk, by bursting 
and discharge of bubbles at this liquid's free surface. The milk contains gas in solution 
and in the form of bubbles. When it is heated from 4 to 37°C, the dissolved gas content 
is reduced but the number of bubbles in the milk increases. If the bubbles of gas in the 
milk are not removed, or at least significantly reduced in number, their presence may 
cause significant unwanted effects: they might disturb the flow and clot deposition; 
scatter the ultrasound beam and thus reduce the quality of imaging (section 5.3.4); 
and provide nucleation sites for cavitation or acoustic streaming phenomena induced 
by ultrasound (section 5.4.1). 
The inability of the existing equipment to deliver deaerated milk to the test-chamber 
became apparent by means of ultrasonic imaging; it was discovered that the milk 
entering the test-chamber was riddled with bubbles. Unfortunately, it was found that 
this was due not only to an ineffective degassing unit but also to the diaphragm 
and peristaltic pumps causing bubble formation. Therefore, additional degassing, 
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(a) The original deaerator 









(e) Baffled P.V.0 vessel used in milk experiments 
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Figure 6.2: Degassing section ideas. 
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flow, using an available deaerator, but with disappointing results; the bubble content 
of the milk entering the test-chamber appeared to be slightly, if at all, reduced, but 
nowhere near as much as desired. The use of a degassing vessel downstream of the 
diaphragm pump would not be ideal in any case, as it would cause damping of the 
pulse. 
Further preliminary attempts to improve degassing resulted in improving the vacuum 
achievable, in some cases, but still did not enable the milk to be satisfactorily degassed. 
All the points in the system with the potential of allowing gas intrusion were checked 
and sealed where necessary, and the number of joints in the flow system was reduced. 
The two perspex vacuum chambers were both cracked, having experienced contraction 
and expansion due to pressure fluctuations, and the glue used on their end plates was 
no longer providing an air-tight seal. These two chambers were therefore replaced by 
two similarly sized glass vessels, and their inlet and outlet stoppers sealed tightly with 
vacuum grease. The water-jet ejector was found to be faulty and was replaced. It was 
discovered that the gauze in the deaerator had somehow moved out of its intended 
position, resulting in some ceramic balls actually blocking the flow outlet; the gauze 
was subsequently rearranged. 
The creation of bubbles by the pumps was unavoidable, but modification or redesign of 
the degassing unit might be able to reduce the gas content of the milk flow. Modification 
of the original device was first considered, since a simple alteration would save the time 
and expense of a new deaerator. During the milk experiments the level in the first 
vacuum chamber was maintained at about one inch. This means the deaerator was 
completely full of heated, aerated liquid. With these conditions in mind, the following 
modifications were considered: 
• The original design allowed the heated milk to enter the deacrator and flow 
straight to the outlet, limiting the duration of exposure of the milk to the vacuum. 
An inlet baffle could be inserted to reduce the range of fluid residence times and, 
as a result, increase the degree of gas disengagement (figure 6.2(b)). 
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. The effect of varying the number of ceramic balls could be assessed. 
. Gauze can act not only as a packing support but also as a trap for bubbles, so 
another gauze could be placed on top of the packing (figure 6.2(c)). 
. To promote the rise of bubbles that have passed through the packing and gauze, 
a column, such as that shown in figure 6.2(d), could be incorporated into the 
deaerator design. 
• To reduce the number of 'dead zones', which lead to large residence time variation, 
the deaerator base could be made conical. This more gradual flow constriction 
would also reduce acceleration at the deaerator outlet, hopefully reducing the 
number of bubbles being carried downstream. 
• A high vacuum is desired. The vacuum could be increased, and a gas membrane 
used(358) so that the milk is not drawn into the vacuum line. 
Some of the above modifications for degassing enhancement were attempted, and it 
was found that none of the inlet-baffle, variation of the number of ceramic balls, 
or additional gauze (40mesh (0.236 mm diameter)) were effective when tried. The 
other proposals (i.e. conical-base; extra column; and increased vacuum) were not 
implemented. A new degassing unit was deemed necessary. 
An 8 litre, baffled P.V.C. vessel was designed (figure 6.2(e)), with a large nitrile rubber 
0-ring fitted in a grooved lid for air-tight performance. A 40mesh gauze was employed 
at the outlet side of the system (to trap bubbles, promoting their coalescence and rise, 
and increase the mean residence time of the bubbles) and a baffle was used to increase 
the mean fluid residence time and to force all milk to pass the inlet of the vacuum 
chamber. It was calculated that the rise velocity of bubbles in this new unit is such 
that 8 ml of milk flows out of the deaerator in the time it takes a bubble to reach the 
top of the deaerator. 
The new degassing unit appeared to reduce the size and number of bubbles passing 
through the test-section, but a large number of bubbles were still present. Radically 
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different deaerating techniques were subsequently considered. Some of the numerous 
methods assessed for degassing the milk are listed below, accompanied by their inherent 
advantages and/or shortcomings. 
Ultrasonic degassing: Swallowe et 	used a 36 kHz source in direct contact with 
a solidifying melt, to induce gas disengagment from the melt. Whilst ultrasound can 
indeed be used for degassing, this action is facilitated by induced transient cavitation 
- a phenomenon that would be likely to denature milk proteins. 
The inability of the original and new degassing units to thoroughly degas the milk, 
perhaps is due to an insufficient residence time of the milk in the degassing unit. If 
the residence time of the milk in the present degassing vessel was markedly increased, 
the flow from this vessel would be much less than that desired (i.e. << 2 1/mm). An 
alternative way to degas the milk for a longer period of time is by degassing the milk 
prior to each experiment. 
Consideration was given to the idea of degassing the milk prior to each experiment, 
by application of a vacuum, but the increased bubble content when the milk is then 
heated during the experiment would still be unresolved. If the milk was not clotted at 
37°C but at, say, 20°C (recall that rennet will not clot milk below 15°C), the bubble 
population might be lower; however, the clotting time would be much greater and the 
clot rheology different (section 4.4.5). 
An alternative way of degassing the milk before experiments, which would not 
be made ineffective by the preference that the milk be at 37°C in experiments, is by 
preheating the milk at, or above, 37'C. 
Many degassing methods involve heating at temperatures of about 100'C. For instance, 
boiling water for 20 mm, or heating it above 80°C for one hour or more, is very 
effective [360].  However, milk is sensitive to such high temperatures. Heating milk 
at 100'C for 15 to 20 min causes extensive denaturation and aggregation of whey 
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- a phenomenon that would be likely to denature milk proteins. 
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by application of a vacuum, but the increased bubble content when the milk is then 
heated during the experiment would still be unresolved. If the milk was not clotted at 
37°C but at, say, 20°C (recall that rennet will not clot milk below 15°C), the bubble 
population might be lower; however, the clotting time would be much greater and the 
clot rheology different (section 4.4.5). 
An alternative way of degassing the milk before experiments, which would not be 
made ineffective by the requirement that the milk needs to be at 37°C in experiments, 
is by heating the milk at, or above, 37°C. 
Many degassing methods involve heating at temperatures of about 100 0 C. For instance, 
boiling water for 20 mm, or heating it above 80°C for one hour or more, is very 
effective [360]. However, milk is sensitive to such high temperatures. Heating milk 
at 100°C for 15 to 20 min causes extensive denaturation and aggregation of whey 
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proteins and flocculation of casein micelles [189a] . Heating milk at lower temperatures, 
on the other hand, might be feasible. It has been found that heating milk at 60°C 
and below, even for prolonged periods (up to 5 hours), has little effect on the rennet 
coagulation time (RCT) 272  (section 4.4.3). This may not always be the case, however, 
as such heating could have an adverse effect on milk, according to Webb and Ho1m[267]. 
They found that there exists a critical value of about 13 % SnF (solids-not-fat) below 
which thermal destabilization occurs (section 4.4.2). The cow milk used in the present 
experiments contained about 8.5% SnF, so heating this milk prior to milk experiments 
might destabilize it. 
In order to determine whether or not the RCT is unaffected and satisfactory degassing is 
achieved when heating the milk used here, small-scale tests were conducted. Heating a 
200 ml milk sample at WC, for about 20 mm, degassed this milk well enough to improve 
ultrasound imaging, while not causing any noticeable changes in the milk's properties. 
This heat treatment, and slight variations of it, were found to be inconsequential to 
the RCT. Three 5 ml samples of unpasteurized milk were maintained at 34°C for 20, 
25, and 30 mm, respectively, before being used in modified Lee-White tests (where 
inversions were every 15 s). All three tests gave both similar clotting times and solid 
plugs of curd. 
Time constraints and delays due to extensive equipment revamping led to some of the 
ideas described above not being tried. The most hopeful degassing idea appears to 
be the preheating of milk prior to an experiment. If the milk were preheated in a 
large diameter container and this container was elevated, so that it acts as a header 
vessel and makes the peristaltic pump no longer necessary, a steady flow of bubble-free 
milk through the test-chamber may be achieved. On the other hand, heating milk 
prior to pulsatile flow experiments would not be expected to allow one to achieve a 
flow of bubble-free milk through the test-chamber, as the diaphragm pumps' pressure 
fluctuations cause bubble formation. The results reported in chapter 7 were obtained 
with the aid of the degassing unit shown in figure 6.2(e), and without preheating the 
milk since equipment for such preheating was not available at the time. 
6 Apparatus and Recommissioning 
	 158 
6.1.4 Peristaltic pump 
A Watson Marlow 603U/R peristaltic pump, with 12.7 mm i.d. tubing, was used to 
draw the milk from the milk containers through the heat exchanger and degassing unit 
and into the header vessel. This pump was operated with feedback control from a level 
controller in the header vessel, and was capable of providing flow rates up to 8 1/mm. 
6.1.5 Header vessel 
An insulated stainless steel container of 5 litre capacity was used as a header tank, 
providing a supply of heated milk at a constant head to the test-section downstream. 
The level control was facilitated by the use of a 'Teistor Series 80' level sensor and 
controller, with feedback to the power supply of the peristaltic pump. A baffle-ring 
surrounding the exit of the header vessel was used to inhibit bubbles being carried 
straight through to the test-section. 
The steady flow experiments were conducted using the gravity driving force provided 
by the height difference between the liquid level of the header vessel and the outlet of 
the test-section exit tube. Pulsatile flow experiments, on the other hand, were carried 
out with the outlet of the test-section exit tube at a height of about 8 cm above the 
liquid level in the header vessel, in order to eliminate the steady flow component. The 
changing of drain or header vessel height, when trying to establish the correct flow 
rate, was made easier by installing a variable-height header vessel support, two drain-
pipe inlet nozzles of different height, and height graduations for both of these pieces of 
apparatus. 
The need to maintain a flow rate through the test-section of 2 1/mm, even when 
clot development impedes flow, requires monitoring of this flow rate. The header 
vessel height could then be altered or, in pulsatile flow studies, the stroke volume of 
the diaphragm pump changed. A rotameter was incorporated but removed, as the 
resistance it caused to the flow made 2 I/min unachievable. A turbine or magnetic flow 
meter was not used either, due to lack of availability or expense, so flow checks at the 
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sink were conducted with a flask and stopwatch. 
6.1.6 Diaphragm pump 
Pulsatile flow experiments were conducted using a hydraulic diaphragm pump capable 
of producing a range of pulse frequencies (20-150 pulses/mm), stroke volumes (0-100 
ml), and systolic/ diastolic duration ratios (0.4-2.0). The pulse frequency was set at 
70 pulses/mm, the stroke volume at about 28.6 ml, and the systolic/ diastolic duration 
ratio at unity, for all of the pulsatile flow experiments. 
A few minor alterations of the pump were required, after which this pump was able to 
provide consistently a flow rate of 2 1/mm. Air in the pump's lines led to inefficiency 
and long tubing led to pulse damping, so the lines between the bellows and diaphragm 
were shortened and well sealed. Diaphragm and bellow repairs were also necessary. 
6.1.7 Dosing pumps 
Since the clotting time (RCT) of the milk mixture was about 35 s in Lewis's net 
experiments (section 4.2.3), here the CaC1 2 and rennet were added to the milk stream 
immediately prior to the test-section to ensure that the mean residence time of the 
mixture in the test-section was significantly less than 35 s. This injection of rennet and 
aqueous CaC12 was performed by two identical Liquid Metronics Series Al metering 
pumps, which can produce flows with dose frequencies in the range 15-100 doses/mm 
and stroke volumes between 0-0.63 ml. 
Difficulties arose with calibration, as these pumps needed extensive servicing and none 
of the readings on the dials directly corresponded to the actual flow and pulse rates 
produced. The pumps were repaired, cleaned and leaks were eliminated, allowing 
accurate calibration. Twenty ml/min of each reagent was supplied continuously, at 
a frequency of 70 beats/min and a stroke volume of about 0.29 ml, for all of the 
experiments. 




The test-section used by Christy is illustrated in figure 6.3(a). It consisted of three 32 
mm i.d., equal-length, flanged perspex pipes, a flow converger and flow diverger, and a 
test-body on a support rod fixed to a circular seat. Silicone rubber tubing of 12.7 mm 
i.d. was used at the entrance and exit of the test-section, and a diffuser and converger 
were employed in the cylindrical test-section to allow the flow area to change gradually. 
The diffuser promoted plug flow in pulsatile flow, and laminar flow in the steady flow 
regime, limiting the spread of residence times of the activated milk mixture. 
Changes were made here, to the original test-section, mostly for ultrasonic imaging 
or procedural purposes (figure 6.3(b)). The middle pipe, housing the test-body and 
referred to as the test-chamber, was replaced by a polypropylene pipe. Leakage at the 
flange/pipe join, previously experienced with the perspex test-chamber, was prevented 
by having the polypropylene test-chamber flanges friction-welded rather than glued. 
The numbers I to VIII were marked on one of the test-chamber's flanges, to allow 
ultrasound probe position to be recorded when conducting clot symmetry checks. The 
stainless steel rod on which the test-body was suspended was changed to a perspex 
rod (figure 6.4), and a new test-object seat was made for dismantling reasons (section 
6.1.10). 
6.1.9 Waste disposal 
The spent milk flows from the test-section to a vertical drain-pipe, which has a high 
flow rate of cold water introduced at its top-end via a conical diffuser. The previous 
drainage system consisted of a flushed drain-pipe, positioned over a sink, with about 
8 feet of tubing attached between this pipe and the exit of the test-section. This 
arrangement allowed the residence time of activated milk to exceed the RCT while in 
the system, leading to extensive clotting in this tubing and consequently flow resistance. 
Accordingly, dilution of the milk stream was performed closer to the test-section exit, 
to reduce the residence time of activated, undiluted milk in the system and thus the 
resistance to flow. A pipe at the base of the water-flushed drain-pipe directed the 
effluent to the sink. 
10mm 
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Figure 6.3: The (a) original and (b) modified test-sections. 










Figure 6.4: Cross-sectional depiction of the perspex support rod and its P.V.C. seat. 
6.1.10 Test-objects and their removal 
The shapes of the test-bodies employed were teardrop, cone and disc, and are illustrated 
in figure 4.8. The conical and disc-shaped test-bodies were constructed of P.V.C., while 
five teardrop-shaped test-bodies were used, each being composed of a different material 
(P.V.C., P.T.F.E., nylon, perspex or polycarbonate). Each body in turn was mounted 
on the perspex support rod (figure 6.4) axially aligned with the flow and positioned at 
the downstream end of the test-chamber. 
Dismantling the test-section is a delicate stage of the milk experiment that has been 
troublesome in the past. The opening of a valve or flange, upstream or downstream 
of the test-object, had to be carried out carefully and in such a way as to prevent 
a sudden flow of fluid or influx of bubbles which could interfere with the final clot 
on the test-object. At the end of a milk experiment, when the test-section contained 
stagnant unrenneted milk, drainage was originally carried out by either slightly opening 
a drainage valve upstream of the test-section or by raising the test-section until the milk 
free surface had passed by the test-body. Both of the above drainage methods remove 
the fluid pressure helping to keep wall clot in place, allowing wall clot to slip from 
the downstream perspex pipe into the test-chamber. Also, the P.V.C. test-object seat 
was previously inserted in a cavity in the downstream perspex flange (figure 6.3(a)), 
and this caused problems with dismantling - the seat was prone to slipping as the two 
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Ranges were separated, causing disruption of the clot on the test-object. 
A new test-object seat arrangement was devised and a new dismantling technique 
developed, allowing the above mentioned problems with the test-object seat and 
wall clot to be solved. The cavity in the perspex flange, previously occupied by 
the test-object seat, was filled and a new test-object seat was made that fitted 
between the perspex and polypropylene flanges. This new arrangement allowed a new 
dismantling procedure to be carried out, after flow was stopped at the end of a milk 
experiment. Wing nuts were used to hold the test-body seat and the polypropylene 
and perspex flanges together, to enable quick dismantling of the test-chamber with 
minimal disruption. After slight loosening of all six of these screws and removal of one 
of them, a thin, 45 mm wide, lightly greased stainless steel plate was inserted between 
the perspex and test-body seat (figure 6.3 (b)), completely occluding the bore of the 
test-section. Once this steel plate separated the contents of the downstream perspex 
pipe and that of the polypropylene pipe, the remaining five screws and perspex pipe 
were removed with no consequence on the test-chamber contents. The dismantling 
procedure is described in more detail in appendix B. 
6.1.11 Ultrasound transceiver and monitor, and recording equipment 
The 7.5 MHz piezoelectric transceiver, used in the milk experiments to obtain 
information about the instantaneous state of the clot and its growth pattern, was 
described in section 5.5.1 and is illustrated in figure 6.5. 
The ultrasound monitor is shown in figure 6.6. It was equipped with nine buttons on 
the left, and five knobs on the right, of its display screen, as well as a keyboard and a 
trackerball. 
The operational controls, on the left side of the display screen, were used as follows. 
The invert button allowed the image to be displayed upside down. Transpose enabled 
the user to alter the image orientation from left to right or vice versa. If focus was 
selected, the focal length was reduced from 60 mm to 35 mm. This option was not 
i 	j)jift'' 	ij I 
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used in the milk experiments, because the region of interest was within 20 mm from 
the probe. The scale up/scale down buttons allowed any one of three magnifications 
to be chosen: 1.5, 2.0 and 3.0, enabling the operator to make a closer study of any 
area on the display screen. The far and near buttons enabled the ultrasound image to 
be moved up or down, so that the lower or upper parts of the image could be viewed 
more closely2 . The screen button allowed storage of two full size images in memory, 
while another screen was provided for real-time imaging. The freeze button, and a 
foot-switch, allowed the user to still-frame the image on the screen. 
The way in which echoes were processed and displayed on the screen was governed 
by the use of the controls to the right of the display screen. Image enhancement 
was performed by varying the brightness and contrast controls, while observing the 
ultrasound image and guided by the grey-scale on the left side of the display screen 
(which should gradually go from black to white). Too high a setting led to a lack 
of image detail, but too low a value led to weak echoes not being displayed. The 
amplification of received echoes can be modified by varying the overall gain, using a 
special screwdriver, or by using time-gain compensation (TGC). While increasing the 
overall gain influences all echo signals, TGC increases amplification of weak echoes 
only. The controls available for establishing the appropriate TGC included: initial 
gain, which enables amplification of echoes received from superficial reflectors and was 
kept low to keep the transducer 'dead space' artefacts (i.e. the bright, cloudy area 
near probe) from saturating the display; near gain, which provides a small level of 
amplification for the echoes received from shallow structures (in the first 5 to 7 cm of 
the beam, approximately) and was kept at about 50% of the range permitted; and far 
gain, which was not of use here, because this control enables amplification of echoes 
received only from distant reflectors in the region 7 to 13 cm away from the transceiver, 
which is outside the region of interest here. While TGC was of limited use, a more 
versatile form of selective amplification compensation, called automatic gain control 
(AGC), was available. AGC automatically compensated for the general decrease in 
echo magnitude with depth, providing the best achievable images by not increasing the 
2The arrow cursor keys, on the keyboard, also allowed the operator to move the image to the near 
and far fields and to the left and right, when the image was scaled-up. 
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overall echo size but only the size of weak echoes, and reduced the demands on the 
operator and the variation in image quality due to the subjectiveness of imaging. Image 
quality was reproduced by establishing good baseline settings. Once it was determined 
how best to enhance imaging, only one or two controls needed to be adjusted during 
scanurng. 
The caliper and mark switches and trackerball were used to measure the dimensions 
of structures in the ultrasonic images, to the nearest whole iiumber of millimetres. 
The trackerball was used to position the calipers once the appropriate programme was 
selected from the menu (i.e. programme A was chosen for area and circumference 
measurements, and D for distance measurements). Pressing the caliper button made 
the first caliper appear on the screen, and the trackerball was rolled to position this 
caliper, and the mark button pressed to fix it in place. The second caliper subsequently 
appeared, which was positioned and fixed as before, enabling a measurement to be 
made. Three distance measurements were able to be held on the screen at any one 
time 
The information obtained during the milk experiments was recorded using a video-tape 
recorder and an ultrasound UP-850 thermal (black and white image) printer, enabling 
detailed analysis of clot deposition and wall clot loss. Replaying the video-tape of 
magnified ultrasound images, on a television screen much larger than the display screen 
on the ultrasound monitor, allowed precise measurements to be made (to the nearest 
0.01 mm) with hand-held digital calipers applied to the television screen. The distance 
between two adjacent scale graduations around the perimeter of the ultrasound image 
corresponds to 10 mm, providing a scale from which to relate measurements made in 
this way. 
6.1.12 Ultrasound probe support 
The probe can be well-coupled acoustically to the curved test-chamber wall, by using 
plenty of gel and manually holding the probe against the test-chamber. However, 
continuous imaging of the milk experiment for its full duration cannot be achieved in 
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this way by one experimenter, as there are numerous experimental tasks which must 
also be performed as the run proceeds. This problem could be resolved by fixing the 
probe permanently to the wail of the test-chamber; however, versatility is essential 
when attempting to establish a new technique, and imaging of the fax side of the test-
body and other regions of interest would not be possible with such an arrangement 
nor would probe maintenance. To resolve this problem, a P.V.C. probe support was 
designed and constructed (figure 6.5), in order to allow a versatile way of clamping the 
ultrasound probe to the test-chamber without interfering with the milk experiment or 
greatly increasing the demands of the experimental procedure. Using this transducer 
support, the probe can be firmly applied to the test-chamber (without the need for 
hand support) and be easily moved to other areas. 
6.2 Reagents and reproducibility 
6.2.1 Consistency of CaC12 concentration and milk & rennet activity 
With the primary aim of achieving reproducible milk experiments, tests were conducted 
to confirm the consistency of composition and properties of the fluids used in the milk 
experiments (CaC12, cow milk and calf rennet). The procedures used for conducting 
these pre-experiment tests are described in appendix B, and their results are reported 
here. 
Calcium Chloride 
Variation of CaCl2 concentration can alter milk clotting time 1011 and rheology of 
the clot formed[189a] (section 4.4.5), so consistency, or accurate knowledge, of this 
concentration is necessary for the type of milk experiments conducted here. Contrary 
to expectation, the available CaCl2 solid, previously used in similar researches, did 
not allow one to achieve consistent, saturated solutions by prolonged contact of excess 
CaCl2 solid with water. It is possible that this batch of solid CaC12 was contaminated in 
some way; but no clear explanation of this anomalous behaviour has so far been found. 
Unfortunately, this impure CaCl2 was used in a number of milk experiments. It was 
therefore necessary to determine the concentration of the CaC1 2 solutions concerned, 
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and this was achieved by titration (section B.1). Tests showed the chosen method 
of titration to be reliable with solutions made not only with distilled water but also 
with Edinburgh tap water, so the latter was then accordingly used (for convenience) in 
these analyses. A new batch of CaC12 was later obtained, which enabled solutions of 
consistent CaC12 concentration to be achieved. 
Milk and Rennet 
The milk used here was unskimmed, unpasteurized whole milk containing no 
preservatives and of a relatively uniform composition. The effects of seasonal, source 
and dietary variations on milk composition (section 4.4) were not considered to be 
significant here. It so happens that the experiments were conducted using milk 
produced during the most heat stable period of the year[266],  and by cows of the same 
type and on a uniform diet; the milk contained 4.38 ± 0.07% butter-fat, 3.48 ± 0.05% 
protein, and 8.5% SnF (solids-not-fat), and the herd of cows from which it came 3 
consisted solely of pedigree Holstein Friesians at the University f arm [361]. 
The only milk treatment prior to experiments was cold storage and this was considered 
unlikely to alter the rennet coagulation time (RCT). The milk was stored at 4°C for 
an average duration of about 7 hours, prior to each experiment. Given the findings 
of Davies and White ( 1601 and others [270][272] (section 4.4.3), regarding cold storage and 
RCT, any alterations to the raw milk properties during this cold storage would not 
have been sufficient to alter the RCT. 
Commercial calf rennet was used in the milk experiments conducted here. The 
reproducibility of this rennet was achieved by similar preparations of each batch (section 
B.2) and proper storage. The rennet age was of concern with regard to variation and 
maintenance of rennet activity. It was desired to know whether or not this rennet 
maintains its activity for a long time; if it does, one large batch of rennet could be 
purchased, as opposed to the 2 litre batches originally purchased, in order to avoid the 
problems which can be caused by differences between rennet batches. The duration 
'The herd was 'closed'; in other words, it did not take in any other cows. 
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for which the rennet maintains its initial activity was assessed by conducting modified 
Lee-White tests, using samples from the same rennet batch and of different ages. It 
was found that the rennet did not experience significant loss in activity over a period 
of 8 months, when stored in a cool (2-5°C), clean and dark place, in closed containers 
(the appropriate storage conditions based on section 4.4.4). 
In order to ensure the milk and rennet activity were consistent, prior to each milk 
experiment pH measurements  and modified Lee-White tests were conducted on both 
fluids (section B.3). 
The pH of the different milk and rennet batches was found to be very consistent. At 
about 14 to 15°C, the average value of the rennet pH was 5.385 (SD = 0.6%), and when 
the rennet temperature was elevated to about 37-38°C, and maintained for 20 mm, 
the rennet pH rose slightly to an average value of 5.480 (SD = 0.6%). The average pH 
of the milk was found to be 6.707 (SD = 0.2%), at about 11 to 12°C, and 6.646 (SD = 
0.6%), after being maintained at 37°C for 20 mm. 
Three modified Lee-White tests were conducted, at a fixed temperature and CaCl2 
concentration, with the consistency of the rennet and milk activities deduced from the 
time taken to form a non-flowing plug of curd. The activity of both the calf rennet and 
milk was expected to be consistent, based on the suppliers' consistency measures and 
the above findings; however, the Lee-White clotting times were not always reproducible. 
These findings appear to be associated with the variation of the CaCl 2 concentrations. 
The impurities present in the original batch of CaC12 were at first thought to be the 
cause of the inconsistent clotting times, but it now appears that the use of solutions of 
low CaC12 concentration could be the cause. 15 of 21 tests had similar results, when 
using CaC12 solutions of similar concentration (3.00-3.05 M) prepared with the new 
batch of CaC1 2 (s), and 14 of 15 Lee-White clotting times were similar, when more 
concentrated CaC12 solutions (3.30-3.38 M) prepared with the impure CaC1 2 (s) were 
'The activity of calf rennet and coagulability of unpasteurized milk are both sensitive to pH (section 
4.4.4 and 4.4.5). 
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used. However, when solutions of low CaC12 concentration (1.72-2.51 M) were used, a 
wide range of clotting times, from 45 s to 105 s, were obtained. 
Reproducible results were obtained in the milk flow experiments (section 6.2.2), but 
not always in the Lee-White tests, perhaps due to certain differences between the two 
systems. The explanation for these differences in ability to achieve reproducible results 
might be that at low CaC12 concentrations, the RCT and rheology of clot may be very 
sensitive to the level of agitation and the temperature (section 4.4.5). Both of these 
variables were greater in the milk experiments than in Lee-White tests. 
8.2.2 Reproducibility of clot deposition 
Christy found the shape and extent of clot deposited on test-objects to be reproducible 
in his milk experiments. Reproducible clot deposition, with the revised milk clotting 
apparatus of Christy, was also indicated here by test-body clot extent and shape, and 
by wall clot growth patterns. 
The final weight of clot on the test-object was recorded in two categories: 'test-body 
clot' weight, which corresponds to the weight of clot associated with the test-body 
(that is clot on the test-body itself and in its immediate downstream region/wake), 
and the 'test-object clot' weight, which is the total weight of clot on the test-body 
and its support rod. When wall clot loss occurred, during experiments or drainage of 
the apparatus afterwards, it did not in all cases interfere with the 'test-body clot' but 
always impinged on the radial portion of the support rod, so the weight of 'test-body 
clot', as opposed to that of the 'test-object clot', was used in most analyses. The 
boundary between the downstream part of the 'test-body clot' and that due to the 
rod was taken, somewhat subjectively, as the location (on the rod) beyond which clot 
shape appeared unaffected by the presence of the test-body. 
Comparison of results from comparable experiments, conducted with pulsatile milk 
flow past a teardrop-shaped test-body, indicates the reproducibility of the test-body 
clot extent (table 6.1). 
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/ I Average (g) = 0.336 (SD 6%) 
Table 6.1: Weights of clot deposited on a teardrop-shaped test-body 
For a given test-body shape and flow condition, the final test-body clot shape at the 
end of an experiment was reproducible. For example, the clot on the teardrop-shaped 
test-body was typically bubbly upstream and smooth elsewhere, in steady flow (figure 
6.7(a)); and, in pulsatile flow, the clot on this body was bubbly upstream, somewhat 
barrel-shaped along its middle and tapered at its downstream end (figure 6.7(b)). 
The plots in figure 7.6, of clot growth in steady and pulsatile milk flow studies using 
similar CaC12  concentrations, illustrate that wall clot growth rates were reproducible. 
6.2.3 The effect of ultrasound on clotting 
An assessment of the effect of ultrasound on milk clotting, further to that reported in 
section 5.5.2, was conducted by comparing results from experiments where ultrasound 
was applied for different durations. The application of diagnostic ultrasound to the 
milk clotting experiments gave results that indicate no effect on clot shape or extent. 
It was found that even when the probe was applied to one part of the clotting chamber 
for the full duration of an experiment (i.e. about 35 mm), no clot irregularities were 
apparent. Acoustic streaming, as defined in chapter 5, might have occurred, as some 
bubbles resided within the scan plane, but no significant effect on the ultimate clot 
extent and shape were observed. 
With the reproducibility problems resolved, milk experiments were conducted and their 
results are reported in chapter 7. 
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Chapter 7 
Results and Discussion 
The aims of the present research were to investigate further the potential and limitations 
of a previously performed milk clotting experiment and assess the application of 
ultrasonic imaging to it, in order to elucidate the relation between milk clotting and flow 
pattern of ren.neted milk. The results presented in this chapter provide, in particular: 
insights into the clot growth pattern at the wall of a pipe and on differently shaped 
test-objects axially located in the pipe flow; the frequency of, and interference caused 
by, wall clot loss in such experiments; the effect of varying CaC12 concentration and flow 
regime on the extent and rate of clot deposition and on wall clot loss; the relationship 
between clot extent and the test-body material; and the ability and limitations of the 
ultrasonic imaging equipment used to aid and extend these enquiries. 
Table 7.1 provides details of the milk experiments conducted here, including values of 
clot extent on the test-object and test-body (in grams) and the thickness of clot at 
the test-chamber wall just upstream of the test-body (in mm) at the end of each milk 
experiment. X denotes a value that is suspect, due to wall clot interference during the 
experiment or in the dismantling stage, and * denotes an experiment where only 14 
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gallons of milk were used, not the usual 15 gallons. If wall clot loss occurred during a 
milk experiment, denoted by a fin table 7.1, the wail clot thickness given is the thickest 
achieved. Additional information is provided by the ultrasound images recorded during 
these experiments and the photographs of the clotted test-objects removed at the end of 
experiments (figures 6.7, 7.1 and 7.2). The disc-shaped test-body had very little clot on 
it after a pulsatile flow experiment, and a somewhat conical wake-region clot in steady 
flow. This clot pattern was also observed for the conical test-body. An approximately 











1.12±0.01 Steady P.V.C. teardrop 0.267 0.125±0.001 2.0* 
1.72 Steady P.V.C. teardrop 0.619X 0.194X 3.5 
1.72 Pulsatile P.V.C. teardrop 0.200 0.07 0.8 
2.12 Steady P.V.C. teardrop 1.800X 0.944X 3.5f 
2.12 Steady P.V.C. teardrop 1.033 0.500 4.0 
2.51 Steady Nylon teardrop 2.144X 0.858 4.8 
2.51 Pulsatile Nylon teardrop 0.551 0.168 2.7 
3.00 Steady P.V.C. cone 1.403 0.749 5.6 
3.00 Pulsatile P.V.C. cone 0.694X 0.156X 3.Of 
3.38 Pulsatile P.V.C. cone 0.619X 0.217X 3.25f 
3.00 Steady P.V.C. disc 0.713 0.420 5.5 
3.05 Pulsatile P.V.C. disc 1.038 0.038 3.5 
3.05 Steady P.T.F.E. teardrop 1.754X 0.614 5.5 - 
3.05 Pulsatile P.T.F.E. teardrop 0.671X 0.267X 2.4f 
3.05 Steady Polycarb. teardrop 0.953X 0.642X 5.5f 
3.05 Pulsatile Polycarb. teardrop 1.099X 0.334 3.3 - 
3.30 Steady Perspex teardrop 2.040 0.430 4.0 - 
3.30 Pulsatile Perspex teardrop 0.735X 0.314 1.7f 
3.38 Steady P.V.C. teardrop 1.840X 0.591 4.5f 
3.38 Pulsatile P.V.C. teardrop 0.890X 0.361 1.7t 
Table 7.1: Details of the milk flow experiments 
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Fiur 	7.1. 	 ii 	 ih 	II -h1I 	t-bot1y, after a) steady and 
(b) pulsatile milk flow experiments. Figure (a) includes a photograph of the upstream 
view of the disc-shaped test-body, after a steady flow experiment. 




Figure 7.2: Photographs of the clot on the conical test-body, after (a) steady and b) 
pulsatile milk flow experiments. Symmetrical clot deposition developed on the test-
object in steady flow; however, on removal of the test-object from the test-chamber, the 
test-body came away from the support rod and was thus replaced before the photograph 
in (a) was taken. The two clotted test-objects pictured in (b) both have wall clot 
deposited on them; wail clot loss occurred in the final stages of both the experiments 
from which these objects came. 
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7.1 Ability and limitations of the imaging of clot 
The amount of information that could be drawn from the ultrasound images was limited 
by their quality. The ultrasound transceiver and monitor, described in sections 5.5.1 
and 6.1.11, enabled images of clot both on the test-bodies and test-chamber to be 
obtained, but of very different quality. Ultrasonic images of test-bodies and their clot 
were inadequate for the intended aim of continuous measurement of clot growth on the 
test-body; however, the images of clot adhered to the far inner-wall of the test-chamber 
were of a quality sufficient to allow the growth of this clot to be continuously measured. 
Geometrical and instrumental limitations were the reasons behind the variation in 
quality of images of curd deposit. In particular, the focus of the ultrasound beam was 
closer to the far wall of the test-chamber than to the test-body, and this wall and the 
clot formed on it were perpendicular to the ultrasound beam axis, while the surfaces of 
the cone, disc and teardrop-shaped test-bodies were curved and mainly at an oblique 
angle thus providing diffuse reflections of the ultrasound. The clot on the near inner-
wall of the test-chamber was not depicted clearly, presumably due to the 'transducer 
dead space' (defined in section 5.5.4), and this region gave rise to spurious images. 
Accordingly, the imaging of clot on the far inner-wall of the pipe was further analysed. 
The accuracy of the continuous ultrasonic measurements of clot deposition was 
estimated. There were several factors determining this accuracy, such as: (a) 
uncertainty about the velocity of ultrasound within the clot, assumed in the calculation 
converting echo signals into distances; (b) the ultrasound beam intensity and resolution, 
and how these were affected by structures within the beam; and (c) the placement and 
accuracy of the calliper markers. Each of these factors is considered, in turn, below. 
(a) In order to be able to convert ultrasonically depicted curd thicknesses into actual 
thicknesses, one must know the speed of sound propagation in milk curd (cd) and 
that used in the depth calculations made by the ultrasound monitor. 1540 m/s, which 
is the speed of sound propagation in soft tissue, was the value used by the ultrasound 
monitor when evaluating the depth of reflective structures. The value of crd was not 
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found in the literature but, as explained in section 5.5.3, test results indicate Cd 
1540 rn/s. It is accordingly assumed that the relative error in Crd is less than 10%, 
which means that the maximum relative error in thickness measurement arising from 
this source of error will be 10%. 
(b) Due to the limiting axial resolution of the ultrasound beam of about 0.31 
mm (calculated in section 5.5.3), interfaces lying along the beam axis cannot be 
distinguished when less than 0.31 mm apart. However, when the interfaces composed 
of clot/milk and clot/wall are separated by distances greater than 0.31 mm, the error 
involved in clot thickness measurements is less than 0.31 mm. 
The accuracy of measurements of wall clot thickness was expected to be adversely 
affected by the marked attenuation which arose mainly from the bubbles in the 
milk; however, the attenuation caused by the bubbles was compensated by the highly 
reflective bubbles flowing over the surface of the wall clot, highlighting the clot/milk 
interface. Bubbles in the milk flow led to poor imaging of clot due to attenuation of the 
ultrasound beam and to the fact that when clot and highly reflective bubbles resided 
side-by-side on the test-object they were sometimes not distinguishable. By comparing 
the ultrasound images in figures 7.3(a) and (b), which were obtained with and without 
bubble-riddled milk flow, it is apparent that bubbles are degradative to ultrasonic 
imaging. Arresting the milk flow at the end of each milk experiment resulted in a large 
reduction in the number of bubbles in the field of scan and significantly better imaging of 
clot on the test-body and far inner-wail. Placing the clotted test-object in an unfouled, 
duplicate polypropylene test-chamber filled with non-flowing, partially degassed milk, 
allowed even better depiction of the test-body clot, indicating that while the near-wall 
clot has properties which suggest it will cause little attenuation, the bubbles in this clot 
can still degrade image quality. The flow of bubbles over the smooth clot surface did, 
however, highlight the clot/milk interface, helping one to establish the exact location 
of the clot/milk interface and thus to measure wall clot thickness. 
( (: 
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Figure 7.3: Ultrasound images of a clotted teardrop-shaped test-body (a) in the 
presence of a bubble-riddled milk flow, and (b) in stagnant, partially deaerated milk. 
The clotted test-object featured in these ultrasound images is shown in (c). 
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(c) The on-screen calipers provided measurements to the nearest millimetre, which 
is not a satisfactory accuracy for the present purpose. A consistent measurement 
technique was developed (described in section 6.1.11), where hand-held calipers (with 
0.01 mm accuracy) and close observation of enlarged ultrasound images and the 
bubble flow over the clot/milk interface allowed one to measure clot thicknesses more 
accurately. 
The growth rate of wall clot was of primary importance here, as opposed to the absolute 
value of clot thickness. The error in calculating the change in clot thickness, in order 
to determine clot growth rate, is believed to have been much smaller than the error in 
the absolute thickness of clot, and is estimated to be +0.1 mm. 
7.2 Clot development and flow conditions 
The deposition rate of clot on a surface in a milk flow will be dependent on the balance 
between flow forces and the clot's adhesive and cohesive bonds, which may vary with 
time as cross-linking and other physical changes within the curd take place, and also 
on the rate at which activated micelles or clot-promoting constituents are conveyed to 
that surface relative to the rate of convective removal. The intention of this section is 
to provide the results of clot deposition both at the test-chamber wall and test-body 
and discuss how flow conditions affected this clot deposition. 
7.2.1 Wall clot growth in steady and pulsatile flow experiments 
Detailed growth rates of wall clot were measured ultrasonically. The four ultrasound 
images shown in figure 7.4 were recorded at different times during the course of a milk 
experiment and illustrate the growth of wall clot with time. The plots of wall clot 
thickness against time, shown in figure 7.6, were constructed using information from 
ultrasonic images recorded during four steady and four pulsatile flow experiments. 
From these plots it can be seen that an apparent lag phase occurs during which no clot 
is observed; that an initially constant rate followed by a diminishing rate of growth 
occurred in the steady flow studies; and that clot grew at an approximately constant. 
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rate in the pulsatile flow experiments, In order to determine why such profiles of clot 
growth occurred, the changes in flow conditions over the duration of the steady and 
pulsatile flow experiments were considered. 
The apparent lag phase observed for all flow experiments, during which no clot was 
observed, was expected. The limiting axial resolution of the ultrasonic imaging delays 
curd depiction in the early stages of the experiment, and curd deposition itself is delayed 
by the enzymic lag phase of milk coagulation. 
In steady flow experiments, the milk flowed steadily under the influence of gravity 
through the test-chamber. The flow rate decreased as these experiments proceeded, 
perhaps due to progressive blockage of the tubing downstream of the test-chamber. 
Consideration of the relative resistances in the test-section and other parts of the 
flow system leads to the conclusion that the the mean fluid velocity (i) would have 
increased as the cross-sectional flow area and volumetric flow rate decreased, as wall 
clot developed. This change in velocity, coupled with the reduced flow area, would 
mean that the shear stress at the wall would increase markedly as clot deposited at the 
pipe wall. The mean fluid residence time within the test-chamber (t res ) would decrease 
as a result of this change in velocity. These changes in shear stress and tres would be 
expected to cause a diminishing rate of clot growth similar to that observed (figure 
7.6). 
In pulsatile flow experiments, the milk flow was produced by a hydraulically driven 
diaphragm pump, which is believed to have maintained a constant volumetric flow rate 
throughout these experiments despite the progressively increasing flow resistance as 
wall clot built up. Both ii and the shear stress at the wall will have increased, while 
tres will have decreased, as wall clot developed. The reduction in tre8 would result in the 
milk being less likely to reside in the test-chamber for a time greater than the clotting 
time; this, and the increase in shear stress, would be expected to reduce the growth 
rate as the experiment proceeded. However, the clot growth rate was approximately 
constant. A possible explanation for this is that a balance may have occurred between 
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Figure 7.4: Ultrasound images 
disc-shaped test-body, recorded 
the start of a milk experiment. 
of a test-CilaflilI)er containing a 
5.25. 6. 7 and 9.5 minutes from 
Figure 7.5: An ultrasound image i1lustratiii wall clot t1iinnin 
in the region adjacent to the test-body. The flow was from left 
to right. 
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experiments. This might have been due to At (the average time taken by the fluid to 
travel from the reagents' injection point to a given distance downstream in the system) 
and the thickness of the boundary layer both increasing with distance downstream and, 
downstream of the test-body, to the mixing induced by the test-body. However, since 
the flow conditions and composition of the pipe wall were not uniform throughout the 
test-section, this cannot be certain. This is further discussed in section 7.4. 
7.2.2 Wall clot growth adjacent to the test-body in steady and 
pulsatile flows 
The effect that a test-body has on the local flow conditions depends on its shape, 
size and the flow Reynolds number. The mean pipe and test-body Reynolds numbers, 
based on the initial experimental conditions, were 1051 and 328, respectively. Each 10 
mm diameter test-body caused a significant decrease in the effective flow cross-section 
and thus local flow acceleration, elevated shear stresses and reduced fluid residence 
time. These changes in flow conditions would explain why thinning of clot at the wall 
occurred opposite the test-body, as they would be expected to inhibit or reduce local 
clot growth. 
Adjacent to each test-body, the local flow conditions were found to have a marked 
effect on wall clot (figure 7.5). The results of a study of the thickness of wall clot 
adjacent to the test-body, at the end of each of the experiments, indicate that wall clot 
adjacent to the test-body was thinner than if no test-object had been present, and the 
level of thinning that occurred was dependent on the shape of the test-body and the 
flow regime. The mean values of percentage reduction of wall clot thickness adjacent 
to the test-bodies, in steady (S) and pulsatile (P) flow were: 11% (S) and 75% (P) 
for the disc; 17% (S) when the cone was in place'; and 4% (S) and 16% (P) for the 
teardrop-shaped test-body. 
'Wall clot loss occurred during the pulsatile flow experiments that were conducted with the conical 
test-body, so measurements of the extent of clot thinning at the end of these experiments were of little 
use. 
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The extent of thinning of the wall clot may be dependent upon the flow acceleration 
(which determines the changes in shear stress and fluid residence time at the wall) and 
the extent of redirection of flow towards the wall, which are a result of the test-body 
being present in the flow. The disc causes a greater flow acceleration and a more 
abrupt change in flow direction than the cone and, in turn, the teardrop-shaped test-
body. Given this, it was expected that the disc would cause more clot thinning than 
the cone and that the cone would be associated with a greater extent of clot thinning 
than the teardrop-shaped test-body. The extent of wall clot thinning adjacent to the 
test-body was indeed smaller with the teardrop than with the other test-bodies, in both 
flow regimes. In steady flow, the conical test-body was associated with the greatest 
reduction in wall clot thickness. The reason for this finding is unknown. 
7.2.3 Variation of test-body clot extent with flow conditions 
More clot deposition results were obtained which indicate that flow characteristics are 
important with regard to clotting. It was found that the shape and extent of test-body 
clot differed with varying flow conditions. The flow conditions were modified by varying 
the test-body shape (cone, disc or teardrop) and the flow regime (steady or pulsatile). 
The approximate sizes and residence times of vortices formed in the wake region of 
the unfouled test-bodies were determined by Ch risty [24] and reported in section 4.2.3. 
For convenience, the ordering of test-bodies, based on their wake vortex residence 
times, is reiterated here alongside the weights of test-body clot 2 recorded at the end of 
experiments in which CaC1 2  solutions of about 3.0 M were used (figure 7.7). The size 
of the wake vortices, which are sketched in figure 4.11, are such that the teardrop has 
the smallest vortex and the cone and disc have vortices of similar size. It should be 
realized that this information on the wake vortices was obtained from dye experiments 
which had conditions that were approximately similar to the initial conditions of the 
milk experiments 3 . 
2 The weight of clot found on the conical test-body at the end of pulsatile flow experiments was 
deemed void due to wall clot interference. 
'Water, which has a kinematic viscosity of about 3/4 that of milk, and an unfouled test-body and 
test-chamber were used in the dye experiments. 
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0.420g 0.749g 0.591g 
Steady flow: 	Disc < 	Cone < Teardrop 
(8sec) (12sec) (>18sec) 
0.038g 0.361g 
Pulsatile flow: 	Cone = 	Disc < Teardrop 
(1 sec) (isec) (14sec) 
Figure 7.7: Ordering of test-bodies, based on the residence times of the vortices formed 
in their wake region. 
A rough indication of how the test-body wake region changed during experiments was 
obtained from echo-information received from bubbles  passing over the clotted test-
object. Bubbles in the flow gave rough indications of certain features of the flow pattern 
in one plane, including the sudden stop and reversal of flow during the transition from 
systole to diastole, the point of flow separation and reattachment, and recirculation in 
the wake region of the test-body. Bubbles recirculated in the wake region and flowed 
along the poorly depicted clot /milk interface and not into dark 'no go areas' which were 
believed to correspond to clot on the ultrasound image. On studying the flow of bubbles 
around the test-object, it appeared that the recirculation zone in the test-body wake 
region decreased in size as clot developed there. Ultrasonic imaging of the wake region 
behind the teardrop-shaped test-body appeared to show this region both elongating 
and becoming thinner, as clot developed in this region. The flow separation point 
appeared to move further upstream, along the test-body, and the flow reattachment 
point on the support rod extended further downstream, as the size of the recirculation 
zone decreased and the wake region filled with clot, in steady flow milk experiments. 
In the pulsatile flow milk experiments the clot extent in the test-body wake region was 
too small for such deductions to be made. 
Correlations between the shape and extent of test-body clot and the size and residence 
times of the test-body wake vortices were attempted, under the assumption that the 
relative values of test-body vortex sizes and residence times were maintained during 
4 1n microbubble echocardiography (ME)1 3621 ,  where microbubbles of air are injected into the blood 
stream, the highly reflective blood/air interface provides a strong echo signal, allowing remarkably 
enhanced imaging of the heart chambers, permitting computation of ejection fractions and noninvasive 
diagnosis of coronary artery disease [363][3641. 
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These results are by no means exhaustive, but may indicate that when wake vortex 
size is similar the difference in vortex residence time may determine the relative extents 
of clot and vice versa. On the other hand, when wake vortex residence time and size 
are both different it cannot be certain which of these two vortex characteristics will 
predominate. 
The extent of clot on a given test-body was smaller in pulsatile than in steady flow 
experiments. This reduction in clot extent might be explained by the reasoning given 
in section 7.2.1 and/or by the change in wake vortex residence time. The residence 
times of wake vortices in pulsatile flow were less than those in steady flow, for each 
test-body; a reduction in wake vortex residence time may act to inhibit clot growth, 
by reducing the amount of milk present in this region that has resided for a time in 
excess of the clotting time. 
The differences between the present experiments and those of Christy are numerous 5 , 
so the comparisons that can be made between the results from these two pieces of work 
are limited. The ordering of the test-bodies, based on the weight of test-body clot at 
the end of experiments of fixed duration, was similar for both sets of experiments. The 
final clot found on each of the test-bodies were quite similar in shape for both sets of 
experiments, but the extent of this clot was in all cases much greater in the work done 
here. Both sets of results failed to indicate a simple relationship between the residence 
time or size of the wake vortex and clot extent. However, the importance of stasis was 
indicated by the finding that all sites where clot formed were regions of stasis. 
'The differences were in CaC1 2 concentration; the shape, diameter and material of the test-body 
support rod; the way the flow conditions changed during the experiment; and the criteria used for 
choosing the section of clot on the test-object for weighing. 
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7.3 Clot development and CaC12 concentration 
With the aim of controlling or enhancing curd adhesion, it was considered a worthwhile 
endeavour to investigate the effect on clot growth of varying the concentration of 
CaC12 and of changing the material of the surfaces on which curd develops in the 
milk experiments. The effect of the former change is considered here, while the latter 
change is addressed in the section 7.4. 
In the milk flow experiments, increasing the CaC12 solution concentration from 1.12 M 
to 3.38 M, of which 1% (vol.) was injected, tended to increase the extent of clotting 
in both steady and pulsatile flow experiments, as indicated in tables 7.2 and 7•36  In 
pulsatile milk flow experiments, use of 1.72 M CaC1 2 produced a wall clot of about 0.6 
mm thickness, while use of 2.51 M or higher CaC1 2 concentration produced wall clot of 
1.7 mm or thicker, 21 minutes into the experiment. In steady flow milk experiments, 
a small increase in CaC12 concentration from 1.12 M to 1.72 M caused no significant 
change in wail clot thickness, giving about 2.0 mm thick wall clot 21 minutes into the 
experiment. A larger concentration increase, to 2.12 M and above, produced a marked 
increase in wall clot extent; wall clot thickness increased up to 4.8 mm, 21 minutes into 
the experiment. 
Figure 7.8 illustrates the general dependence of wall clot growth on CaCl 
concentration; both the clot growth rate and final extent tend to increase with 
increasing CaC12 concentration. 
Increasing the concentration of CaCl 2 increased the extent of test-body clot also (table 
7.1). For example, on the P.V.C. teardrop-shaped test-body, in pulsatile milk flow 
experiments, use of 1.72 M CaC12 gave a final test-body clot of 0.07 g, while use of 3.38 
M gave a much larger clot weight of 0.316 g. In steady flow milk studies, the CaC12 
concentrations employed and the corresponding clot extents on the P.V.C. teardrop- 
'Wall clot loss occurred during a significant number of the milk experiments, generally later than 
21 minutes after the rennet and CaC1 2 dosing pumps were turned on, so comparisons of wall clot 
thicknesses recorded 21 minutes into each experiment were accordingly carried out. 
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Table 7.2: Wall clot thickness after 21 minutes (pulsatile flow) 










Table 7.3: Wall clot thickness after 21 minutes (steady flow) 
shaped test-body were: 1.12 M (0.125 g), 2.12 M (0.500 g) and 3.38 M (0.591 g). 
Calcium ions are known to accelerate the rate of milk clotting and affect curd rheology 
(section 4.4.5). The apparent relationship between clot extent and CaC1 2 concentration, 
found under the milk experiment conditions used here (i.e. 37'C, initial flow rate 
of 2 1/mm, and duration of about 35 mm), may arise from the increase in CaCl 2 
concentration altering curd rheology and reducing the rennet coagulation time (RCT) 
and thus the fluid residence time necessary for milk to clot. These changes are the 
likely causes of the observed increases in growth rate of wall clot and extent of clot on 
the pipe wall and test-body. 
The effect on the rennet coagulation time of varying the concentration of the CaCl 2 
solution in milk is made apparent by Lewis's curve of clotting time vs. percent added 
saturated aqueous CaCl 2 (figure 4.6). The range of CaCl 2 concentrations used here 
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Figure 7.8: The growth profiles of clot at the test-chamber wall in steady milk flow 
experiments, using different concentrations of CaC12. 
lie on the part of this curve which indicates that an increase in this concentration 
would be expected to reduce the RCT. On the other hand, when using much greater 
concentrations of CaC12 solution than those used here, the opposite effect would be 
expected according to Lewis's curve of clotting time vs. CaC12 concentration. 
7.4 Clot development and surface material 
The choice of test-body materials was made mainly on the basis of reflectivity, while 
those materials chosen for the test-chamber were ones sufficiently transparent to 
ultrasound. Two test-chambers composed of different materials were employed, namely 
polyethylene and polypropylene, and the results used to relate wall clot extent to test-
section material. The teardrop was the best delineated test-body shape, and thus 
was the shape chosen for the test-body material assessments. The teardrop-shaped 
test-bodies constructed of the hydrophobic materials P.T.F.E., P.V.C., polycarbonate, 
perspex and nylon for use in the ultrasound imaging assessments described in chapter 
5 were used in these tests. 
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Wall clot 
Comparison of the wail clot growth with time in steady flow milk experiments, using 
the polyethylene and polypropylene test-chambers and the same CaC12 concentration 
of 2.12 M, was made impractical by the loss of wall clot after about 10 minutes into 
the latter experiment. However, comparing the plot of clot growth against time from 
the experiment with the polyethylene test-chamber with the plot from a steady flow 
milk experiment conducted with the polypropylene test-chamber and a 2.51 M CaCl 2 
solution, it was found that a slightly greater extent of wall clot occurred in the latter 
experiment. This could be accounted for by the higher CaCl 2 concentration (figure 
7.8). 
The test-section was constructed from three flanged pipes in series, two made of perspex 
and the middle one, the test-chamber, made of polypropylene (section 6.1.8). This 
difference in pipe composition was chosen for the ultrasound imaging analyses detailed 
in chapter 5, not for the purpose of correlating clot extent with differences in test-
section wall material. Direct comparison between the clot adhesiveness and extent on 
these pipes and their material differences was not possible, because the flow conditions 
and At (the average time taken by the fluid to travel from the reagents' injection 
point to a given distance downstream in the system) were different in each of the 
pipe sections composing the test-section. Thus, although the test-section wall clot 
was tapered, gradually increasing in thickness with distance downstream, this does not 
inform one of the effect of material type on clot thickness, as the conditions in each pipe 
were different. In the perspex pipe, upstream of the test-chamber, the flow was not 
fully developed and At was relatively small; At increased as the milk mixture flowed 
through the test-chamber, and this milk flow was considered to be fully developed and 
then disturbed in the latter half of this pipe by the presence of the test-body; the milk 
entering the perspex pipe downstream of the test-chamber was better mixed, due to 
the mixing induced by the test-body, and, being furthest downstream, had milk flowing 
through it which had the greatest values of At. 
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Test-body clot 
Test-body clot weights measured at the end of experiments, known to be unaffected by 
lost wall clot, were used to compare the clot-forming propensities of different test-body 
materials. Test-body clot was not depicted ultrasonically with a quality sufficient to 
allow its growth rate to be estimated. The ordering of materials, based on the weight of 
clot found on the differently composed teardrop-shaped test-bodies at the end of steady 
and pulsatile milk flow experiments, together with the concentrations of CaC1 2 used, 
are given in tables 7.4 and 7.5; clot weights were measured to the nearest milligram. 
Quantity\ T-body Material Nylon P.T.F.E. P.V.C. P.V.C. j Perspex I 
[CaC12] (M) 2.51±0.01 3.05 3.38 2.12 3.30 
Test-body clot (g) 0.858 0.614 0.591 0.500 0.430 	I 
Table 7.4: Clot weights in steady flows past teardrop-shaped test-bodies 
Quantity\ T-body Material P.V.C. Polycarb. Perspex Nylon P.V.C. 
[CaC12] (M) 3.38±0.01 3.05 3.30 2.51 1.72 
Test-body clot (g) 0.361 0.334 0.314 0.168 0.070 
Table 7.5: Clot weights in pulsatile flows past teardrop-shaped test-bodies 
The differences in material and CaCl2 concentration were expected to determine the 
extent of clot on the test-bodies, and indeed this was apparent in the results, but 
to different degrees depending on the flow regime. In steady flow, the influence of 
test-body material on clot extent was obvious and appeared to predominate over the 
influence of variations in CaC12 concentration. With test-bodies composed of different 
materials, use of similar CaCl 2  concentration did not result in similar test-body clot 
weights, and increasing the CaC1 2  concentration did not affect the order of the test-
bodies, based on their clot extents. In pulsatile flow trials, it was found that the CaC1 2 
concentration predominated, with increases in this concentration generally leading to 
greater clot extent. 
The extent of test-body clot and ordering of materials in steady and pulsatile flows, 
based on clot extent, have been compared. The final clot extent is greater in steady 
flows, and it appears that in pulsatile flows the dependence of clot extent on CaC1 2 
concentration is greater than that on materials whereas in steady flows the converse 
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appears to be true. This may arise because the change in flow regime from steady to 
pulsatile results in a shorter mean fluid residence time in the wake of the test-body, as 
well as greater flow velocities and more agitation. The consequence of these changes 
may be more forceful collisions between aggregates and the test-body surface but for 
a shorter duration; the greater the CaC12 concentration the more aggregates will be 
formed in a given time and the more prominent the effect of these changes in flow 
conditions on clot extent. In addition, it may be that the effect of changes in curd 
rheology, on increasing the CaC12 concentration, becomes more obvious when the more 
extreme conditions of pulsatile flow are present. 
7.5 Wall clot loss 
7.5.1 The consequences of wall clot loss 
Wall clot interference with test-object clot has been suspected but unverified in 
previous milk studies (section 4.3.1). Bubbles in the milk flow have been observed 
(ultrasonically) impinging on and adhering to both the test-object and its adhered 
clot, resulting in crater-shaped clots. Irregular clot formations on the upstream-face 
of the test-body, other than those known to be due to bubbles, that were observed 
by Christy (section 4.2.3) are now believed to have been due to wall clot interference. 
Such deposits were observed at the end of the present experiments only when loss of 
wall clot was known to have occurred. 
It should be realized that, under the conditions of the present experiments, even when 
clot lost from the pipe wall during an experiment does not directly interfere with the 
test-object clot, it does tend to restore the flow rate towards the initial 2 I/min and 
thus makes the conditions, such as shear stress and mean fluid residence time, vary in 
a way different from that in milk experiments where no wall clot loss occurred. On 
one occasion only, dislodged wall clot temporarily arrested the flow, presumably due 
to momentary blockage of the converger at the exit of the test-section. 
Eight of the 20 milk experiments discussed in this chapter experienced wall clot loss 
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during their course. Table 7.6 provides details of these wall clot losses, including the 
thickness of wall clot immediately prior to its loss, denoted by xj 0 . On studying the 
video cassette-tape records of ultrasonic images depicting the loss of wall clot, it was 
found that: 
• Following the loss of wall clot, a new layer of clot develops at the wall. 
• When this loss occurred, all of the wall clot was lost and in some cases impinged 
on the test-body. The results for test-body clot shape and extent were considered 
to be of use (i.e. not noticeably affected by the loss of wall clot) at the end of 3 
of the 8 experiments in which wall clot loss occurred. 
• No pattern of wall clot loss became apparent for either flow regime. That is, 
there was no specific time, thickness or CaCl 2 concentration at which wall clot 
was consistently lost. 
. There were warning signs prior to wall clot loss in pulsatile, but not in steady, 
flow experiments. Prior to its loss, the wall clot was in all cases observed shaking. 
This was followed by the clot pulsing; it began to move slightly up- and down-
stream synchronistically with the systolic and diastolic phases of each pulse, 
before moving downstream. 
Regime CaC12 conc 	(M) xj 0 (mm) Time of loss (mm.) 
steady 2.12±0.01 2.0 10 
steady 3.05 5.5 37 
steady 3.38 2.1 8 
pulsed 3.00 3.0 32 
pulsed 3.05 2.4 33 
pulsed 3.30 1.7 26 
pulsed 3.38 1.7 23 
pulsed 3.38 3.25 34 
Table 7.6: Wall clot loss details 
The prevention of wall clot formation has been addressed (section 4.3.1 and appendix 
A), but there appears to be no simple way to achieve this in both steady and pulsatile 
flows without disrupting the milk coagulation studies. Until the formation of clot at 
the test-chamber wall can be prevented, the avoidance of wall clot loss will remain of 
primary importance. The effect of certain system conditions on wall clot integrity have 
been assessed and the findings reported below. 
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7.5.2 Wall clot loss and flow regime 
The choice of flow regime, either steady or pulsatile, appears strongly to affect wall clot 
integrity. 27% (3 of 11) of the steady flow milk experiments and 56% (5 of 9) of the 
pulsatile flow milk studies experienced wall clot loss. Pulsatile flow is accompanied not 
only by greater agitation and peak shear stresses than is steady flow, but also by an 
increase in the number of bubbles in the milk flow (section 6.1.3). Some or all of these 
factors may promote wall clot loss 8 , thus explaining why twice as many experiments 
of the pulsatile regime lost wall clot. But it is possible that not all of the changes, 
when going from steady to pulsatile flow, have an adverse effect on clot adhesion. On 
studying table 7.6, it can be seen that two of the three steady flow experiments, which 
experienced wall clot loss, lost wall clot at a much earlier stage than any of the pulsatile 
flow experiments. The better adhesion of clot in the early stages of the pulsatile flow 
experiments may arise due to the greater agitation (section 4.1.3) which occurs in these 
flows. The greater shear stresses present in these flows (and perhaps the increase in 
the number of bubbles) do, however, appear to take their toll; in principle, the shear 
stress at the wall increases as the pulsatile flow experiment proceeds and the increasing 
wall clot reduces the flow area, and this may be why in an extended experiment clot 
was lost more frequently in pulsatile, as opposed to steady, flows. 
These findings appear to indicate that enhanced mixing and thus better clot adhesion 
is obtained in pulsatile, rather than steady, flow and that this improved adhesion may 
just postpone wall clot loss; the adhesive bonds of the wall clot may be overcome by 
the injurious effects of elevated shear stresses. 
7.5.3 Wall clot loss and CaC1 2 concentration 
There appears to be a link between the occurrence of wall clot loss and the concentration 
of CaC12 used. Increasing the CaC12 concentration was associated with an increasing 
occurrence of wall clot loss (table 7.1). When the concentration of the CaC1 2 solution 
'The pulsatile flow experiments involved the use of two pumps, whereas only one pump was used 
in the steady flow studies. Both pumps were found to generate bubbles. 
'Berridge spoke of the "fragile nature of the curd at the moment of formation", and pulsation has 
been used in cheesemaking to shift wail clot or inhibit clot adhesion [2461[248] . 
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was 2.51 M or less, 1 of 7 experiments experienced wall clot loss; where a CaC1 2 
concentration of 3.00 M or greater was used, 7 of 13 experiments experienced wall clot 
loss; and when a CaC1 2  concentration of 3.30 M or greater was used 4 of 5 experiments 
suffered wall clot loss. Increasing the CaCl 2 concentration may make wall clot loss 
more likely by the consequent changes in clot rheology and clot extent. A more rigid 
clot is expected to occur when increasing the CaCl 2 concentration, and such a clot may 
be more likely to dislodge from the pipe wall than a less rigid clot. An increase in clot 
extent may cause greater shear stresses at the wall, as it results in a smaller flow area, 
which will be more likely to overcome the adhesive bond between curd and the pipe 
wail. 
While the implications of the above findings on wall clot loss are interesting, these 
results are too few to be conclusive. Vibrations of the test-chamber or slight jolts to it, 
for instance when the ultrasound probe is contacted with the test-chamber, could also 
affect the integrity of the adhesive bonds between the pipe wall and clot. Extensive 
testing would be needed to determine the factors relevant to wall clot loss. Further 
analysis of the reasons behind wall clot loss was not attempted here. 
Chapter 8 
Conclusions and 
Recommendations for Future 
Work 
8.1 Conclusions 
Curd deposition rate can be measured non-invasively using ultrasonic imaging 
equipment similar to that used in clinical practice. No influence of ultrasound on 
the final extent or shape of clot was apparent, even when the test-chamber was 
sonicated for the full 35 minute experimental duration. 
Deposition of curd on the test-bodies used here was difficult to measure 
ultrasonically due to scattering of the ultrasound beam reflected from the test-
bodies' surfaces. Deposition on the wall of the cylindrical test-chamber, on the 
other hand, was clearly depicted and its growth and shedding ultrasonically 
observed. 
198 
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The extent and deposition rate of curd are affected by the flow conditions. For 
both steady and pulsatile flows, following a short 'lag phase', the wall clot growth 
rate was at first constant. In steady flow, the deposition rate fell rapidly after.  
about 20 minutes, before tapering-off to zero to give what appears to be a limiting 
deposit thickness. For pulsatile flows, the wall clot continued to grow at an 
approximately constant rate. This growth rate was lower than that in the initial 
stages of steady flow and, over the time interval used in both kinds of experiments, 
the extent of clot deposited in pulsatile flows was markedly less. The influence of 
flow conditions on clot extent was also apparent adjacent to the test-body, where 
wall clot thinning was found to occur. 
The extent and rate of curd deposition are influenced by the concentration of 
CaC12. Increasing this concentration over the range studied here tended to 
increase the deposition rate and the ultimate extent of curd. 
Ultrasonic imaging allows one to determine whether or not wall clot loss occurs. 
By this means it was sometimes found that all clot at the pipe wall is dislodged 
and washed downstream, usually towards the end of the experiment, after which 
a new layer of clot begins to form at this wall. 
Wall clot loss was found to occur more often with pulsatile flow, as opposed to 
steady flow, and at higher CaC1 2 concentrations. Uncontrolled factors may also 
affect wall clot integrity; there was no specific time, curd thickness or CaC12 
concentration at which clot was consistently lost from the pipe wall. 
The cause of some of the irregular clot formations on the upstream-face of test-
bodies observed by Christy and myself appears to be wall clot impingement and, 
in some cases, adherence. 
Ultrasonic imaging of the deposition of clot, from renneted milk which is flowing 
past an implant, appears to have potential as a method for non-invasively 
determining the location, extent and deposition rate of clot in studies aimed 
at predicting the flow-related thrombogenicity of artificial implants. 
The full potential of this ultrasound application has yet to be seen. In the present 
arrangement, the growth rate of deposition on the wall but not on the test-bodies 
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was successfully observed. It is conceivable, however, that ultrasonic imaging 
could be of use for studying curd deposition on test-bodies, such as artificial 
heart valves, if certain modifications to the initial set-up are made (section 8.2). 
8.2 Recommendations for future work 
Milk experiments with the flow apparatus and ultrasound equipment used here 
could be performed with test-objects whose surfaces are perpendicular to the 
ultrasound beam axis (i.e. parallel to the test-chamber pipe wall), notably 
with the flow shunts described by Stein and Sabbah and with ridged Gott rings 
(reported in section 3.3.3). Results from such experiments with milk would allow 
one to compare further milk and blood deposition, and would enable one to assess 
further the effect of varying flow conditions on curd deposition. 
The ultrasonic imaging equipment used here requires to be refined, or perhaps 
replaced by a more appropriate ultrasound system, to allow measurement of 
the thickness .of curd adhered to surfaces not perpendicular to the ultrasound 
beam axis, such as those surfaces of the test-bodies used here. A phased-
array transceiver with a beam-steering facility could be used to make the angle 
of incidence more favourable. This probe could also overcome the problem 
associated with ultrasonic imaging of artificial heart valves, namely attenuation 
by their housing, by positioning this probe either just upstream or downstream of 
the valve. Alternatively, a flexible stand-off would enable the operator to position 
the probe at better angles to heart valves and the otherwise oblique surfaces of 
the test-bodies used here, while maintaining good coupling; this may also allow 
the ultrasound beam's focal point to be positioned at the centre of the region of 
interest. Perhaps a fluid, or gel-filled, stand-off, in the form of a band encircling 
the test-chamber, would be useful. 
If the above recommendation was implemented, one would be able to image curd 
on test-bodies; however, information on changes in the local flow conditions, as 
clot developed on these bodies, would still be needed to correlate flow conditions 
to the deposition rates and extent of curd. 
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A combination of particle image velocimetry (PTV) with ultrasonic measurements 
could be very fruitful. One way to achieve this combination, would be to utilize 
the bubbles in the milk flow by using them as tracer particles in ultrasonic studies. 
Adaptation of ultrasonic Doppler and imaging technology to the milk clotting 
system used here may be a useful way of obtaining information both on flow 
velocities and deposition rates. Alternatively, if the population of bubbles in the 
milk flow is inadequate for this purpose, one could use PIV with tracer particles 
and an optically clear fluid in experiments with test-bodies of progressively 
different shapes. If the ultrasonically recorded changes in effective test-object 
shape were mimicked, using moulds that represent the progression from the initial 
to the final shape of the test-object, one could study the change in size, level of 
mixing and fluid residence time of vortices in the wake region of test-bodies, over 
the duration of the milk experiment. This might throw light on the hydrodynamic 
causes of the ultrasonically observed rate and extent of clot deposition on the 
test-bodies. 
Efforts should be made to identify, and perhaps remove, the cause(s) of the 
progressive decline in flow rate during the steady flow experiments. 
Calculations indicate that the mean fluid velocity in the test-chamber increased, 
as wall clot developed in steady flow experiments, but this was not ascertained 
directly. An experimental programme of controlled and measured variation of 
mean fluid velocity, and thus knowledge of the changes in mean fluid residence 
time and shear stress in the test-chamber, would throw light on the effect on clot 
deposition of such changes. 
Difficulties with degassing warm, flowing milk, and bubble creation by the pumps, 
limited the success of achieving bubble-free milk flow in the test-chamber, which 
had an impact on imaging and possibly clot adhesion. Preheating stagnant 
milk prior to its use in flow experiments, and removal of the peristaltic pump 
previously used in these experiments, may be an effective way to ensure bubble-
free milk flows through the test-chamber in steady flow studies. In addition to 
these measures, for pulsatile flow experiments, use of a degassing unit downstream 
of the diaphragm pump may be fruitful, but at a price - the pulsations may be 
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markedly damped. 
Wail clot loss alters flow conditions and has the potential to interfere with test-
object clot, so the prevention of wall clot formation is desired. To this end, the 
feasibility of such means as a test-section whose walls act as a Ca2+  sink, or of 
the core-annular flow column designed in this laboratory, could be assessed using 
ultrasonic imaging. 
Tests could also be carried out to determine the effects on clot adherence and 
rheology of Ca 2+ concentration and temperature. 
The colloidal and soluble calcium in raw milk will vary with the diet of the source 
animal. Since the Ca 2+ concentration strongly influences coagulation, this should 
be checked prior to each experiment. Such testing was not performed here, given 
the fixed diet of the herd and lack of variation in milk composition data, but is a 
recommended addition to pre-experiment tests. 
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Analysis of Proteinaceous Deposition Rates from Ultrasonic measurements 
Christy J.R.E., Macleod N.,. Marosek K. - University of Edinburgh 
Abstract 
Fluid flow in the vicinity of artificial cardiovascular implants is known strongly to influence the deposition of 
thrombus around such devices. However, the relationship between flow characteristics and deposition 
tendency is not clear. Previous work in this laboratory, using a blood analogue fluid, has shown that stasis is 
not the only factor controlling clot deposition; high shear stresses may limit deposit growth and high mass 
transfer rates may promote it In order to appraise these factors, it is necessary to observe the growth of 
deposit as it occurs. Since the fluid is opaque, ultrasound is to be used for such observation. 
Introduction 
The purpose of this research is to throw light on mechanisms of flow-related thrombus formation in 
artificial heart valves, thus facilitating the identification and design of valves of minimal clotting tendency. 
As we have indicated in reference 1, in the continuing search for an athrombogeniC mechanical prosthetic. 
heart valve the influence of flow pattern on blood clotting has received relatively little systematic attention 
compared with that given to chemical and surface material properties. Accordingly, artificial materials are now 
available for mechanical valve construction which are intrinsically less thrombogenic than the valves made from 
them. In these circumstances, the logical way forward toward development of a mechanical valve usable 
without anticoagulants is to identify those features of the flow through existing valves that lead to thrombus 
formation, with a view to eliminating or reducing such undesired fluid effects in new designs. 
Many physical flow characteristics have been proposed as determinants of thrombus formation, including: 
high local values of shear stress 
high local values of mass transfer coefficient 
stagnation points 
and 	 d) regions of stasis. 
Experimental evidence, such as that of Tiederman 2  and Taylor3
, show no correlation between a) and b) and the 
formation of particulate deposits from flowing blood. Vorhauer's experiments  with bodies of revolution 
supported in the canine descending aorta point, on the other hand, to wake regions behind bluff bodies, at 
which c) and d) occur together. as favoured site for thrombus growth. Figliola 5 
 and Voganathafl 6  in their 
studies of prosthetic valves have likewise linked observed sites of coagulation in viva 
with regions where 
separated flow and stasis are found in vitro 
under steady flow conditions at the same mean Reynolds number. 
Since such regions are associated with high local mass transfer, stagnation points and stasis together, 
identifying the effects of any particular flow property remains a problem. 
An Analogue of Thrombus Formation 
With this difficulty of isolating such flow effects in mind, an analogue fluid for the experimental 
determination of thrombogenic tendency of implant devices has been developed in this laboratory to facilitate 
the making of in vitro 
observations, it appears that such a coagulable 'analogue fluid need not mimic the 
cascade of reactions leading to the formation of thrombin,
7  but only the action of thrombin on fibrinogen and 
the subsequent formation of a fibrin thrombus. Heated milk, to which are added rennet (containing the enzyme 
Chymosin) and Calcium Chloride (which accelerates clotting and controls the rheology of the formed clot), 
provides an analogue for this. 8 ' 9 
 Chemically the final blood and milk clotting reactions are similar. 10 both 
systems involving the enzymic cleavage of a soluble protein to yield an insoluble protein and soluble 
glycopeptides, the insoluble protein undergoing a second order polymerisation reaction to form a fibrous mesh. 
On a macroscopic scale both reactions exhibit an induction period, during which no solid material is visible, 
followed by the appearance of particles which rapidly coagulate to form a structured clot Lewis 9 
 has shown 
that the behaviour of this analogue liquid in impinging jet experiments 11 
 and HladoveC's net-clotting 
experiments 12 
 is remarkably similar to that of blood; and that the milk curd formed around Bjork-Shiley and 
Starr-Edwards prostheses in an experimental heart chamber occur at the same sites as are prone to 
thrombosis in viva 
With the aim of studying these similarities in simpler and more determinate flow situations, we have more 
recently examined the extent of the resemblance between the clotting of blood flowing past certain solids of 
revolution placed in the canine aorta, observed in vivo 
by Vorhauer, and that of comparable flows of milk about 
similar test bodies in our own experiments. We find that milk clotting in steady and pulsatile flow around four 
simple bodies of revolution (Fig 1) shows many similarities of location and extent with 
in vivo canine 
thrombosis formation for similar bodies as reported by Vorhauer and Tarnay 4 . 
Findings and Further Questions 
A dye injection investigation of the fluid residence time distribution under the hydrodynamic conditions of 
our milk flow experiments reveals that a permanent or trapped vortex (Fig 2) persists at each downstream site 
where clot is found, implying that stasis, or stagnation, is of predominant importance in causing milk clotting. 
While clot deposition in pulsatile flow occurred always within regions of stasis, it did not, however, occur 
everywhere in such regions. Thus, whilst it is apparent that stasis is a prerequisite for thrombus formation, the 
extent and subsequent shape of the clot would appear to be governed by other factors. 
These might be mass transfer or shearing effects. Indeed it is likely that the growth of the clot deposit will 
be limited either by the rate of transfer of the clotting species to the deposit surface or by the action c 
shearing forces preventing adhesion of further material 
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Evidently. It Is important to distinguish between these two possibilities In the case of any particular device 
that shows promise 04 remaining clot-tree in the fluid stream. To be able to make this distinction 
experimentally it is necessary to observe the growth of deposit continuously during the experiment rather than 
solely at the and as is done at present. We propose to use an ultrasound technique for such continuous 
monitoring of the deposit growth in the opaque liquid. 
A New Experimental Technique 
We have found in experiments using pre-formed milk clot suspended in either water or fresh milk, that it is 
possible to observe the location and shape of the fluid/solid boundaries ultrasonically in such systems. A 
conventional 7.5MHZ a-scan ultrasonic probe was used in these tests, loaned to us for these trials by the 
manufacturer. Dynamic Imaging Ltd of Livingston. With this equipment we have further identified means of 
incorporating the probe Into the wall of our milk flow-system In such a way that It can continuously and 
non-invasively monitor the deposition of clot on the test body within. 
Applications of the New Technique 
Following installation of the ultrasonic equipment thus proven in preliminary trials we intend: 
To extend further our fundamental enquiries into the course and mechanism of clot formation in 
disturbed flows of milk and, by inference, of blood: 
To set up a test procedure or facility for rapidly evaluating and ranking artificial heart valves with 
respect to their liability to thrombose. 
Sysoie 




Fig 1 Photographs: al-d) Stedy 110w. el-11) puialde 1)0w. 	 Fig 2. Dva movements during pulsatile flow ycIs. 
Disc resembled the cone and th.re resembled the tear-drOD. 
Permanent wake varies observed for ill objects in Heady flow. 
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DEVELOPMENT OF A CONCURRENT LIQUID-LIQUID 
CORE-ANNULAR FLOW COLUMN TO PREVENT WALL 
DEPOSITION IN COAGULATION STUDIES 
K. W. MAROSEK, J. R. E. CHRISTY,t N. MACLEOD and S. WILLIAMSON 
Department of Chemical Engineering. University of Edinburgh, The King's Buildings, Mayfield Road, 
Edinburgh EH9 33L, U.K. 
(First received 29 August 1991; accepted in revised form 26 May 1992) 
Abstract—This paper-describes a method of avoiding the formation of deposits at the wall of a vertical 
cylindrical tube carrying a steady flow of coagulable fluid (rennetised milk) by providing a cocurrent 
annular film of inert, immiscible fluid adjacent to the tube wall. A liquid-liquid core-annular flow column, 
24 cm long and 3.2 cm diameter, intended for use as a cardiac valve test chamber, was designed and tested to 
determine the flow conditions under which a continuous annular film of fluid down the wall could be 
maintained in the presence of a downward flow of relatively low-viscosity aqueous core fluid. Ultimately, 
for film fluid Reynolds numbers of 880 and above, it was found that a continuous film can be maintained 
throughout this vertical cylindrical test chamber for all core fluid flow rates attainable in our apparatus. 
The results indicate that a downward coaxial-flow chamber for milk experiments is indeed feasible. Such 
coaxial flow systems have been used in reducing pressure drops in the pumping of viscous fluids. Our results 
suggest also that a core-annular flow might be used to provide protection of pipe walls of short length from 
fouling or corrosion by a core fluid. 
I. INTRODUCTION 
Lewis and Macleod (1983) have shown that the clot-
ting behaviour of a flowing milk mixture is remark-
ably similar to that of blood in similar flow situations. 
In a further study of fluid-mechanical influences on 
the clotting of blood and milk flows, Christy and 
Macleod (1989) examined the clotting of this milk 
mixture in .. steady and pulsatile flows past certain 
axisymmetrical objects located axially in a cylindrical 
test chamber, and compared their results with those 
reported for clot deposition from blood flow around 
similar test bodies suspended in the canine descending 
aorta (Vorhauer and Tarnay, 1967) in an attempt to 
relate both to known flow patterns. However, milk 
clotting along the wall of the cylindrical test chamber, 
presumably due to a slow-moving boundary layer in 
this region, leads to problems in analysing clot depos-
ition on the test body; this layer of deposit on the wall 
not only makes it difficult to remove the test object for 
examination undisturbed, but also renders uncertain 
the origin of any clot deposit then found on the test 
object. For instance, wall clot dislodged upstream of 
the test body may impinge on the test body during an 
experiment, either adhering to or dislodging the clot 
already formed on it. 
The purpose of this research was to find means 
either of preventing formation of wall clot or of 
reducing its influence by modification of the wall 
conditions in the cylindrical test chamber. The follow-
ing possibilities were considered: 
(i) Liquid-liquid core-annular flow. Removal of 
the reactive fluid from the wall region by pro- 
tAuthor to whom correspondence should be addressed.  
viding an annular film flowing coaxially and 
cocurrently with the core fluid. 
Enlargement of the test-chamber diameter so 
as to reduce the possibility of dislodged wall 
clot coming into contact with the axially 
mounted test body. 
Coating of the test chamber wall to inhibit clot 
deposition. 
Arranging for a thin sheath of flexible solid 
material, acting as an inner lining to the test 
chamber, to be pulled through the column, 
thus removing the wall clot as it forms. 
The potential of each of these ideas was considered 
systematically. Solution (i) would be suitable if it were 
indeed possible to maintain a Continuous annular film 
at the wall. Facilitating option (ii) would make the 
removal of the test body easier but would not solve 
the whole problem; the possibility of dislodged wall 
clot impinging on the test body would remain, and a 
larger volumetric flow rate of milk would be necessary 
to maintain the desired Reynolds number. Option (iii) 
would probably fail, as the stagnant layer adjacent to 
the wall would still promote clotting and the poorly 
adhered clots would probably, and most undesirably, 
be carried downstream, impinging on the test object. 
Alternative (iv) would prevent the formation of 
stationary clots on the wall of the test chamber with-
out disturbing the flow significantly. However, apart 
from the obvious mechanical difficulties of such an 
arrangement, the possibility of clot formed on this 
material, upstream of the test object, becoming dis-
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Option (i), two-phase core-annular flow was, there-
fore, chosen for investigation as offering the best 
prospect of success. 
The main aim of the present research was accord-
ingly to ascertain whether this liquid-liquid cocurrent 
annular flow mode of operation is possible with a core 
fluid of relatively low viscosity, determining the flow 
conditions, if any, under which a liquid-liquid 
core-annular flow column can be operated to give a 
continuous annular film throughout the length of the 
test chamber. 
Several investigators have analysed core-annular 
flow in liquid-liquid systems. Hickox (1971) carried 
out a theoretical analysis of stability using a standard 
method of small perturbations on a laminar, 
core-annular flow. His analysis indicates that 
core-annular flow is unstable for any case where the 
viscosity of the outer phase is greater than the vis-
cosity of the inner phase. This result agrees well with 
the experimental findings and has been predicted by 
thermodynamic considerations. [From the minimum-
energy approach (Everage, 1973; Maclean, 1973), the 
two liquids minimize their viscous dissipation in 
core-annular flow when the more viscous phase is 
surrounded by a less viscous phase.] Hickox (1971) 
also examined the influence of the velocities of the 
phases on the stability of the core-annular flow. 
However, Hickox's linear analysis is valid only for 
small perturbations whose wavelength is long, not for 
large amplitude or high-frequency disturbances. 
Charles et al. (1961) worked with horizontal pipe-
line flow of equal-density oil-water mixtures. He in-
vestigated the reduction of the pressure gradient for 
oil flowing along a pipeline; on introducing a concen-
tric flow of water, less viscous than oil, a uniform 
annulus in the region next to the pipe wall was 
obtained. From experimental observations of the flow 
patterns obtained with different oil flow rates and 
constant water flow rates, Charles (1961) found that 
there was, in his equipment, a low critical oil (core) 
velocity, below which core-annular flow cannot be 
maintained. An upper critical oil velocity was also 
found to exist, above which the shear between the 
water annulus and the oil core renders the 
core-annular flow regime unstable. 
Shertok (1976) substituted the fluid properties used 
by Charles (1961) into the linear stability theory 
equations developed by Hickox (1971). The agree-
ment between the theory and the experimental find-
ings is good for low superficial velocities of the oil and 
water. However, the results diverge at higher superfi-
cial velocities due to a breakdown in the constraints of 
Hickox's formulation. 
The experimental work conducted by Shertok 
(1976) involved cocurrent liquid-liquid upward 
vertical core-annular flow. He found, using a density 
ratio substantially different from unity, unlike 
Charles, that there are upper limiting core and film 
fluid superficial velocities, beyond which core-
annular flow is unattainable. Shertok's employment 
of laser Doppler velocimetry led him to conclude that  
although vertical core-annular flow is characterized 
by ripples at the fluid-fluid interface, these have little 
measurable effect on the bulk flow. 
Oliemans and Oorns (1986), like Charles et al. 
(1961), sought to facilitate the flow of  highly viscous 
heavy crude oil through a horizontal pipe by at-
tainment of a core-annular flow, with the annulus of 
water. However, their application was for heavy oils 
with p > 500 cP and p > 900 kg/m l ; the difference in 
viscosity from the annular fluid was so great that the 
core approximated to a rippled solid rod; their results 
are of limited use to us. 
Thus, it appears that no complete theoretical treat-
ment is available for the stability of downward ver-
tical core-annular flows, adequate for the design of 
our proposed non-fouling milk column, and that there 
is no published experimental work directly applicable 
to our system. Because our aim was unique, our 
experiments having a much smaller viscosity ratio (i.e. 
1.5) than other studies (all in excess of 6.3), the literat-
ure was able to provide us with approximate guide-
lines only. We. therefore, undertook the preliminary 
analysis described in Section 2 as a guide to the 
experimental work described in Section 3. 
2. DESIGN AND STABILITY CRITERIA 
The following parameters were considered relevant 
to the stability of a liquid-liquid core-annular flow 
with a continuous liquid film (Fig. I): interfacial ten-
sion, a, component densities, pt,, p1 , component vis-
cosities, p, p1 , component flow rates. IV, W1 and the 
geometry of the entrance section. The following pre-
liminary analysis aided the choice of film fluid and 
materials of construction. Throughout this discus-
sion, it is assumed for simplicity that the fluids are 
Newtonian. 
Surface tension (a). This tension may govern the 
waviness and stability of the fluid-fluid interface 
(Wallis, 1969) and, hence, affect the ease of emulsifi-
cation. Energy considerations would suggest that for 
stability the wetting propensity of the film fluid on the 
wall should be greater than that of the core fluid. 
Oliemans and Ooms (1986) used physicochemical 
agents both to facilitate the wetting of the pipe wall by 
the film fluid and to improve the stability of the 
fluid-fluid interface. 
Regarding the liquid-liquid interface, Hutchinson 
and Whalley (1973) suggest that the entrainment rate 
for core-annular flow columns is an increasing func-
tion of t,x/a, where the interfacial shear stress, t., is 
competing against the containment effect of the sur-
face tension, a, and x is the film thickness. This would 
imply that we desire a high surface tension at the 
liquid-liquid interface to prevent droplet formation. 
Fluid densities (pa. Pr). A vertical configuration 
was chosen to minimize gravitational stratification 
problems. For stability at the liquid-liquid interface, 
it would seem preferable to employ liquids of equal 
density in the film and core. However, in order to aid 
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Fig. I. Parameters for vertical downward two-phase flow. 
separation of the liquids on exit by decanting, fluids of 
different density are required. By limiting this density 
difference and arranging that the denser fluid forms 
the film in downward flow [or forms the core in 
upward flow (Shertok, 1976)], the destabilizing effect 
of gravitational stratification may be minimized. For 
downward flow, with the denser fluid next to the wall 
and moving more slowly than the core, the buoyancy 
force at the liquid-liquid interface will act so as to 
reduce the interfacial shear stress, whereas with the 
denser fluid in the core the converse is true. 
Fluid viscosities 	Pr).  A source of instability, 
according to Ooms (1971, 1972), is an imbalance of 
the interfacial velocities of the fluids. If the core and 
film fluid viscosities differ, then the velocity gradients 
in the two fluids at the interface will be different: the 
abrupt change in the velocity profile will prove to be 
the primary cause of instability. Hickox (197 1) showed 
that having the film fluid viscosity larger than the core 
fluid viscosity always leads to instability. 
Core and film fluid flow rates (W,, W r ). The 
core-annular flow configuration is quite dependent 
on the velocities of the two phases. For stability it is 
preferable to have a low interfacial shear stress to 
minimize the variation in velocity gradients across the 
interface. From the work by Hutchinson and Whalley. 
(1973), mentioned above, it would appear that the 
interfacial shear stress should be kept low to prevent 
entrainment. For constant liquid viscosities, keeping 
the fluid-fluid interfacial velocity gradients small will 
keep Tj low, if waves are not present. However, to 
ensure low velocity gradients either the overall flow 
rate, W + W1 , must be kept low or the ratio WI! W 
must not be too small. Since the Reynolds number for  
the overall flow is to be fixed, the ratio WI/We must 
be chosen large enough to keep r low. This may lead 
to a large film thickness. Unfortunately, if the film 
flow rate and thickness are large then, as is commonly 
found experimentally, the tendency for wave forma-
tion increases. For instance, Gill et al. (1964) found 
that in an upward core-annular air-water flow the 
entrainment flow rates increase continuously with 
increasing W1 , at all air flow rates. Some compromise 
between W, and x may be necessary. 
History of the flow. Charles et al. (1961), 
Shertok (1976) and Oliemans and Ooms (1986), all 
utilized special inlet nozzles to prevent disorderly 
mixing of the two fluids prior to their introduction to 
the test chamber. There are a number of ways to 
initiate core-annular flow (Kubie and Gardner, 1977) 
with minimum interfacial disturbance (Fig. 2). For 
example, a porous circumferential zone of the wall 
through which unreactive fluid diffuses into the region 
adjacent to the wall, or a conical diffuser with a 
uniform circumferential gap, may be provided to in-
troduce the two fluids cocurrently at the top of the test 
chamber. The latter configuration was chosen here 
since it appeared to be the easiest one to install. 
From the above analysis it was decided that for 
downward core-annular flow the film fluid should 
possess the following properties. It should wet the 
test-chamber wall preferentially, relative to the core 
fluid (i.e. have a lower surface tension than the core 
fluid) and be immiscible with, less viscous than, and 
have a density equal to or greater than the core fluid. 
Since water was chosen to be the core fluid, a non-
ionic (or covalent) compound was sought for use as 
the film fluid so as to ensure a high interfacial tension 
Core fluid 
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Fig. 2. Preliminary design ideas for a two-phase liquid—liquid annular flow column. 
between them and easy separation of the two fluids 
downstream of the test-chamber. Of the suitable or-
ganic fluids available, 1,1 ,2-trichloro- I ,2,2-trifluoro-
ethane (C 2C1 3 F3 ) was chosen. At 25°C, water and 
C 2 C1 3 F3 have surface tensions of about 72 x 10 - land 
19 x lO N/rn, viscosities of about 1.002 and 
0.680 cP, and densities of 998 and 1565 kg/m 3 , re-
spectively. An interfacial tension between the two 
liquids of about 40x io - N/rn is expected. 
Simple wetting propensity tests were conducted to 
aid the choice of a suitable material from which to 
construct the test chamber, the criterion being that 
the material should be wet more easily by the film 
fluid than by water. Several different materials 
(Perspex, PTFE, PVC, aluminium, brass and stainless 
steel) were tested. It was found that trichlorotri-
fluoroethane will wet most of the materials tested 
preferentially to water, with PVC and Perspex per-
forming best in these tests. 
3. EQUIPMENT AND PROCEDURE 
The apparatus for providing a steady flow of core 
and film fluid to the test chamber containing the test 
body is illustrated in Fig. 3. Water flows by gravity 
through the test chamber from a constant head tank, 
and the film fluid (C 2 C1 3 F3), which is stored at the 
base of the settling tank, is pumped to the top of the  
test chamber. Within the test chamber the test body is 
fixed at its downstream end to a vertical 50 mm long 
metal "sting" coaxial with the vertical test chamber, as 
shown in Fig. 4. 
Cocurrent core—annular flow is produced by the 
water flowing within the diffuser and the C 2 C1 3 F 3 
flowing between the test-chamber wall and the out-
side of this diffuser. The PVC diffuser was designed to 
minimize flow separation. A "reservoir" for the 
C 2 CI 3 F3 was incorporated into the diffuser to assist in 
distributing the flow. The width of the gap between 
the diffuser and test-chamber wall, from which the 
film fluid is introduced, was not designed to be van-
able since the film thickness will not depend on the 
gap width once the film is established on the wall. 
The water—C 2 C1 3 F3 stream leaving the base of the 
test chamber enters a settling tank. A baffle is posi-
tioned in this tank to dissipate the kinetic energy of 
the inlet fluid and to provide a way of keeping the 
denser recyclable film fluid from leaving through the 
overflow to the drain. A large-diameter settling tank 
(about 50cm) was used so that no large circulation 
and relatively small velocities are present. 
By varying both the film and core fluid flow rates, it 
was possible to evaluate the flow ranges and Reynolds 
numbers for which a continuous film is obtainable 
within the test chamber. To enable observation of the 
-s-I- 
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Fig. 4. The two-phase annular flow test chamber. 
film's performance, a red dye (Sudan IV), miscible ous film was obtained, photographs were taken 
with the film fluid but immiscible with water, was through the transparent wall of the test chamber for 
used. The use of this dye allowed a definite interface to use in further analysis. 
be seen when the film became discontinuous along the 	The fact that the dye is immiscible with water may 
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and core fluid interaction, as it will be contained 
within the film fluid. However, Davies and Rideal 
(196 1) have observed that wetting by liquids is poorer 
when the liquids are contaminated rather than pure. 
Consequently, all preliminary tests were performed 
with the dye present. as the significance of the dye for 
the film's performance was unknown. 
When the dyed film fluid was continuous through-
out the test chamber, the appearance. to the naked 
eye, was a uniform pale red. Still photographs showed, 
however, that this colour was not uniform, but was 
crossed by circumferential, horizontal lines of a 
deeper red, the spacing between such lines increasing 
from the top to the bottom of the test chamber. These 
lines may have indicated the presence of waves or 
ripples. No entrainment of film fluid was apparent 
when the film was continuous. 
When film discontinuity occurred, a clear and de-
finite ragged interface between the two fluids was 
observed at the wall; the film fluid in contact with the 
wall had a pale red appearance whilst the water was 
transparent, containing some red droplets whose 
colour was deeper than that of the film, suggesting 
that they were thicker than the film. Isolated drops of  
film fluid can be seen even through a continuous film, 
because the overlap of dyed film fluid is depicted by a 
deeper shade of red. It is. therefore, probable that 
entrainment from a continuous dyed film would have 
been observed had it occurred. 
4. RESULTS 
The desired result, a vertical liquid-liquid 
core-annular flow column with a continuous film 
down the test-chamber wall, was achieved over a 
range of flows. It was found that, for film fluid 
Reynolds numbers of 880 or above, any non-zero core 
fluid flow rate achievable with our equipment could 
be employed to obtain a continuous film' both up-
stream and downstream of the test body. Values of the 
flow rates, the corresponding Reynolds numbers (as 
defined below), and the observed flow characteristics 
for the film and core fluids (C 2 CI 3 F 3 and water, 
respectively) are tabulated in Table 1. The film and 
core Reynolds numbers were defined using the follow-
ing two equations: 
Ref 
= 2p1 W1 	
(I) 
p1 itD 
Table I. The results obtained using the vertical two-phase liquid-liquid core-annular flow column, where 










± 135 Observations 
0.12 90 0-5.78 0-3565 Deficiency of C 2CI 3 F3 results in only droplets 
of the film fluid, at all core fluid flow rates 
0.22 170 0-5.78 0-3565 This increase in film fluid flow rate does not 
improve the result 
0.34 260 0-5.78 0-3565 Incipient film at the diffuser exit 
0.47 360 0-5.78 0-3565 Similar results as those found at Ref of 260 
+20 
0.61 465 0-5.78 0-3565 Very short film at diffuser outlet 
Increased water flow rate extends the film 
slightly 
0.74 565 0-5.78 0-3565 Longest film observed is about a third of the 
length of the test chamber, at Re, of 700. 
Higher water flow rates resulted in film break- 
up 
0.88 670 0-5.78 0-3565 Similar results as those obtained at Ref of 565; 
however, the film is slightly longer here 
1.02 780 0.38 250 A continuous film is obtained down to the test 
body, after which discontinuity in the film 
occurs 
1.02 780 1.18 780 Continuous 	film 	obtained 	throughout 	test 
chamber 
1.02 780 2.68 1780 Continuous 	film 	obtained 	throughout 	test 
chamber 
1.02 780 5.78 3565 Continuous 	film 	obtained 	throughout 	test 
chamber 
1.15 880 0-5.78 0-3565 Continuous film throughout the test chamber 
over the full range of attainable core flows 
1.28 975 0-5.78 0-3565 Continuous film throughout the test chamber 
over the full range of attainable core flows 
1.54 1175 0-5.78 0-3565 Continuous film throughout the test chamber 
over the full range of attainable core flows. 
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The equipment available limited the range of 
Reynolds numbers we could explore. So, here, no 
upper limit was found for the Reynolds number range 
for which a continuous film is obtainable. The max-
imum Reynolds numbers attainable with our pumps 
were 1175 (± 20) for the film fluid and 3565 (± 135) 
for the core fluid. 
At the different values of flow rate in Table 1, the 
dependence of the column's performance on the film 
and core fluid Reynolds numbers was determined by 
visual observations of the dyed film. 
At low film fluid flow rates (i.e. Re f 670), any 
continuous film formed was fragmentary and did not 
extend from the diffuser down as far as the test body. 
Increasing Re, was found either to increase the extent 
of the film slightly or, under certain circumstances, to 
cause its disruption. 
With Ref  780, a continuous film from the diffuser 
down to the test body was achieved irrespective of the 
value of Re,. This continuous film extended past the 
test body when Ref 880, for all values of Re,. At 
Re = 780, the continuous film extended downstream 
of the test body only when Re, 780 (corresponding 
to a Reynolds number based on the diameter of the 
test body, body 250). 
5. DISCUSSION 
A range of film Reynolds numbers was sought for 
which a continuous annular film is attained in a 
relatively short length of vertical pipe (24 cm). For our 
milk coagulation studies, a core Reynolds number of 
about 1000 is employed. A stable regime is, therefore, 
desired, in which the core flow is laminar and not 
disturbed by the presence of the film fluid. These 
requirements appear to have been satisfied. 
When the film is not continuous down to the test 
body, an increase in the core fluid flow rate may either 
extend or disrupt it (see Table I). 
At the critical film fluid Reynolds number, increas-
ing Ref stabilizes the, film; beyond this Ref , the value 
of Re, appears to have little significance with regard to 
the stability of the film within the range of Ref 
attainable here. 
The film fluid Reynolds number was, thus, found to 
be of primary importance for film stability. For 
Ref 780, a continuous film in the region up to the 
test body is obtained. It is remarkable that for film 
fluid Reynolds numbers above 880 the film remains 
continuous throughout the test chamber, even beyond 
the test body, in spite of the expected tendency of 
disturbances around this body to destabilize the 
core-annular flow system beyond it. 
At the transition film Reynolds number of 780, it 
was found that the extension of the continuous film 
beyond the test body occurred only if the core fluid 
Reynolds number was 780 or more. At this Re 1 , and 
core fluid Reynolds number values less than 780, the 
film breaks down in the region adjacent to the test  
body; for core fluid Reynolds numbers greater than 
780, the film remains Continuous. This stabilizing 
effect of the core fluid at the transition film Reynolds 
number of 780 is at first surprising, since at other film 
fluid Reynolds numbers the core fluid does not appear 
to have any appreciable influence on the behaviour of 
the film. It may be significant that for a core fluid 
Reynolds number of 780 the Reynolds number based 
on the diameter of the test body is 240, whereas at the 
next lowest core Reynolds number measured (250) 
this test body Reynolds number is only 80. At a body 
Reynolds number of 80, it is unlikely that a turbulent 
wake will be present downstream of the test body, 
whereas at a body Reynolds number of 250 or above, 
a wake will almost certainly form. Perhaps this 
turbulent wake permits the film to remain continuous, 
possibly by reducing the degree of local deceleration 
of the core fluid in the region near its interface with 
the film fluid. 
Viscosity and density were considered very import-
ant for flow stability by several authors; for instance. 
when the two phases in horizontal how have unequal 
density, it was found that for establishment of a 
core-annular regime the core viscosity needs to be 
very large (i.e. greater than 500 cP; corresponding to a 
viscosity ratio between the two fluids that exceeds 
500), and the density difference less than 100 kg/m 3 . 
Charles et al. (1961) adopted a similar orientation, 
finding that the use of equal density fluids allows 
lower viscosity core fluids to be used (viscosity ratios 
from 6.3 to 65) whilst still attaining core-annular flow. 
The experimental work in the literature most closely 
resembling ours is that carried out by Shertok (1976). 
The differences between our configuration and his, 
such as flow direction and viscosity ratio; render a 
direct comparison meaningless. Shertok's results do, 
however, indicate the dependence of core-annular 
flow on the two fluid flow rates, with critical velocities 
defining the velocity window in which such a flow is 
obtainable. Here we observed the lower critical 
Reynolds number but not the upper, due, no doubt, to 
the limitations of our pumps' maximum capacities. 
6. CONCLUSIONS 
A cocurrent downward-flow vertical core-annular 
flow column was designed and tested using trichloro-
trilluoroethane (C 2 Cl 3 F 3) as the film fluid, immiscible 
with the core fluid, water, to determine the feasibility 
of a proposed non-fouling chamber for milk coagula-
tion experiments. 
It was discovered that this mode of cocurrent 
contacting can be established, even with a viscosity 
ratio as small as 1.5, for film and core fluid flows of 
Reynolds numbers in excess of 780. Relating this 
result to our blood analogue experiments, the use of 
treated milk in this core-annular flow column may be 
able to show whether the clotting on the walls of the 
conventional test chamber significantly affects obser-
vations of test-body clotting. This information should 
lead to a more reliable comparison between the 




K. W. MAROSEK et al. 
characteristics of the clotting of milk and blood. For 
our application, that of providing a clot-free bound-
ary layer in thrombogenicity experiments, these 
results are, therefore, promising, a continuous thin 
fluid annulus being achieved with apparently minimal 
disturbance of the core fluid. 
NOTATION 
D internal diameter of the test chamber, m 
Re core fluid Reynolds number 
Ref film fluid Reynolds number 
Re, t.. I y Reynolds number based on the diameter 
of the test body 
core fluid velocity 
J4' core fluid volumetric flow rate, m'/s, un- 
less otherwise stated 
WI  film fluid volumetric flow rate, m
3 /s, un- 
less otherwise stated 
X mean thickness of fluid film, m 
z axial distance through test chamber, m 
Greek letters 
Pc core fluid density, kg/m 3  
pf  film fluid density, kg/m' 
PC core fluid viscosity, kg,'m s 
film fluid viscosity, kg/rn s 
interfacial tension, N,'m 
interfacial shear stress, N/rn 2 
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DETERMINATION OF MILK CLOT DEPOSITION RATES BY ULTRASONIC 
IMAGING 
Christy J.R.E. and Marosek K.W. 
]Department of Chemical Engineering, University of Edinburgh, EH9 3JL, Scotland 
Previous studies 11,21,  using milk to which cheesemakers' rennet is added as a blood 
analogue for thrombosis, have revealed a dependence of the extent of milk clot 
deposition on flow characteristics such as stasis and shear stresses. Such studies, 
however, were limited in relation to determining deposition rates as the deposit was 
only measured on dismantling the apparatus. The present study involves the use of 
ultrasonic imaging equipment to determine the thickness of clot adhering to the wall 
of a vertical, cylindrical test chamber as the experiment proceeds. The maximum 
deposition rate in pulsatile flow is found to be significantly less than in steady flow 
at the same mean flowrate (Re = 1040). 
'INTRODUCTIO N  
Previously enzymic coagulation of milk has been studiedt 1 in a vertical pipe around axially mounted test-
]bodies, in order to assess the relationship between clot deposition and flow characteristics. That study, 
Ihowever, was limited in relation to determining deposition rates in that the extent of deposition was only 
ascertained at the end of an experiment of fixed duration. In some experiments it was suspected that clot 
:formed on the test-chamber wall upstream of the test-body may have become dislodged, impinging on the 
test-body, but this could not be confirmed. Ways to eliminate wall clot formation have been considered t 31 , but 
there appears to be no simple way of maintaining clot-free walls in both steady and pulsatile flows without 
disrupting the milk coagulation studies. Therefore, imaging of clot deposition was considered necessary to 
obtain information on clot growth rates and wall clot behaviour. Ultrasonic imaging was the technique chosen, 
as it has been successfully used non-invasively for in vivo deposition studies[') and the results of preliminary 
imaging tests indicated its feasibility. 
Ultrasonic imaging equipment, such as is used clinically for foetal measurements in the womb, is used here 
for continuous measurement of deposit thickness during the experiment. Ultrasonic measurement of the clot 
thickness is made possible by the interfaces between both the clot & fluid and clot & surface to which it 
is adhered reflecting some of the incident ultrasound beam, with the monitor transforming the time delay 
between ultrasound transmission and echo reception into interface depths and displaying the interfaces one-
dimensionally. The depiction of clot forming on each test-body using ultrasound was poor, as the test-body 
shapes cause extensive ultrasound scatter. Ultrasonic imaging of clot deposition at the far inner-wall of the 
test-chamber, on the other hand, was sufficient to allow clot growth rates to be determined and these are 
reported here. 
EXPERIMENTAL APPARATUS AND PROCEDURE 
The experimental arrangement used in earlier milk studies has been described elsewhere [' ] . Equipment ad-
ditions/modifications made since these studies include the use of a polypropylene, as opposed to perspex, 
test-chamber, a perspex rather than stainless steel test-body support, a Concept 2000 ultrasound scanner 
from Dynamic Imaging' equipped with a linear-array piezoelectric transceiver operating at 7.5MHz (intensity 
9.6mW/cm2 , beam power 4621.iW) and supported in a customised holder, a video recorder and printer. 
The milk apparatus under ultrasonic study comprises a cylindrical test-chamber, on the axis of which is 
rftounted an axially symmetrical test-body and through which is passed a steady or pulsatile flow of a heated, 
unpasteurized milk mixture containing 1% (vol) cheesemakers' rennet and CaC12 (aq.). The concentration of 
the CaCl2 solution ranged from 1.12 to 3.38M. The milk flow rate adopted at the onset of each experiment was 
2 I/min and the duration of each study was about 35 minutes. The ultrasound beam scanned a diametrical 
1 Dynamic Imaging Ltd., Young Square, Brucefleld industrial park, Livingston, Scotland. 
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section of the chamber around the test-body. Deposition rates were determined by analysing the video-tape 
records of the continuous ultrasound imaging of each experiment, using a large television screen and hand-held 
digital calipers. 
RESULTS 
Fur ultrasound images taken at different stages of a milk experiment using 3M CaC12 are given in figure 1. 
Iere the flow is from left to right and the wall clot thickness is indicated by markers ('+', 'x') at the bottom 
left of each image. The wall clot was depicted as a smooth deposit, symmetrical about the pipe axis, and its 
g:rowth was found to be dependent on flow regime. Frm the graph of deposit thickness against time (figure 2), 
it is clear that the initial rate of deposition and maximum thickness of deposit are both significantly greater 
iii steady flow (-4.0mm/mm and —5mm) than in pulsatile flow (0.1mm/min and —3mm) at the same mean 
flow rate (pipe Reynolds number, based on mean velocity, of 1040). 
PISCUSSION 
There are at least two possible explanations for the different initial rates of clot growth in steady and pulsatile 
fl.ows. It is known that the two stage reaction sequence leading to coagulation exhibits a 'lag' phase during 
shich no particulate matter is visible, followed by rapid coagulation to form a solid clo t(1, 2 , 51. The extent 
of deposition in previous studies [' ]  has been explained in terms of stasis being required for ,c-casein in the 
rriilk to undergo enzymic transformation before coagulation will occur. This is borne out by clot deposition 
ciniy occurring in regions where the local residence time approaches the duration of the 'lag' phase. Indeed, 
,in Figure 2, extrapolation of the growth curves back to zero deposit suggests the existence of a lag phase of 
between 1 and 1.5 minutes duration from commencing injection of enzyme into the fresh milk upstream of the 
t;est chamber. One explanation is therefore that in pulsatile flow, due to the transient nature of the boundary 
I ayer, the region having a residence time in excess of the 'lag' phase duration is smaller than that for steady 
'low, resulting in less fluid being in an active coagulating state and hence a lower rate of coagulation. The 
inass transfer coefficient predicted (1 j.im/s) for proteins in steady flow is low suggesting limited diffusion into 
the bulk fluid (cf maximum clot growth rate 20 jrn/s). Another explanation would be that in pulsatile flow 
che maximum fluid shear forces near the wall of the test chamber are greater than those in steady flow and 
lhat these fluid shear forces act against the cohesive forces of the coagulating species, - reducing the net rate 
deposition. 
The reduction in rate of deposition in steady flow as the experiment proceeds may be due to thinning of the 
effective region of the boundary layer as the flow channel becomes more restricted or to a balance between 
the forces of clot cohesion and the fluid shear forces, or indeed to depletion of coagulating species from the 
boundary layer as material deposits. In pulsatile flow it is possible that the clot did not grow sufficiently to 
"ignificantly alter the nature of the transient boundary layer nor the fluid shear forces acting. 
In both steady and pulsatile flow experiments, shedding of the wall clot was observed in some experiments after 
20-34 minutes. This may be due to hydrolysis of the clot (a natural process in milk following coagulation). 
Renewed growth of clot commences immediately following such shedding of deposit without a further lag 
phase, presumably because activated species are already present. This growth occurs at a rate comparable to 
that in the early stages of the initial clot formation. 
It has been found that reduction of the CaC12 concentration leads to a reduction in the maximum rate of 
deposition and in the maximum thickness of clot and appears to lead to an increase in length of the lag 
phase. These would support previous observations[) that calcium ions enhance the coagulation process, both 
increasing the rate of coagulation and stabilising the resultant clot. 
CONCLUSIONS 
Ultrasound has been shown to provide a convenient measurement of milk clot deposition rates on a cylindrical 
test chamber wall. Deposition rates are higher in steady rather than pulsatile flow, presumably due to 
differences in boundary layer characteristics between these flow regimes. 
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Figure : Ultrasound images of a test-chamber containing a disc-shaped test-boy. 
taken 3.25, 6. 7, and 9.3 minutes from the start of a milk experiment. 
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This appendix provides descriptions of the tests carried out before each milk 
experiment, the rennet used, and the procedures adopted when performing experiments, 
shutdown, dismantling and cleansing. 
B.1 Titrations 
Titrations were conducted to ensure the concentration of the CaC12 solutions was 
consistent, as milk coagulation is sensitive to fluctuations of this concentration (figure 
4.6). The aqueous CaC12 solution was prepared by adding crushed CaC12 flakes to 
about 2 litres of soft tap water, which was then shaken, allowed to dissolve and then 
filtered. The method adopted for titrating the filtrate is described below, preceded by 
the theory on which it is based. 
Ethylenediaminetetra- acetic acid (EDTA) is very effective in forming complexes with 
metal cations, and reacts with most metals in a 1:1 ratio. Since EDTA is a complexing 
agent for hydrogen ions, pH has a marked effect on its complex formation; the complexes 
formed with divalent metals are stable in ammoniacal solution but tend to decompose 
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in acid, and most EDTA-metal complexes are very soluble in water. 
In solution, an EDTA-metal chelate exists in equilibrium with its component ions; for 
example, an EDTA-calcium (Y-Ca) complex: 
Ca Y2 -_ Ca2+ + Y4 
In alkaline solution, the equilibrium lies far to the left and very few free Ca2+  ions 
exist. The stability constant for the EDTA-calcium complex is defined as: 
K = [Ca Y2j / [Ca2 ][Y4j 
The metal-specific indicator method of titration requires an indicator to be added to 
the reaction mixture to form a distinctively coloured product with the metal cation 
being titrated. In this case, Ca 2+  was the cation. The indicator must have a colour 
that is different from the Ca-indicator complex, and this complex must form under the 
same conditions as, and be significantly less stable than, the EDTA-metal complex. 
Solochrome Black T (SBT), which is blue when free, was chosen as the most suitable 
indicator for this task. Ca-indicator complexes are unstable and thus give poor end-
point indication, so a small amount of magnesium was used to give a (pink) Mg-SBT 
complex more stable than the Ca-SBT complex but less stable than the corresponding 
EDTA complexes of the metals concerned (table B.1). 
Metal logK of SBT complex logK of EDTA complex 
Mg 7.0 8.7 
Ca 5.4 10.7 
Table B.1: The stability constants for the complexes formed by SBT 1"1 and EDTA 3571 , 
with Mg and Ca at 20'C. 
The CaC12 concentration was evaluated by conducting a titration where 1 M EDTA 
(pH 8.5) was gradually added from a burette to a conical flask containing a solution at 
pH 11 and consisting of 6.75 g NH4C1, 57 ml NH3 (conc.), 40 ml distilled water, 2 ml 
Solochrome Black T (SBT) indicator, 0.0616 g of MgSO 4 .71120 and a chosen volume 
of the CaC12 solution - a modified version of the procedure detailed in West and Sykes' 
publication [356]. The solution was initially pink, due to the formation of the Mg-SBT 
complex but, by addition of a sufficient volume of EDTA, the solution became blue. 
Addition of EDTA leads to EDTA-Ca complexes being formed. EDTA-Mg complexes 
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form, once the Ca2+  is consumed in this way, resulting in the breakdown of SBT-Mg 
complexes. When there are no more SBT-Mg complexes (i.e. when all the Mg has 
complexed with EDTA), the SBT free-state colour of blue is once more resumed. A 
small amount of Mg 2+  was used so that the colour change, from pink to blue, occurred 
close to the equivalence point and thus an accurate value for the CaC1 2 concentration 
was obtained. The volume of EDTA sufficient to achieve a colour change (VEDTA) was 
used to determine the concentration of the CaC12 solution (MCaCl2), using equation 
B.1. 
EDTA4 + CaC12 [Ca(EDTA)] 2 
No. of moles of EDTA = No. of moles of CaC12 
MEDTA X  VEDTA = Mcac12 X  VCaC12 
= MEDTA X  VEDTA / VCaCl2 ... (B.l) 
B.2 Rennet used in this laboratory 
The details of the calf rennet' used here are as follows. The commercial calf rennet 
(also called essence of rennet) was an aqueous solution of rennet enzymes with added 
salt (mm. 16%) and sodium benzoate (max. 0.3%). The active milk-clotting enzymes 
present in the rennet were chymosin and bovine pepsin, extracted from the fourth 
stomach of bovine animals using methods developed by "Chr. Hansen's Laboratory" 
(CHL). 85-95% of the rennet's milk clotting activity was related to chymosin, and 5-
15% to bovine pepsin 2 . The strength of the rennet 3 , controlled by comparison against 
a known standard, was 10.0 CHU/mi ±2. The specific gravity and pH of the rennet 
'Rennet was supplied by Bannerman (J.M.) & Co., 7 Grange Road, Edinburgh, Scotland. 
'Consistent pepsin content in the calf rennet is important, because this concentration determines 
the dependence of clotting activity on PH; bovine pepsin is much more sensitive to pH than chymosin, 
and pepsin has a more general proteolytic activity than chymosin. 
i CHTJ (Chr. Hansen's Unit) is defined as the milk clotting activity present when 1 ml of enzyme 
solution is able to clot 50 g of substrate (low heat-treated non-fat dry milk, Peake, grade A, Galloway 
West) at pH 6.5 in 420 seconds at 32'C. 
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were 1.165 ±0.015 and 5.50 ±0.2, respectively. 
B.3 Milk and rennet tests 
A "Philips PW9421" pH meter, which covers the range pH 0.000 to 14.000 with a 
resolution of 0.001 pH, was employed for milk and rennet pH readings. Two buffer 
solutions were made: a pH 7.0 tablet was added to a bottle containing 100 ml of 
distilled water, sealed and shaken; this was repeated with a pH 4.0 tablet. The 
two containers were sealed to avoid the effect of air interference while the tablets 
dissolved overnight. On the following day, the day of the experiment, the pH meter 
was prepared by: first immersing the Pt 100 resistance thermometer and glass probe in 
the pH 7 buffer solution; then pressing the ATC and pH buttons to select automatic 
temperature compensation and pH measurement; followed by setting the slope to 
100% and adjusting the 'asymp pot' until the pH value of the buffer (at the buffer 
temperature) was displayed. The electrode and probe were then rinsed in distilled 
water and wiped dry with a clean cloth. This was repeated using the pH 4.0 buffer 
solution, since the pH range involved here lies within the range pH 4.0 - 7.0. Two 
samples of both rennet and milk were prepared in flasks, and one of each immersed in 
a water bath at 37°C for 20 minutes. The probe and electrode were immersed in each 
sample and the pH of the rennet and the milk recorded, at both 37°C and ambient 
temperature. 
To avoid unproductive experiments, due to discrepancy in the reagents or a variation 
in the quality of the day's milk, Christy and myself conducted three modified Lee-
White tests prior to each milk experiment. These tests were carried out at 33.5°C, 
with inversions every 15 seconds, using samples from the rennet, CaCl2 and milk to 
be used in the subsequent milk experiment. Each test required a dry, 0.8 cm diameter 
test-tube, a rubber cork, one 5 ml syringe, two microsyringes and a water bath with 
temperature control. Three test-tubes, each containing 5 ml of milk, were immersed in 
the water bath for about 15 minutes. Each test-tube was then removed from the bath, 
in turn, and the tests performed. 1% (vol.) of aqueous calcium chloride and rennet 
were added, the test-tube was then stoppered and briefly shaken and the time set at 
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t=O. This mixture was then inverted every 15 seconds, starting at t=O, until no flow 
was present. The point at which the non-flowing milk-plug was achieved was taken 
as the clotting time. The reason for using a temperature and inversion time less than 
those used in the standard Lee-White procedure (viz. 37°C and 30 seconds) was that a 
more sensitive test was achieved; a lower temperature was used to prolong the clotting 
time, so that any variations in this time would be more noticeable, and more frequent 
inversions were made to allow a more accurate detection of changes in clotting time. 
B.4 Experimental procedure 
The experimental procedure adopted for the main milk experiments is described below 
(refer to figure 6.1). 
The test-body was thoroughly cleaned and mild adhesive was applied to the tip of 
its support rod, to ensure the test-body did not fall off. The test-section was then 
reassembled with the test-body in place. The water supply to the water tank was sent 
to the sink, to expel sediment in the water pipes, before being redirected to the top 
of the water tank, at which point a slight water tank overflow was established. By 
activating the water-jet ejector, a vacuum was achieved and water (from the water 
tank) was allowed to flow through the milk rig. When water began to appear in the 
first vacuum chamber, the peristaltic pump was turned on. The liquid level setpoint 
for the header vessel was set at 40%, and the level controller set to regulate the speed 
of the peristaltic pump based on this value. For pulsatile flow experiments, the outlet 
of the test-section exit tube was positioned about 8 cm above the level in the header 
vessel. Once the level in the header vessel had risen to over 50% the diaphragm pump 
was started. The frequency and stroke volume of the diaphragm pump were then 
adjusted to provide the desired 70 pulses/mm and 2 1/mm. In preparation for steady 
flow experiments, the diaphragm pump chamber was removed from the flow system 
and the header vessel height was raised until the desired flow rate was achieved (by 
gravity). 
Appendix B: Experimental Details 	 225 
A preliminary water wash of the milk rig was performed to prevent the formation of 
an air-milk interface and the trapping of air bubbles and to heat up the equipment, 
whilst adjusting the water-jet ejector to obtain a water level of approximately one inch 
in the first vacuum chamber. A flow rate of 2 I/min was established and residual air, 
not removed by the vacuum chamber, was bled-off at the high points within the system 
or helped out by manipulation of the tubing. The heating-fluid pump and 6 kW heater 
were turned on and the temperature controller tuned, to give a setpoint temperature 
of 37°C. 
The outlets from the three 5 gallon milk containers were connected to the main flow 
line. The lids were removed from these containers and from the rennet and CaC12 
vessels, to ensure no vacuum was created. The flow rate at the test-section outlet was 
checked and the ultrasound probe, with gel on its face, was clamped firmly against the 
test-chamber wall, using the probe support. The best image of the test-object was then 
achieved by manipulation of the various monitor settings. Experimental details were 
typed on the monitor screen and the video recorder started. The ultrasound probe was 
repositioned, when desired, by slightly loosening the wing-nuts of the probe support or 
by removing the support backing which allows removal of the probe from the support. 
Once the desired temperature and flow rate (37°C, 2 1/mm) were achieved, the 
apparatus was ready for a milk experiment. The water supply to the water tank 
was stopped and a changeover, from water to milk flow, was implemented by opening 
the outlet valve of the milk container closest to the heat exchanger. This changeover 
corresponded to 'time = 0'. Water was supplied to the top of the drain-pipe downstream 
of the test-section, to prevent extensive clotting there, and milk was allowed to flow 
through the system. As many bubbles as possible were dislodged from the test-section 
and test-object, percussively and by tube manipulation, prior to the stage where milk 
entered the test-section. The milk was allowed to run through the test-section for about 
one minute before starting the rennet and CaC12 dosing pumps. 
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Throughout the experiment ultrasound images (of the test-section contents) and the 
milk temperature were recorded, and the calipers on the display screen were used 
for clot measurements. When time allowed, the flow rate was measured using a 
measuring cylinder at the sink. Once the level of milk in the first milk container 
dropped significantly, a wooden wedge was used to tilt this container to allow most 
of its contents to be used. To prevent air intrusion and discontinuity in milk flow 
on changeover between containers, the valve on the next milk container was opened 
before closing the valve of the emptying milk container and before the level in this 
container was as low as the outlet valve. This changeover procedure was repeated for 
the changeover from the second to the third milk container, with the remnants of the 
previous container being poured into the top of the next milk container. 
B.5 Shutdown and dismantling 
When the last milk container was almost empty, flow from the water tank was reinstated 
(to replace the milk flow) and this milk container's outlet valve closed. The water supply 
to the top of the water tank was also reintroduced. Once water appeared in the line to 
the header vessel, the peristaltic, heating-fluid and dosing pumps were turned off, the 
water supply to the water tank and the water-jet ejector was terminated, and the header 
vessel was allowed to empty; the milk remaining in the header vessel was allowed to 
flow through the test-chamber, flushing out the enzyme-activated milk. After a minute, 
or when the liquid level in the header vessel had dropped to about 10%, the pulsatile 
pump was turned off (if it was on-line). At this point, the fluid-content of the test-
section was unrenneted milk, and not water or activated milk. A final ultrasound image 
was recorded and the transducer and its support were removed from the test-chamber. 
The dismantling of the test-section was performed very carefully, so as not to dislodge 
any clot on the wails or test-object. A Hoffman clip was put on the tube between 
the header vessel and test-section, to prevent milk surges occurring. The exit-tubing 
of the test-section was removed and the supply of water to the top of the drain-pipe 
terminated. A steel plate was used to section-off the upper perspex pipe from the 
polypropylene test-chamber, by sliding it between their flanges (as described in section 
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6.1.10). A basin was placed directly below the test-section to collect spillage from the 
perspex pipe, when this pipe was removed from the top of the test-section. The clotted 
test-object was then delicately raised, passing through the free surface of the milk, and 
removed from the test-chamber. It was sketched and photographed, before hand-held 
digital calipers were used to measure the diameter of the clotted test-object in several 
different places, and the test-object was weighed. 
B.6 Cleansing 
The transducer was cleaned with great care, as the piezoelectric crystals are brittle and 
surface scratches on the plastic protective layer affect the focusing and the "matching" 
properties of this layer. 
The partly-disassembled test-section was cleaned with a large brush and then 
reassembled, in preparation for a thorough cleansing method. The pulsatile pump 
(if not on-line) was inserted into the milk flow line, and the system flushed with water, 
as if preparing for another experiment but with the water at 55° C. The flow to the water 
tank was stopped so that its liquid level would drop to about 15 cm. At this stage the 
pumps, water-jet ejector and heaters were turned off. The system was then rearranged 
into two cleaning loops. The outlet of the test-section exit tube was detached from 
the drain-pipe and inserted into the top of the header vessel, which now contained 
hot water. 35 g of Tergazyme, in solution, was added to the header vessel and the 
diaphragm pump started. To clean the heating and degassing section of the rig (i.e. 
the side of the rig upstream of the header vessel), the flow from the peristaltic pump 
was diverted from the top of the header vessel to the top of the water tank, which 
now contained a dilute caustic soda solution. The peristaltic pump was turned on 
to circulate this mixture, and the flow rate achieved by modifying the level controller 
setpoint and by use of the vacuum line. Some of this mixture was later used to clean 
the milk containers. The single-pass milk flow system was reinstated, after cleaning 
was complete and this system was flushed with water for about one hour. 
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